000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki|ţp|N05AX08|01.04.2000||R|||0|0|0|0|JAS|0|1|0|100|SEK|1572|3129|lyfalmen|V0045|1588||20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1572||1572|3129|
000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól||||||
000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|30826|40569|lyfsjukr||||2|0|24,0000|Icepharma hf|Roche|Epóetín||30826||30826|40569|
000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|46309|60000|lyfsjukr||||2|0|36,0000|Icepharma hf|Roche|Epóetín||46309||46309|60000|
000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||||
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|9774|14349|lyfalmen|V0457|4689||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||9774||9774|14349|
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|28488|38298|lyfalmen|V0475|18351||28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||28488||28488|38298|
000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|||0|0|0|0|ELD|0|1|0|100|XEU|37049|49042|lyfalmen|V0540|29298||28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||37049||37049|49042|
000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|19929|27556|lyfalmen|V0456|9109||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||19929||19929|27556|
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|||0|1|0|1|FER|0|0|0|100|DKK|4638|6694|lyfsjukr||||1|0|0,0400|Vistor hf|Ferring|Atosíban||4638||4638|6694|
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|||0|0|0|0|BOI|0|0|0|100|DKK|7015|13642|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||7015||7015|13642|
000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|||0|1|0|1|FER|0|0|0|100|DKK|12422|17472|lyfsjukr||||5|0|0,2300|Vistor hf|Ferring|Atosíban||12422||12422|17472|
000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|||0|1|E|0|ORG|0|0|0|100|DKK|18684|25994|lyfalmen||||0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||18684||18684|25994|
000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|||0|1|E|0|ORG|0|0|0|100|DKK|36266|48059|lyfalmen||||1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||36266||36266|48059|
000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|||0|0|E|0|MSD|0|0|0|100|DKK|4931|7724|lyfalmen||||6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||4931||4931|7724|
000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|||0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr||||10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657|
000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|||0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr||||5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139|
000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|3027|5120|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||||3027|5120|
000530|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|||0|0|0|0|SPM|0|0|0|100|XEU|25812|34939|lyfalmen||||10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||25812||25812|34939|
000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|||0|0|E|0|LTH|0|0|0|100|SEK|1770|3400|lyfalmen||||5|0||Vistor hf|Laboratoires THEA|Ketotifen||1770||1770|3400|
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|4507|7144|lyfalmen||||2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4507||4507|7144|
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|||0|0|E|0|JAS|0|0|0|100|SEK|3604|5909|lyfalmen||||60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3604||3604|5909|
000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|||0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Laboratoires THEA|Ketotifen||||||
000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|||0|0|E|0|LTH|0|0|0|100|SEK|5255|8167|lyfalmen||||24|0||Vistor hf|Laboratoires THEA|Ketotifen||5255||5255|8167|
000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|6565|9475|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Fitusambönd||6565||6565|9475|
000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|2841|4865|lyfalmen||||30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||2841||2841|4865|
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|3498|5764|lyfalmen||||2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3498||3498|5764|
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||||
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||||
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|||0|1|0|1|MSE|0|0|0|100|SEK|165999|210211|lyfsjukr||||6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||165999||165999|210211|
000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|20726|27894|lyfsjukr||||1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||20726||20726|27894|
001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|||0|1|0|1|ORG|0|0|0|100|DKK|5289|7633|lyfsjukr||||0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||5289||5289|7633|
001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|||0|0|E|0|PER|0|0|1|100|DKK|1350|2826|lyfalmen|V0037|2271||10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1350||1350|2826|
001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|5896|9044|lyfalmen||||30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5896||5896|9044|
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|19508|27028|lyfalmen|V0115|18735||100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||19508||19508|27028|
001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|||0|0|B|0|AZD|0|0|0|100|SEK|2303|4129|lyfalmen||||100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2303||2303|4129|
001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|||0|1|0|1|ORG|0|0|0|100|DKK|26444|35070|lyfsjukr||||2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||26444||26444|35070|
001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|2374|1787|lyfalmen|V0278|1787||28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||591||591|1787|
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|5662|8724|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5662||5662|8724|
001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|||0|0|E|0|SNO|0|0|0|100|NOK|4079|6559|lyfalmen||||100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4079||4079|6559|
001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|||0|0|0|0|ACA|0|1|0|100|IKR|883|2187|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2187|
001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|2456|4339|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4339|
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|||0|0|0|1|FRP|0|0|0|100|DKK|20380|27459|lyfsjukr||||4104|0||Icepharma hf|Fresenius Kabi|Blöndur||20380||20380|27459|
001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|||0|0|E|0|VIF|0|0|1|100|CHF|14193|20357|lyfalmen|V0034|18077||25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíđ (sykurflétta)||14193||14193|20357|
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|||0|0|0|1|FRP|0|0|0|100|DKK|29696|39151|lyfsjukr||||6160|0||Icepharma hf|Fresenius Kabi|Blöndur||29696||29696|39151|
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|||0|0|0|1|NOH|0|0|0|100|DKK|2247|3243|lyfsjukr||||10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2247||2247|3243|
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|||0|0|*|0|ALC|0|0|0|100|USD|4088|6571|lyfalmen|V0444|6571||15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíđ||4088||4088|6571|
001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|827|2110|lyfalmen|V0004|418||7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||827||827|2110|
001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|1946|3373|lyfalmen|V0291|3373||60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1750||1750|3373|
001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|6936|10467|lyfalmen|V0294|10467||60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10467|
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|||0|0|0|0|BIG|0|0|1|100|SEK|4238|6776|lyfalmen||||45|0||Icepharma hf|Bioglan AB|Capsaicin||4238||4238|6776|
001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|3353|5566|lyfalmen|V0292|5566||60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5566|
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|4308|6872|lyfalmen|V0004|1671||28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4308||4308|6872|
001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|5263|8178|lyfalmen|V0293|8178||60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8178|
001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|8553|12679|lyfalmen|V0011|2864||56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8553||8553|12679|
002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|1358|2837|lyfalmen|V0005|442||7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1358||1358|2837|
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|6028|9225|lyfalmen|V0005|1768||28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6028||6028|9225|
002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|5259|8173|lyfalmen||||100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5259||5259|8173|
002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|5279|8200|lyfalmen|V0011|2557||50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5279||5279|8200|
002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|23991|31991|lyfsjukr||||5760|0||Icepharma hf|Fresenius Kabi|Blöndur||23991||23991|31991|
002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|13110|7103|lyfalmen|V0011|5114||100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4477||4477|7103|
002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|9614|14130|lyfalmen|V0012|2557||50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9614||9614|14130|
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|||0|0|*|0|NAS|0|0|0|100|DKK|2900|4946|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2900||2900|4946|
002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|17433|24424|lyfalmen|V0012|5114||100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||17433||17433|24424|
002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003|31.08.2012|L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||||
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|||0|0|B|0|MSD|0|0|0|100|DKK|15909|22511|lyfalmen|V0492|18379||98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||15909||15909|22511|
002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|99171|126342|lyfsjukr||||1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||99171|126342|
002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|50549|65321|lyfsjukr||||1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||50549|65321|
002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|26170|34726|lyfsjukr||||1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||26170|34726|
002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|||0|0|0|0|BYP|0|0|0|100|SEK|3162|5304|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||||3162|5304|
002413|G03AA1204|Yasmin 28|töflur|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2007||R|||0|0|0|0|BYP|0|0|0|100|SEK|3162|5304|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3162||3162|5304|
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín||||||
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín||||||
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||R|||0|0|E|0|ACA|0|0|1|100|XEU|1538|2202|lyfalmen|V0362|2176||100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín||894||894|2202|
002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000|31.07.2012|R|||0|1|0|1|NOO|0|0|0|100|DKK|218235|275767|lyfsjukr||||1|0||Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||218235||218235|275767|
002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|SEK|3420|5966|vetorma||||10|0||Icepharma hf|Bayer Animal Health GmbH|||3420||3420|5966|
002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|||0|0|*|0|SAO|0|0|0|100|XEU|1168|2577|lyfalmen||||5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1168||1168|2577|
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|||0|1|0|1|ALL|0|0|0|100|SEK|30044|39588|lyfsjukr||||1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||30044||30044|39588|
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|||0|0|0|0|MSD|0|0|0|100|DKK|13148|14338|lyfalmen|V0089|2627||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||9766||9766|14338|
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|9719|14274|lyfalmen|V0515|5515||100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||9719||9719|14274|
003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|||0|1|0|1|ZEP|0|0|0|100|DKK|228609|288787|lyfsjukr||||2|0||Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||228609||228609|288787|
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|16780|23604|lyfalmen|V0253|8411||100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||16780||16780|23604|
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|32603|43462|lyfalmen|V0516|16359||100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||32603||32603|43462|
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|||0|1|*|0|PFP|0|0|0|100|SEK|10178|14902|lyfalmen||||1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||10178||10178|14902|
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|||0|1|*|0|PFP|0|0|0|100|SEK|15130|21533|lyfalmen||||1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||15130||15130|21533|
003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|||0|0|0|1|BYP|0|0|0|100|SEK|187953|237764|lyfsjukr||||150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||187953||187953|237764|
003310|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|||0|0|0|0|AZD|0|0|0|100|SEK|9200|13564|lyfalmen|V0356|12394||120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9200||9200|13564|
003325|R03AK0702|Symbicort mite Turbuhaler|innúđadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|||0|0|0|0|AZD|0|0|0|100|SEK|8528|12645|lyfalmen||||120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8528||8528|12645|
003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|ţpakki||L04AA10|01.04.2004||R|||0|1|*|0|WTE|0|0|0|100|DKK|55237|71868|lyfalmen|V0567|71868||100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||55237||55237|71868|
003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|4339|6914|lyfalmen||||28|0|14,0000|Icepharma hf|Takeda Europe -|Píóglítazón||4339||4339|6914|
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|||0|0|E|0|PER|0|0|0|100|DKK|3005|5090|lyfalmen||||60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3005||3005|5090|
003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|14991|21359|lyfalmen|V0572|17349||98|0|49,0000|Icepharma hf|Takeda Europe -|Píóglítazón||14991||14991|21359|
003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|6563|9957|lyfalmen||||28|0|28,0000|Icepharma hf|Takeda Europe -|Píóglítazón||6563||6563|9957|
003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|22399|30656|lyfalmen|V0573|25775||98|0|98,0000|Icepharma hf|Takeda Europe -|Píóglítazón||22399||22399|30656|
003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|||0|0|E|0|SCP|0|0|1|100|DKK|815|2094|lyfalmen||||10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||815||815|2094|
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|||0|0|0|0|ACA|0|1|0|100|IKR|1017|2049|lyfalmen|V0151|2039||28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|2049|
003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|||0|0|E|0|NOH|0|0|1|100|DKK|549|1730|lyfalmen||||20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||549||549|1730|
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|2389|4247|lyfalmen|V0322|4247||98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||2389||2389|4247|
003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|5|glös|80 + 20 mg/ml|J05AE06|01.08.2003||R|||0|1|0|1|ABL|0|0|0|100|DKK|67906|87105|lyfsjukr||||300|0|30,0000|Vistor hf|Abbott Laboratories A/S|Lopinavír||67906||67906|87105|
003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|||0|0|E|0|NOH|0|0|1|100|DKK|1987|3697|lyfalmen|V0469|2387||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1987||1987|3697|
004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|||0|0|0|1|NOH|0|0|0|100|DKK|20372|27449|lyfsjukr||||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||20372||20372|27449|
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|7395|11095|lyfalmen||||250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7395||7395|11095|
004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||||||
004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|||0|0|B|0|GSK|0|0|0|100|GBP|4105|6594|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4105||4105|6594|
004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|||0|0|0|0|PER|0|1|0|100|DKK|553|1735|lyfalmen||||7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||553||553|1735|
004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|||0|0|0|0|MAB|0|0|1|100|DKK|990|2333|lyfalmen||||30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||990||990|2333|
004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|||0|0|0|0|PER|0|1|0|100|DKK|5113|7973|lyfalmen||||14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5113||5113|7973|
004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|||0|0|0|0|GSK|0|0|0|100|GBP|7584|11353|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7584||7584|11353|
004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|||0|0|0|0|GSK|0|0|0|100|GBP|10653|15552|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10653||10653|15552|
004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|593|1790|lyfalmen|V0366|777||10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||593||593|1790|
004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|5538|8555|lyfalmen||||66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||5538||5538|8555|
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|19682|26583|lyfsjukr||||1|0|0,5000|Icepharma hf|Pfizer ApS|Voricónazól||19682||19682|26583|
004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|1546|3094|lyfalmen|V0366|2332||30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1546||1546|3094|
004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|||0|0|E|0|GSK|0|0|0|100|GBP|7086|10672|lyfalmen|V0381|4946||10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7086||7086|10672|
004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|4328|6899|lyfalmen|V0458|6010||100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4328||4328|6899|
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|||0|0|0|0|BOI|0|0|0|100|DKK|4481|8777|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||4481||4481|8777|
004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|3034|5129|lyfalmen||||56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3034||3034|5129|
004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|||0|0|B|0|REP|0|0|0|100|SEK|634|1846|lyfalmen||||100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||634||634|1846|
004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|4046|6514|lyfalmen|V0226|2608||56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4046||4046|6514|
004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|5715|8797|lyfalmen|V0227|3963||56|0|28,0000|Icepharma hf|Norpharma |Tramadól||5715||5715|8797|
004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|7607|11385|lyfalmen|V0228|5094||56|0|37,3333|Icepharma hf|Norpharma |Tramadól||7607||7607|11385|
004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|||0|0|0|0|GSK|0|0|0|100|GBP|2176|3956|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||2176||2176|3956|
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|||0|0|*|0|AVP|0|0|0|100|NOK|3429|3084|lyfalmen|V0494|3084||90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1539||1539|3084|
004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|2556|4475|lyfalmen|V0318|3615||100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4475|
004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|||0|1|0|1|EMA|0|0|0|100|SEK|35587|46544|lyfsjukr||||1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||35587||35587|46544|
004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|||0|0|0|0|AGT|0|0|1|100|DKK|1325|2791|lyfalmen||||25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1325||1325|2791|
004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dćla|einnotadćl|J07BC01|01.01.1990||R|||0|0|0|0|GSK|0|0|0|100|GBP|3212|5373|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||3212||3212|5373|
004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|0|0|ACA|0|1|0|100|IKR|1836|2164|lyfalmen|V0071|2164||28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2164|
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|0|0|ACA|0|1|0|100|IKR|5614|7418|lyfalmen|V0320|6407||100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||4707||4707|7418|
004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|0|0|ACA|0|1|0|100|IKR|776|2040|lyfalmen|V0062|1753||28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||776||776|2040|
004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|2703|4676|lyfalmen|V0317|3823||100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4676|
004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|926|1921|lyfalmen|V0067|1644||28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||689||689|1921|
004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|||0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen||||100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1711|
004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|||0|1|0|1|BIA|0|0|0|100|DKK|35608|46571|lyfsjukr||||5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||35608||35608|46571|
004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|1778|3411|lyfalmen|V0318|2024||56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3411|
004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan||||||
004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|||0|1|0|1|EMA|0|0|0|100|SEK|177934|225190|lyfsjukr||||5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||177934||177934|225190|
004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|||0|0|*|0|SDE|0|0|0|100|NOK|10173|14895|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10173||10173|14895|
004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|6430|7023|lyfalmen|V0250|4404||100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||4418||4418|7023|
004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|8308|3919|lyfalmen|V0251|3919||100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||2149||2149|3919|
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|607|1809|lyfalmen||||24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||607||607|1809|
004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|13897|6929|lyfalmen|V0282|6752||56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||4350||4350|6929|
004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|||0|0|0|1|PER|0|0|0|100|DKK|5060|7303|lyfsjukr||||1|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5060||5060|7303|
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|||0|0|0|0|AGT|0|0|1|100|DKK|349|1456|lyfalmen|V0352|684||8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||349||349|1456|
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|||0|0|0|0|AGT|0|0|1|100|DKK|613|1817|lyfalmen|V0352|1197||14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||613||613|1817|
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|||0|0|0|0|AGT|0|0|1|100|DKK|1160|2566|lyfalmen|V0352|2566||30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1160||1160|2566|
005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|1762|3389|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1762||1762|3389|
005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|2163|3938|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||||2163|3938|
005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|||0|0|E|0|ASP|0|0|0|100|XEU|8188|6681|lyfalmen|V0148|3837||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4168||4168|6681|
005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|2070|3811|lyfalmen||||30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2070||2070|3811|
005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|2385|4241|lyfalmen||||20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2385||2385|4241|
005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|3260|5438|lyfalmen||||30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||3260||3260|5438|
005241|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|||0|0|0|0|AZD|0|0|0|100|SEK|27599|37182|lyfalmen|V0356|37182||360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27599||27599|37182|
005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|||0|0|0|0|AZA|0|1|0|100|SEK|50708|66184|lyfalmen|V0287|56533||100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||50708||50708|66184|
005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|||0|0|E|0|ASZ|0|0|0|100|SEK|3326|5529|lyfalmen||||10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3326||3326|5529|
005330|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|||0|0|E|0|LEP|0|0|1|100|DKK|1052|2418|lyfalmen||||2|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1052||1052|2418|
005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.04.1996||R|||0|1|*|0|AZA|0|0|0|100|SEK|61332|79517|lyfalmen|V0451|76945||1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||61332||61332|79517|
005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|||0|0|B|0|BOI|0|0|0|100|DKK|1388|2878|lyfalmen||||200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1388||1388|2878|
005503|N05AH0301|Zyprexa|húđuđtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|*|0|ELD|0|1|0|100|XEU|27600|17133|lyfalmen|V0283|8475||28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||11809||11809|17133|
005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|||0|0|0|0|ELD|0|1|0|100|XEU|35102|46598|lyfalmen||||28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||35102||35102|46598|
005538|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.06.1977||R|||0|0|0|0|BAP|0|0|0|100|SEK|1228|2659|lyfalmen|V0545|2656||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1228||1228|2659|
005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0||Actavis Group hf|Actavis hf|Slímlosandi lyf nema slímţynnir (mucolytica)- guaifenesin||||||
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|||0|0|0|0|BII|0|0|0|100|DKK|5846|8976|lyfalmen||||30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||5846||5846|8976|
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|||0|0|0|0|BII|0|0|0|100|DKK|6161|9407|lyfalmen||||30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||||6161|9407|
005606|J07AH0703|NeisVac-C|bóluefni|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|||0|0|0|0|BAX|0|0|0|100|USD|4109|6600|lyfalmen||||0|0||Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4109||4109|6600|
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|1492|3020|lyfalmen||||30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1492||1492|3020|
005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|2601|4537|lyfalmen|V0020|3475||60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||2601||2601|4537|
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|6906|10426|lyfalmen|V0020|10426||180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||6906||6906|10426|
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|3795|6170|lyfalmen|V0020|5213||90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||3795||3795|6170|
005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra||||||
005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|1670|3263|lyfalmen||||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1670||1670|3263|
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|6207|8545|lyfalmen|V0324|2466||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5531||5531|8545|
005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|2943|4697|lyfalmen|V0035|3462||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2718||2718|4697|
005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|||0|0|0|0|MEF|0|0|0|100|XEU|16759|29235|vetorma||||5|0||Vistor hf|Merial (MSD)|||16759||16759|29235|
005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|5850|8981|lyfalmen|V0325|2662||56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5850||5850|8981|
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|9870|13334|lyfalmen|V0325|4753||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9032||9032|13334|
005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|4727|7053|lyfalmen||||28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4440||4440|7053|
005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008|31.07.2012|R|||0|0|0|0|BII|0|0|0|100|DKK|3036|5132|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3036||3036|5132|
005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|ţpakki||P01BC02|01.01.1993||R|||0|0|0|0|ROC|0|0|0|100|DKK|3264|5444|lyfalmen||||8|0|2,0000|Icepharma hf|Roche|Meflókvín||3264||3264|5444|
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|||0|0|*|0|ELD|0|1|0|100|XEU|824|2106|lyfalmen||||1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||824||824|2106|
005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008|31.07.2012|R|||0|0|0|0|BII|0|0|0|100|DKK|10408|15217|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||10408||10408|15217|
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|15280|19660|lyfalmen|V0326|4623||100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13637||13637|19660|
005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|3334|5540|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3334||3334|5540|
005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|6038|8251|lyfalmen|V0246|4277||28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5316||5316|8251|
005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|8819|11736|lyfalmen|V0072|3003||98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||7864||7864|11736|
005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|11831|17163|lyfalmen|V0327|2589||56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||11831||11831|17163|
005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|4381|6972|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4381||4381|6972|
005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|11986|16543|lyfalmen|V0073|3073||98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||11378||11378|16543|
006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|||0|1|0|1|NYC|0|0|0|100|DKK|78604|100531|lyfsjukr||||2|0|0,7500|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||78604||78604|100531|
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|5400|8366|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5400||5400|8366|
006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|97487|124229|lyfsjukr||||1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||97487||97487|124229|
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|||0|0|*|0|NAS|0|0|0|100|DKK|5238|8144|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5238||5238|8144|
006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|||0|1|0|1|NYC|0|0|0|100|DKK|146374|185582|lyfsjukr||||3|0|1,5000|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||146374||146374|185582|
006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|74450|95317|lyfsjukr||||1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||74450||74450|95317|
006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|||0|0|0|0|REP|0|0|1|100|SEK|2544|4459|lyfalmen||||30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2544||2544|4459|
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|||0|0|0|0|BOI|1|0|0|100|DKK|8234|15983|vetalmen||||50|0||Vistor hf|Boehringer Ingelheim|||8234||8234|15983|
006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|spr|áfyllt sprauta|B01AX05|01.07.2012||R|||0|0|E|0|GGL|0|0|0|100|GBP|6505|9877|lyfalmen||||5|0|10,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||6505||6505|9877|
006558|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.03.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|12941|18786|lyfalmen||||10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||12941||12941|18786|
006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|||0|0|B|0|LEP|0|0|0|100|DKK|6523|9902|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||6523||6523|9902|
006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
006732|A16AB0401|Fabrazyme|irţ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|||0|1|0|1|GZE|0|0|0|100|XEU|505241|635960|lyfsjukr||||35|0|35,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||505241||505241|635960|
006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|||0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa||||2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel||||||
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|||0|0|0|0|MSD|0|0|0|100|DKK|13677|19710|lyfalmen||||98|0|196,0000|Vistor hf|M.S.D.|Lósartan||13677||13677|19710|
007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|4496|7129|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4496||4496|7129|
007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|||0|0|0|0|SNO|0|1|0|100|NOK|690|1923|lyfalmen||||100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||690||690|1923|
007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|||0|0|0|0|BID|0|0|0|100|DKK|23732|45742|vetalmen||||20|0||Vistor hf|Boehringer Ingelheim Danmark|||23732||23732|45742|
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|13592|19603|lyfalmen|V0117|19603||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13592||13592|19603|
007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|||0|0|*|0|SNO|0|1|0|100|NOK|2020|3742|lyfalmen||||100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2020||2020|3742|
007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|6780|10254|lyfalmen||||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6780||6780|10254|
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|20518|28295|lyfalmen|V0118|28295||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||20518||20518|28295|
007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|||0|0|*|0|SNO|0|1|0|100|NOK|5130|7996|lyfalmen||||100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5130||5130|7996|
007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|8521|12635|lyfalmen||||28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8521||8521|12635|
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|25667|34757|lyfalmen||||98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||25667||25667|34757|
007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|||0|1|0|1|BAX|0|0|0|100|SEK|166337|210635|lyfsjukr||||1|0||Icepharma hf|Baxter|Prótein C||166337||166337|210635|
007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|||0|1|0|1|BAX|0|0|0|100|SEK|317424|400250|lyfsjukr||||1|0||Icepharma hf|Baxter|Prótein C||317424||317424|400250|
007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|||0|0|*|0|ALL|0|0|0|100|SEK|2973|5046|lyfalmen|V0377|4317||3|0|30,0000|Vistor hf|Allergan|Bimatóprost||2973||2973|5046|
007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|91781|117068|lyfsjukr||||3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||91781||91781|117068|
007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983||L|||0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa||||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||||||
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|262392|331184|lyfsjukr||||30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||262392||262392|331184|
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|3017|5106|lyfalmen|V0374|4102||2|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3017||3017|5106|
007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|||0|0|0|1|CPS|0|0|0|100|SEK|8545|12333|lyfsjukr||||50|0||Icepharma hf|Clintec parenteral SA|Vítamín||8545||8545|12333|
007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|||0|0|0|1|OPO|0|0|0|100|XEU|110468|140520|lyfsjukr||||100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||110468||110468|140520|
007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|||0|0|0|1|ABS|0|0|0|100|DKK|21834|29284|lyfsjukr||||250|0||Vistor hf|Abbott Scandinavia AB|Sevóflúran||21834||21834|29284|
007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||L|||0|0|0|0|BAN|0|0|0|100|DKK|1839|3208|vetorma||||7|0||Icepharma hf|Bayer Animal Health GmbH|||||1839|3208|
007505|G04BD0702|Detrusitol Retard|forđahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|5833|8958|lyfalmen||||30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||5833||5833|8958|
007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.1998||R|||0|0|0|0|AZD|0|0|0|100|SEK|3616|5925|lyfalmen|V0079|5925||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3616||3616|5925|
007538|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|||0|0|B|0|SPL|0|0|0|100|DKK|4630|7313|lyfalmen||||30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||4630||4630|7313|
007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|||0|0|0|1|BRS|0|0|0|100|DKK|4196|6056|lyfsjukr||||1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4196||4196|6056|
007541|J07BL0101|Stamaril|bóluefni|||0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|20064|27725|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||20064||20064|27725|
007549|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|||0|0|B|0|SPL|0|0|0|100|DKK|9024|13323|lyfalmen||||60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||9024||9024|13323|
007760|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|5989|9172|lyfalmen||||30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||5989||5989|9172|
007769|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|20331|28061|lyfalmen||||100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||20331||20331|28061|
007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|||0|0|*|0|ACA|0|1|0|100|IKR|1728|3099|lyfalmen|V0290|3099||60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1550||1550|3099|
007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|||0|0|0|0|ORG|0|0|0|100|DKK|3737|6091|lyfalmen||||3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||3737||3737|6091|
007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|||0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa||||2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|||0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa||||5000|0||Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|||0|0|0|0|ALC|0|0|0|100|USD|1306|2765|lyfalmen||||5|0||K.Pétursson hf|Alcon|Ólópatadín||1306||1306|2765|
007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002|30.06.2012|R|||0|1|0|1|ELD|0|0|0|100|XEU|185394|234552|lyfsjukr||||1|0|0,5000|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||185394||185394|234552|
007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|||0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa||||15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||||
007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|||0|1|0|1|AGA|0|0|0|100|XEU|19158|25926|lyfsjukr||||10|0||Ísaga ehf|AGA AB|Nituroxíđ||19158||19158|25926|
007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|||0|0|E|0|LOL|0|0|1|100|IKR|729|1976|lyfalmen||||30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|1976|
008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002|30.06.2012|R|||0|1|0|1|ELD|0|0|0|100|XEU|46355|60058|lyfsjukr||||1|0|0,1300|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||46355||46355|60058|
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|||0|0|*|0|MCK|0|0|0|100|SEK|602|1802|lyfalmen||||30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||602||602|1802|
008058|B05BA1011|Oliclinomel N4 550E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|23566|31458|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||23566||23566|31458|
008069|B05BA1011|Oliclinomel N4 550E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|29238|38576|lyfsjukr||||8000|0||Icepharma hf|Baxter Medical AB|Blöndur||29238||29238|38576|
008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|||0|0|E|0|MSD|0|0|0|100|DKK|5143|8014|lyfalmen||||6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5143||5143|8014|
008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|51572|66605|lyfsjukr||||4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||51572||51572|66605|
008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|103144|131328|lyfsjukr||||4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||103144||103144|131328|
008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|||0|1|0|1|SCP|0|0|0|100|DKK|82194|105036|lyfsjukr||||4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||82194||82194|105036|
008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|||0|1|0|1|SCP|0|0|0|100|DKK|121591|154479|lyfsjukr||||4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||121591||121591|154479|
008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|142834|181139|lyfsjukr||||4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||142834||142834|181139|
008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|||0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||||
008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|||0|0|B|0|ASP|0|0|1|100|XEU|1425|2928|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1425||1425|2928|
008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|||0|0|B|0|GSK|0|0|1|100|GBP|286|1370|lyfalmen||||20|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||286||286|1370|
008223|B05BA1013|Oliclinomel N6 900E|irl|||1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|36461|47641|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||36461||36461|47641|
008234|B05BA1013|Oliclinomel N6 900E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|28550|37713|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||28550||28550|37713|
008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|||0|0|B|0|GSK|0|0|1|100|GBP|558|1742|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||558||558|1742|
008245|B05BA1013|Oliclinomel N6 900E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|33359|43748|lyfsjukr||||8000|0||Icepharma hf|Baxter Medical AB|Blöndur||33359||33359|43748|
008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|833|1976|lyfalmen||||20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||729||729|1976|
008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|||0|0|B|0|GSK|0|0|1|100|GBP|1260|2703|lyfalmen||||100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1260||1260|2703|
008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|2689|4657|lyfalmen|V0226|4657||100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||2689||2689|4657|
008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|4457|7076|lyfalmen|V0227|7076||100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||4457||4457|7076|
008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|6015|9096|lyfalmen|V0228|9096||100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||5934||5934|9096|
008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|||0|1|0|1|GEZ|0|0|0|100|XEU|143595|182094|lyfsjukr||||2|0||Vistor hf|Genzyme BV|Thýrótrópín||143595||143595|182094|
008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|||0|0|B|0|MKA|0|0|0|100|SEK|815|2094|lyfalmen|V0153|2066||100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||815||815|2094|
008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|||0|0|B|0|MKA|0|0|0|100|SEK|709|1949|lyfalmen|V0154|1949||100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||709||709|1949|
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|||0|0|0|0|CHP|0|0|0|100|USD|5035|8783|vetorma||||1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5035||5035|8783|
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|||0|0|0|0|CHP|1|0|0|100|XEU|11858|22942|vetalmen||||50|0||Icepharma hf|Chanelle Pharmaceuticals |||11858||11858|22942|
008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.09.2012||R|||0|0|E|0|RGM|0|0|1|100|XEU|2148|3332|lyfalmen|V0575|3332||100|0|100,0000|Medical ehf|ratiopharm GmbH|Cetirizín||1720||1720|3332|
008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|||0|0|E|0|NAS|0|0|0|100|DKK|2699|4671|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2699||2699|4671|
008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|ţpakki||R06AE07|01.09.2012||L|||0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Medical ehf|ratiopharm GmbH|Cetirizín||||||
008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|||0|1|0|1|RRL|0|0|0|100|DKK|101934|129810|lyfsjukr||||2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||101934||101934|129810|
008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|||0|1|0|1|RRL|0|0|0|100|DKK|107529|136831|lyfsjukr||||2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||107529||107529|136831|
008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002|31.08.2012|R|||0|0|E|0|MAB|0|0|1|100|DKK|3044|5143|lyfalmen||||15|0||Vistor hf|Meda AB|Pímekrólímus||3044||3044|5143|
008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|||0|0|0|0|PER|0|0|0|100|DKK|1808|3452|lyfalmen||||60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1808||1808|3452|
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|5642|8697|lyfalmen|V0145|8091||4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||5642|8697|
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|11114|16182|lyfalmen|V0145|16182||8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||11114|16182|
009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002|31.08.2012|R|||0|0|E|0|MAB|0|0|1|100|DKK|5136|8005|lyfalmen||||30|0||Vistor hf|Meda AB|Pímekrólímus||5136||5136|8005|
009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8184|11812|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8184||8184|11812|
009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8184|11812|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8184||8184|11812|
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|||0|0|0|0|IPI|0|0|1|100|DKK|13352|19302|lyfalmen||||10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||13352||13352|19302|
009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8184|11812|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8184||8184|11812|
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|48706|63009|lyfsjukr||||30|0|3,7500|Icepharma hf|Pfizer ApS|Voricónazól||48706||48706|63009|
009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|||0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen||||400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1757|
009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|||0|0|E|0|ASP|0|0|1|100|XEU|5086|7936|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5086||5086|7936|
009340|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1065|2436|lyfalmen||||8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1065||1065|2436|
009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1175|2586|lyfalmen|V0130|1646||8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1175||1175|2586|
009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1359|2838|lyfalmen|V0131|2409||8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1359||1359|2838|
009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1702|3307|lyfalmen|V0132|2674||8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1702||1702|3307|
009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|6922|9990|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6922||6922|9990|
009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|6922|9990|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6922||6922|9990|
009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|6922|9990|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6922||6922|9990|
009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|185928|235222|lyfsjukr||||30|0|15,0000|Icepharma hf|Pfizer ApS|Voricónazól||185928||185928|235222|
009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|||0|0|E|0|ASP|0|0|1|100|XEU|4926|7717|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||4926||4926|7717|
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|||0|1|0|1|GIS|0|0|0|100|DKK|55637|71707|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||55637||55637|71707|
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|||0|0|0|0|DPL|0|0|1|100|XEU|8133|12104|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Mepívakaín||8133||8133|12104|
009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|7655|11451|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||7655||7655|11451|
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|7511|11254|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7511||7511|11254|
009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|8803|13021|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8803||8803|13021|
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|7668|11468|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7668||7668|11468|
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|7537|11289|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Mepívakaín||7537||7537|11289|
010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|2029|3754|lyfalmen|V0329|2373||30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2029||2029|3754|
010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|3862|6262|lyfalmen|V0330|2722||30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||3862||3862|6262|
010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|5520|8530|lyfalmen||||30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5520||5520|8530|
010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|||0|0|0|1|ROA|0|0|0|100|DKK|211535|267359|lyfsjukr||||60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||211535||211535|267359|
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|6784|9791|lyfsjukr||||1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||6784||6784|9791|
010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|11989|17379|lyfalmen|V0331|4943||96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||11989||11989|17379|
010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|16905|23761|lyfalmen|V0332|8079||96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||16905||16905|23761|
010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|||0|0|E|0|LBK|0|0|0|100|DKK|13362|19314|lyfalmen||||50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||13362|19314|
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|||0|0|E|0|LBK|0|0|0|100|DKK|21662|29731|lyfalmen||||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||21662||21662|29731|
010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008|31.07.2012|R|||0|0|0|0|BII|0|0|0|100|DKK|3760|6122|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3760||3760|6122|
010348|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|||0|0|0|0|SPM|0|0|0|100|XEU|6887|10400|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||6887||6887|10400|
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|11719|17010|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||11719||11719|17010|
010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|||0|0|0|0|ELA|0|0|0|100|DKK|69152|120632|vetorma||||1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||69152||69152|120632|
010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|||0|0|B|0|TIL|0|0|0|100|SEK|6796|10275|lyfalmen||||60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6796||6796|10275|
010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|7202|10394|lyfsjukr||||2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7202||7202|10394|
010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|8605|12419|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||8605||8605|12419|
010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|||0|0|0|0|SAO|0|0|1|100|XEU|1109|2496|lyfalmen||||5|0||Icepharma hf|Santen Oy|Levófloxacín||1109||1109|2496|
010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.12.2002||R|||0|0|0|0|SNO|0|0|0|100|NOK|5438|8418|lyfalmen|V0207|1038||4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5438||5438|8418|
010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|5910|8530|lyfsjukr||||7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5910||5910|8530|
010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|9089|13118|lyfsjukr||||5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||9089||9089|13118|
010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|4021|5803|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||4021||4021|5803|
010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|2305|3327|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2305||2305|3327|
010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||||||
010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|||0|0|*|0|ALL|0|0|0|100|SEK|8752|12951|lyfalmen|V0377|12951||9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8752||8752|12951|
010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|9077|13100|lyfsjukr||||5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9077||9077|13100|
010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|RAT|0|0|0|100|XEU|2292|2842|lyfalmen|V0006|2362||56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1362||1362|2842|
010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|6516|9404|lyfsjukr||||7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6516||6516|9404|
010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|3955|5708|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3955||3955|5708|
010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|||0|0|0|0|SNO|0|0|0|100|NOK|14059|5717|lyfalmen|V0207|3113||12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3464||3464|5717|
010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|2129|3073|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2129||2129|3073|
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|||0|1|0|1|ACT|0|0|0|100|DKK|330308|416419|lyfsjukr||||56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||330308||330308|416419|
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|||0|1|0|1|ACL|0|0|0|100|DKK|330308|416419|lyfsjukr||||56|0|28,0000|Actelion Registration Ltd|Actelion Registration Ltd.|Bósentan||330308||330308|416419|
010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|||0|0|0|0|ACA|0|0|0|100|XEU|1269|1972|lyfalmen||||28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||726||726|1972|
010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|||0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa||||300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín||||||
010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|||0|0|E|0|ACA|0|0|0|100|XEU|4614|4385|lyfalmen|V0006|4217||100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||2490||2490|4385|
010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|||0|0|0|0|ACA|0|0|0|100|XEU|2975|2972|lyfalmen|V0006|2362||56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||1457||1457|2972|
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|48549|62811|lyfsjukr||||10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||48549||48549|62811|
010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|||0|0|0|1|REP|0|0|0|100|SEK|3143|4536|lyfsjukr||||10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3143||3143|4536|
010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|ţpakki||A02BC03|01.01.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|2774|4774|lyfalmen||||28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2774||2774|4774|
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|18916|26285|lyfalmen||||28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18916||18916|26285|
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|18696|26009|lyfalmen||||28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18696||18696|26009|
010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|||0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa||||50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín||||||
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|32207|42965|lyfalmen||||56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||32207||32207|42965|
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|31988|42690|lyfalmen||||56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||31988||31988|42690|
011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|||0|0|B|0|AZD|0|0|0|100|SEK|18933|26306|lyfalmen||||100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||18933||18933|26306|
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|||0|0|E|0|MSD|0|0|1|100|DKK|4225|6758|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4225||4225|6758|
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|||0|0|E|0|MSD|0|0|1|100|DKK|4390|6984|lyfalmen||||28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4390||4390|6984|
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|19009|24929|lyfalmen|V0327|4623||100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||17836||17836|24929|
011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|||0|0|E|0|MSD|0|0|1|100|DKK|1120|2511|lyfalmen||||7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1120||1120|2511|
011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002|31.08.2012|R|||0|0|0|0|ACA|0|0|0|100|XEU|761|2020|lyfalmen||||28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||761||761|2020|
011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|6933|4821|lyfalmen|V0457|4689||28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||2809||2809|4821|
011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|||0|0|*|0|LBK|0|1|0|100|DKK|11402|16576|lyfalmen||||5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11402||11402|16576|
011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|||0|0|0|0|ACA|0|0|0|100|XEU|994|2339|lyfalmen||||28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||994||994|2339|
011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|||0|0|B|0|ACA|0|0|0|100|XEU|2742|2359|lyfalmen|V0069|2359||98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1009||1009|2359|
011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|9226|13600|lyfalmen|V0357|12426||60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9226||9226|13600|
011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|||1|0|0|0|JAS|0|0|0|100|SEK|7122|10721|lyfalmen||||30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7122||7122|10721|
011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007|31.08.2012|R|||0|0|0|1|BAM|0|0|0|100|SEK|9205|13285|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Mannitól||9205||9205|13285|
011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|||1|0|0|1|PER|0|0|0|100|DKK|2277|3286|lyfsjukr||||50|0||Icepharma hf|Pfizer ApS|Esketamín||2277||2277|3286|
011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|||1|0|0|0|JAS|0|0|0|100|SEK|9348|13766|lyfalmen||||30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9348||9348|13766|
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|||0|0|0|0|CHP|1|0|0|100|XEU|1805|3590|vetalmen||||25|0||Icepharma hf|Chanelle Pharmaceuticals |||1805||1805|3590|
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|||1|0|0|1|PER|0|0|0|100|DKK|4642|6700|lyfsjukr||||20|0||Icepharma hf|Pfizer ApS|Esketamín||4642||4642|6700|
011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|||0|0|E|0|OYL|0|0|0|100|SEK|1590|3154|lyfalmen||||64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1590||1590|3154|
011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|||0|1|0|1|ROA|0|0|0|100|DKK|82726|105704|lyfsjukr||||168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||82726||82726|105704|
011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|||0|0|0|0|OCO|0|0|0|100|SEK|2802|5553|vetalmen||||1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2802||2802|5553|
011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002|31.08.2012|R|||0|0|E|0|MAB|0|0|1|100|DKK|10218|14957|lyfalmen||||60|0||Vistor hf|Meda AB|Pímekrólímus||10218||10218|14957|
011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|||0|0|0|0|ACA|0|1|0|100|IKR|1486|2049|lyfalmen|V0152|2039||28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|2049|
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|4738|6676|lyfalmen|V0323|6587||98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||4165||4165|6676|
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|||0|0|0|1|AZD|0|0|0|100|SEK|4393|6340|lyfsjukr||||20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||4393||4393|6340|
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|||0|0|0|1|AZD|0|0|0|100|SEK|2542|3669|lyfsjukr||||20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2542||2542|3669|
011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|||0|0|E|0|LBK|0|0|0|100|DKK|7483|11215|lyfalmen||||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||7483|11215|
012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|||0|1|0|1|MSD|0|0|0|100|DKK|38041|49624|lyfsjukr||||30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||38041||38041|49624|
012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003|31.08.2012|R|||0|0|E|0|GSK|0|0|0|100|GBP|13574|19581|lyfalmen||||90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||13574||13574|19581|
012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|||0|0|E|0|GSK|0|0|0|100|GBP|4532|7178|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||4532||4532|7178|
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|5622|8670|lyfalmen||||4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||5622||5622|8670|
012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|||1|0|0|0|JAS|0|0|0|100|SEK|11910|17271|lyfalmen||||30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||11910||11910|17271|
012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|||0|1|0|1|WTE|0|0|0|100|DKK|418880|527577|lyfsjukr||||1|0||Icepharma hf|Wyeth Europe|Díbótermín alfa||418880||418880|527577|
012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|||0|0|0|0|GSK|0|0|1|100|IKR|718|1961|lyfalmen||||80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1961|
012921|G03AA1301|Evra|forđapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|||0|0|0|0|JCI|0|0|0|100|SEK|4661|7355|lyfalmen||||9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4661||4661|7355|
012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|||0|0|E|0|LBI|0|0|0|100|SEK|6745|10206|lyfalmen||||30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||6745||6745|10206|
012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|3142|4404|lyfalmen|V0250|4404||100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||2504||2504|4404|
012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|3421|4560|lyfalmen|V0251|3919||100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||2618||2618|4560|
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|5779|8884|lyfalmen||||30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||5779||5779|8884|
013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|6527|12705|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||6527||6527|12705|
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|8724|12913|lyfalmen||||30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||8724||8724|12913|
013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|1643|3268|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||1643||1643|3268|
013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|||0|1|0|1|AGA|0|0|0|100|XEU|20762|27939|lyfsjukr||||2|0||Ísaga ehf|AGA AB|Nituroxíđ||20762||20762|27939|
013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|||0|0|0|1|ZLB|0|0|0|100|SEK|6986|10083|lyfsjukr||||2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||6986||6986|10083|
013259|B02BD0901|BeneFIX|sts|||250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|27690|36633|lyfsjukr||||250|0|0,5600|Icepharma hf|Wyeth Europe|Storkuţáttur IX||27690||27690|36633|
013270|B02BD0901|BeneFIX|sts|||500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|46868|60702|lyfsjukr||||500|0|1,1100|Icepharma hf|Wyeth Europe|Storkuţáttur IX||46868||46868|60702|
013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|||0|0|E|0|ANO|0|0|0|100|XEU|3155|4456|lyfalmen|V0042|4456||100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2542||2542|4456|
013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|4286|8402|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||4286||4286|8402|
013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|10002|19378|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||10002||10002|19378|
013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|1049|2087|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||1049||1049|2087|
013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BAL|0|0|0|100|SEK|148757|188573|lyfsjukr||||1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||148757|188573|
013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|||0|1|0|1|AZD|0|0|0|100|SEK|405527|451019|lyfsjukr||||30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||357878||357878|451019|
013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|26165|34720|lyfsjukr||||1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||26165|34720|
013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|99171|126342|lyfsjukr||||1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||99171|126342|
013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|50549|65321|lyfsjukr||||1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||50549|65321|
013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|5079|7927|lyfalmen||||28|0||Vistor hf|M.S.D.|Ezetimíb||5079||5079|7927|
013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003||R|||0|0|0|0|MSD|0|0|0|100|DKK|17293|24248|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb||17293||17293|24248|
013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|||1|0|0|0|NOP|0|0|0|100|DKK|1232|2664|lyfalmen||||5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1232||1232|2664|
013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen||||90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1510|
013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|||1|0|0|0|NOP|0|0|0|100|DKK|2356|4202|lyfalmen||||10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2356||2356|4202|
013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|||0|0|E|0|SNO|0|0|0|100|NOK|1398|2815|lyfalmen||||40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1342||1342|2815|
013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|406|1534|lyfalmen||||30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||406||406|1534|
013718|M05BA0801|Zometa|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|35049|45869|lyfsjukr||||5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||35049||35049|45869|
013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|||0|0|0|0|NOH|0|0|0|100|DKK|4399|6997|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4399||4399|6997|
013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|904|2216|lyfalmen||||1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||904|2216|
013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|||0|0|0|0|GSK|0|0|1|100|IKR|1215|2641|lyfalmen|V0168|2641||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2641|
013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|5813|8931|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||5813||5813|8931|
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|||0|0|*|0|NAS|0|0|0|100|DKK|2421|4291|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2421||2421|4291|
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|||0|0|*|0|NAS|0|0|0|100|DKK|4342|6919|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4342||4342|6919|
013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.06.2012||R|||0|1|0|1|NOE|0|0|0|100|DKK|166431|210753|lyfsjukr||||60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||166431||166431|210753|
013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|353786|445884|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||353786||353786|445884|
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|||0|0|*|0|NAS|0|0|0|100|DKK|2343|4184|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2343||2343|4184|
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|||0|0|0|1|AZD|0|0|0|100|SEK|8987|12970|lyfsjukr||||50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8987||8987|12970|
014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|||0|0|0|0|UCB|0|0|0|100|DKK|16999|23879|lyfalmen||||300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||16999||16999|23879|
014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|||0|0|0|0|ELD|0|0|0|100|XEU|53568|69773|lyfalmen||||3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||53568||53568|69773|
014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|27905|36903|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||27905||27905|36903|
014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|sk|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|||0|0|0|0|AZD|0|0|0|100|SEK|27676|37279|lyfalmen|V0357|37279||180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27676||27676|37279|
014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|||0|0|0|0|IGB|0|0|0|100|SEK|1538|3083|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1538||1538|3083|
014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||4|0||Vistor hf|McNeil Sweden AB|Levókabastín||||||
014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|18536|25145|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||18536||18536|25145|
014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|24265|32335|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||24265||24265|32335|
014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|||0|0|0|0|PCO|0|0|1|100|NOK|2516|4421|lyfalmen||||100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2516||2516|4421|
014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|||0|0|0|0|VET|0|0|0|100|XEU|2145|4267|vetalmen||||45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2145|4267|
014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|||0|0|0|0|BOY|0|0|0|100|SEK|18338|25559|lyfalmen||||1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||18338||18338|25559|
014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|||0|1|0|1|GIS|0|0|0|100|DKK|77514|99163|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||77514|99163|
014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|||0|0|0|0|PAL|0|0|0|100|XEU|5333|10413|vetalmen||||24|0||Icepharma hf|Pfizer Oy Animal Health|||5333||5333|10413|
014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|225872|285352|lyfsjukr||||60|0|36,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíđ||225872||225872|285352|
014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|||1|0|E|0|NOP|0|0|0|100|DKK|2153|3924|lyfalmen||||28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2153||2153|3924|
014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|1331|2800|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||1331||1331|2800|
014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|||0|1|0|1|AEU|0|0|0|100|DKK|59036|75973|lyfsjukr||||2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||59036||59036|75973|
014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|||0|1|0|1|AEU|0|0|0|100|DKK|94455|120424|lyfsjukr||||2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||94455||94455|120424|
014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|||0|0|E|0|MYL|0|0|0|100|SEK|875|2176|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||||875|2176|
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|18089|25247|lyfalmen||||60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||18089||18089|25247|
014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|||0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa||||20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350||||||
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|54584|71048|lyfalmen||||60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||54584||54584|71048|
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|36333|48143|lyfalmen||||60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||36333||36333|48143|
015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|||0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa||||90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín||||||
015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|||0|0|E|0|MAB|0|0|1|100|SEK|765|2025|lyfalmen||||10|0|17,8571|Vistor hf|Meda AB|Azelastínum||765||765|2025|
015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|||0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa||||270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín||||||
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|||0|0|B|0|ACA|0|1|0|100|XEU|2991|5070|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||2991||2991|5070|
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|||0|0|*|0|NAS|0|0|0|100|DKK|8060|12005|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8060||8060|12005|
015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|||0|0|0|0|ACA|0|1|0|100|XEU|1035|2373|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1019||1019|2373|
015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|||0|0|E|0|LOL|0|0|1|100|IKR|2760|4754|lyfalmen||||100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4754|
015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|||0|0|E|0|NOH|0|0|0|100|DKK|1021|2376|lyfalmen|V0129|1665||8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1021||1021|2376|
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|||0|0|E|0|GSK|0|0|0|100|GBP|1918|2545|lyfalmen|V0234|2246||6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1145||1145|2545|
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|||0|0|E|0|GSK|0|0|0|100|GBP|2740|2921|lyfalmen|V0233|2681||12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1420||1420|2921|
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|||0|0|*|0|NAS|0|0|0|100|DKK|9603|14115|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||9603||9603|14115|
015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|||0|1|0|1|PAM|0|0|0|100|DKK|323913|408393|lyfsjukr||||1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||323913||323913|408393|
015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|||0|1|0|1|PAM|0|0|0|100|DKK|86094|109930|lyfsjukr||||1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||86094||86094|109930|
015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|4979|7790|lyfalmen||||30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4979||4979|7790|
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|12659|18432|lyfalmen||||100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12659||12659|18432|
015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|4979|7790|lyfalmen||||30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4979||4979|7790|
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|13684|19719|lyfalmen||||100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13684||13684|19719|
015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|||0|1|0|1|BRS|0|0|0|100|DKK|66042|84765|lyfsjukr||||60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||66042||66042|84765|
015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|||0|1|0|1|BRS|0|0|0|100|DKK|66042|84765|lyfsjukr||||60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||66042||66042|84765|
015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|||0|1|0|1|BRS|0|0|0|100|DKK|57428|73955|lyfsjukr||||60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||57428||57428|73955|
015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|4979|7790|lyfalmen||||30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4979||4979|7790|
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|12525|18264|lyfalmen||||100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12525||12525|18264|
015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|||0|1|0|1|BRS|0|0|0|100|DKK|66042|84765|lyfsjukr||||60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||66042||66042|84765|
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|||0|1|*|0|NOH|0|0|0|100|DKK|21177|29122|lyfalmen||||120|0|10,8000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||21177||21177|29122|
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|||0|1|*|0|NOH|0|0|0|100|DKK|44110|57903|lyfalmen||||120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||44110||44110|57903|
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2987|5211|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||2987||2987|5211|
015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|4197|7321|vetorma||||12|0||Icepharma hf|Bayer Animal Health GmbH|||4197||4197|7321|
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2665|4649|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||2665||2665|4649|
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3341|5828|vetorma||||3|0||Icepharma hf|Bayer Animal Health GmbH|||3341||3341|5828|
015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|||0|0|B|0|SGM|0|0|0|100|DKK|4257|6802|lyfalmen|V0200|5185||50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4257||4257|6802|
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3743|6529|vetorma||||8|0||Icepharma hf|Bayer Animal Health GmbH|||3743||3743|6529|
015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|||0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa||||100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól||||||
015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|||0|0|E|0|ASP|0|0|1|100|XEU|1880|3551|lyfalmen||||10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||1880|3551|
015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|||0|0|E|0|ASP|0|0|1|100|XEU|2112|3868|lyfalmen||||10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2112||2112|3868|
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|||1|0|0|0|MAP|0|0|0|100|GBP|1555|3106|lyfalmen||||10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1555||1555|3106|
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2987|5211|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||2987||2987|5211|
015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|||0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa||||60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól||||||
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|||0|0|0|0|GSK|0|1|0|100|GBP|1985|3694|lyfalmen||||28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1985||1985|3694|
016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|||0|0|0|0|AZD|0|0|0|100|SEK|14742|21046|lyfalmen|V0117|20003||100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14742||14742|21046|
016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|||1|0|0|0|MAP|0|0|0|100|GBP|1155|2559|lyfalmen||||10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1155||1155|2559|
016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|||0|0|0|0|AZD|0|0|0|100|SEK|22074|30248|lyfalmen|V0118|28872||100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||22074||22074|30248|
016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|||1|0|0|0|MAP|0|0|0|100|GBP|1225|2655|lyfalmen||||20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1225||1225|2655|
016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.05.2001||R|||0|0|E|0|ALM|0|0|0|100|SEK|2521|4428|lyfalmen|V0236|3794||3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2521||2521|4428|
016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|||24|stk|1|ţpakki||R02AA03|01.10.2005|31.07.2012|L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|2492|4388|lyfalmen||||14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2492||2492|4388|
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|6273|9560|lyfalmen||||56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6273||6273|9560|
016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|||0|1|E|0|MSE|0|0|0|100|SEK|5085|7935|lyfalmen||||0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5085||5085|7935|
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|9513|13992|lyfalmen||||56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||9513||9513|13992|
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|1643|3226|lyfalmen||||14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1643||1643|3226|
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|13819|19888|lyfalmen||||56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||13819||13819|19888|
016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|||0|0|B|0|NOH|0|0|0|100|DKK|8295|12326|lyfalmen||||100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||8295||8295|12326|
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|||0|0|0|1|PER|0|0|0|100|DKK|90264|115164|lyfsjukr||||70|0|7,0000|Icepharma hf|Pfizer ApS|Voricónazól||90264||90264|115164|
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|||0|1|0|1|PER|0|0|0|100|DKK|3997|5769|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3997||3997|5769|
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|2452|4333|lyfalmen||||56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2452||2452|4333|
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|||0|0|0|0|OTS|0|1|0|100|DKK|16487|23236|lyfalmen||||28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||16487||16487|23236|
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|||0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen||||250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7371|
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|||0|0|0|0|OTS|0|1|0|100|DKK|32207|42965|lyfalmen||||56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||32207||32207|42965|
016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|||0|0|0|0|LPM|0|0|1|100|IKR|1026|2367|lyfalmen|V0169|2367||12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2367|
016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|||0|1|0|1|ROC|0|0|0|100|DKK|173637|219797|lyfsjukr||||2|0|120,0000|Icepharma hf|Roche|Epóetín||173637||173637|219797|
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|7350|11033|lyfalmen||||30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||7350||7350|11033|
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|||0|0|E|0|LVR|0|0|0|100|DKK|2877|4914|lyfalmen|V0240|4914||200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2877||2877|4914|
016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|||0|0|E|0|LVR|0|0|0|100|DKK|5311|8244|lyfalmen|V0433|8244||200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5311||5311|8244|
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|57455|74651|lyfalmen||||28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||57455||57455|74651|
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|84660|108793|lyfalmen||||28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||84660||84660|108793|
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|27359|36881|lyfalmen||||28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||27359||27359|36881|
016930|A16AB0401|Fabrazyme|irţ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|||0|1|0|1|GZE|0|0|0|100|XEU|73875|94596|lyfsjukr||||5|0|5,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||73875||73875|94596|
016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|ţpakki||A02BC03|01.02.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|1889|3563|lyfalmen||||14|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||1889||1889|3563|
016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|||0|0|0|0|PER|0|0|0|100|DKK|3339|5546|lyfalmen|V0007|5546||56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3339|5546|
016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|ţpakki||A02BC03|01.01.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|7363|11051|lyfalmen|V0007|9705||98|0|49,0000|Icepharma hf|Pfizer ApS|Lansóprazól||7363||7363|11051|
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|||0|1|0|1|GIS|0|0|0|100|XEU|37332|48734|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||37332||37332|48734|
016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|ţpakki||A02BC03|01.02.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|13101|18987|lyfalmen||||98|0|98,0000|Icepharma hf|Pfizer ApS|Lansóprazól||13101||13101|18987|
016979|N02AE0103|Norspan|forđapl|5|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|2958|5025|lyfalmen||||4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||2958||2958|5025|
016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|||0|0|0|0|PAL|0|0|0|100|DKK|17670|34102|vetalmen||||60|0||Icepharma hf|Pfizer Oy Animal Health|||17670||17670|34102|
017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|23991|31991|lyfsjukr||||4824|0||Icepharma hf|Fresenius Kabi|Blöndur||23991||23991|31991|
017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|||0|0|E|0|PER|0|0|0|100|DKK|1439|2947|lyfalmen||||3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1439||1439|2947|
017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|||0|0|E|0|DSG|0|0|0|100|XEU|1348|2823|lyfalmen||||100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1348||1348|2823|
017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|||0|1|0|1|SKY|0|0|0|100|DKK|248411|313638|lyfsjukr||||5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||248411||248411|313638|
017145|C08DB0102|Cardizem Retard|forđatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|||0|0|B|0|FRO|0|0|0|100|DKK|7437|11152|lyfalmen||||60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||7437||7437|11152|
017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|||0|1|0|1|JCI|0|0|0|100|SEK|178440|225825|lyfsjukr||||1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||178440||178440|225825|
017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|||0|0|0|1|ROC|0|0|0|100|DKK|37914|49465|lyfsjukr||||6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||37914||37914|49465|
017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|1283|2734|lyfalmen|V0046|2170||100|0|33,3333|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||1283||1283|2734|
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|||0|1|0|1|BIB|0|0|0|100|XEU|120352|152924|lyfsjukr||||2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||120352||120352|152924|
017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|||0|0|0|0|ROC|0|0|0|100|DKK|45060|59095|lyfalmen||||28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||45060||45060|59095|
017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|||0|0|0|0|ROC|0|0|0|100|DKK|139929|178156|lyfalmen||||84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||139929||139929|178156|
017266|N02AE0103|Norspan|forđapl|10|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|5135|8003|lyfalmen||||4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5135||5135|8003|
017326|N02AE0103|Norspan|forđapl|20|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|9778|14355|lyfalmen||||4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||9778||9778|14355|
017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|2538|4451|lyfalmen||||100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||2538||2538|4451|
017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|||0|0|0|1|MSD|0|0|0|100|DKK|8496|12262|lyfsjukr||||3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||8496||8496|12262|
017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|||0|0|0|0|LPM|0|0|1|100|XEU|835|2121|lyfalmen||||20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2121|
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|||0|0|E|0|REP|0|0|1|100|SEK|2986|5064|lyfalmen||||30|0|150,0000|Vistor hf|Recip AB|Prednisón||2986||2986|5064|
017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|||0|0|0|0|LPM|0|0|1|100|IKR|1459|2641|lyfalmen|V0168|2641||20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2641|
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|||0|0|0|0|BOI|0|0|0|100|DKK|6306|12281|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||6306||6306|12281|
017763|N06DA0401|Reminyl|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|40260|31757|lyfalmen|V0350|27473||84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||23276||23276|31757|
017773|N06DA0401|Reminyl|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|13117|11768|lyfalmen|V0348|10683||28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||7887||7887|11768|
017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|9816|14407|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||9816||9816|14407|
017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|43274|56854|lyfalmen||||84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||43274||43274|56854|
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|8964|13241|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||8964||8964|13241|
018268|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.06.2005||R|||0|0|0|0|BYP|0|0|0|100|SEK|7122|10721|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7122||7122|10721|
018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|2136|3901|lyfalmen||||28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2136||2136|3901|
018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|3136|5269|lyfalmen||||28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3136||3136|5269|
018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|10121|14824|lyfalmen||||98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||10121||10121|14824|
018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|7045|10616|lyfalmen||||98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||7045||7045|10616|
018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|||0|0|0|0|BAA|0|0|0|100|SEK|3852|6248|lyfalmen||||0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||3852||3852|6248|
018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|||0|0|0|0|BAA|0|0|0|100|SEK|4207|6734|lyfalmen||||0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4207||4207|6734|
018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|8371|12430|lyfalmen||||98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||8371||8371|12430|
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|||0|0|E|0|GSK|0|0|0|100|IKR|1499|1878|lyfalmen|V0243|1632||42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||657||657|1878|
018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|2623|4567|lyfalmen||||28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2623||2623|4567|
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|7773|11612|lyfalmen||||30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||7773||7773|11612|
018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|12879|18046|lyfsjukr||||5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||12879||12879|18046|
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|19058|26463|lyfalmen|V0441|26462||90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||19058||19058|26463|
018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA03|01.07.2005||R|||0|0|0|0|NOH|0|0|0|100|DKK|2750|4741|lyfalmen||||28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||2750||2750|4741|
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|11.06.2004||R|||0|0|B|0|MKA|0|0|1|100|SEK|964|2298|lyfalmen|V0414|1981||100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||964||964|2298|
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|5505|8509|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5505||5505|8509|
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|15517|22019|lyfalmen|V0440|22019||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||15517||15517|22019|
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|32401|43208|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||32401||32401|43208|
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|||0|1|0|1|TEP|0|0|0|100|NOK|119223|151507|lyfsjukr||||28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||119223||119223|151507|
018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|||0|1|0|1|VII|0|0|0|100|GBP|59541|76606|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||59541||59541|76606|
018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|561|1746|lyfalmen||||100|0|50,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||561||561|1746|
018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|||0|0|0|0|KEL|1|0|0|100|NOK|1275|2536|vetalmen||||100|0||Icepharma hf|Kela Laboratoria NV|||1275||1275|2536|
018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|10183|14909|lyfalmen|V0221|10663||5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||10183||10183|14909|
019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|||0|0|0|1|GEH|0|0|0|100|NOK|20749|27922|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20749||20749|27922|
019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|7279|10936|lyfalmen|V0220|8444||5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7279||7279|10936|
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|23417|31271|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23417||23417|31271|
019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|4036|6500|lyfalmen|V0219|5315||5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4036||4036|6500|
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|32510|42683|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||32510||32510|42683|
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|33334|43717|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jódixanól||33334||33334|43717|
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|40730|52999|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jódixanól||40730||40730|52999|
019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|9473|13937|lyfalmen|V0223|12263||5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||9473||9473|13937|
019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|14035|20159|lyfalmen||||98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||14035||14035|20159|
019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|4813|7563|lyfalmen||||28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||4813||4813|7563|
019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|||0|1|0|1|NYC|0|0|0|100|DKK|48851|63191|lyfsjukr||||1|0||Vistor hf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||48851||48851|63191|
019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|||0|1|0|1|THE|0|0|0|100|XEU|698015|877891|lyfsjukr||||10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||698015||698015|877891|
019308|QG03X0001|Alizin, vet.|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03X|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|IKR|4877|9537|vetalmen||||10|0||Vistor hf|Virbac S.A|Aglepristóne||4877||4877|9537|
019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|stk|10 áf.spr|QJ51CE09|01.04.2010||R|||0|0|0|0|VET|0|0|0|100|DKK|19889|38362|vetalmen||||1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||19889|38362|
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|||0|0|0|0|ELD|0|0|0|100|XEU|6420|9761|lyfalmen||||56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6420||6420|9761|
019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|||0|1|0|1|RRL|0|0|0|100|DKK|49236|63674|lyfsjukr||||4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||49236||49236|63674|
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|||0|0|0|0|ELD|0|0|0|100|XEU|6420|9761|lyfalmen||||56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6420||6420|9761|
019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|563|1749|lyfalmen||||100|0|100,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||563||563|1749|
019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|||0|1|0|1|ELI|0|0|0|100|XEU|3515|5073|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3515||3515|5073|
019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|||0|0|E|0|NYC|0|0|0|100|DKK|589|1785|lyfalmen||||250|0|250,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||589||589|1785|
019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|||0|1|0|1|ELI|0|0|0|100|XEU|15443|21263|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||15443||15443|21263|
019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|||0|1|0|1|RRL|0|0|0|100|DKK|182836|231342|lyfsjukr||||16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||182836||182836|231342|
019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|||0|0|0|0|MYL|0|0|1|100|SEK|1109|2496|lyfalmen|V0159|2495||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1109||1109|2496|
019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|||0|1|0|1|ELD|0|0|0|100|XEU|186155|235507|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||186155||186155|235507|
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12105|17737|lyfalmen||||28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12105||12105|17737|
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12105|17737|lyfalmen||||28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12105||12105|17737|
019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|||0|1|E|0|ORG|0|0|0|100|DKK|52323|68211|lyfalmen||||1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||52323||52323|68211|
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12105|17737|lyfalmen||||28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12105||12105|17737|
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12105|17737|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12105||12105|17737|
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12105|17737|lyfalmen||||28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12105||12105|17737|
019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|||0|1|0|1|BIA|0|0|0|100|DKK|738601|928827|lyfsjukr||||6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||738601||738601|928827|
019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|393|1517|lyfalmen||||12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||393||393|1517|
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|||0|1|0|1|GGL|0|0|0|100|GBP|67471|86559|lyfsjukr||||30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||67471||67471|86559|
019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|||0|0|0|0|MYL|0|0|1|100|SEK|1661|3198|lyfalmen|V0160|3196||30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1622||1622|3198|
020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Ferrósúlfat||||||
020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||||
020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|||0|0|E|0|ASP|0|0|0|100|XEU|2738|4724|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2738||2738|4724|
020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|26307|35560|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||26307||26307|35560|
020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|||0|0|0|0|LVR|0|0|0|100|NOK|2711|4687|lyfalmen||||50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2711||2711|4687|
020277|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.02.2007||R|||0|0|0|0|PER|0|1|0|100|DKK|543|1722|lyfalmen|V0333|1558||7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||543||543|1722|
020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||||
020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|||0|0|E|0|ASP|0|0|0|100|XEU|6391|9721|lyfalmen||||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6391||6391|9721|
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|||0|1|*|0|ASP|0|0|0|100|XEU|49887|65153|lyfalmen||||2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||49887||49887|65153|
020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|6247|5869|lyfalmen|V0530|5641||84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||3575||3575|5869|
020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|13919|6955|lyfalmen|V0531|6676||84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4369||4369|6955|
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|||0|1|*|0|ASP|0|0|0|100|XEU|22513|30799|lyfalmen||||2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||22513||22513|30799|
020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|||0|0|B|0|ASP|0|0|1|100|XEU|567|1755|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||567||567|1755|
020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|||0|0|0|0|SEV|0|0|0|100|DKK|5349|8296|lyfalmen||||28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5349||5349|8296|
020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|||0|0|B|0|ASP|0|0|1|100|XEU|1726|3340|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1726||1726|3340|
020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|||0|0|0|0|SEV|0|0|0|100|DKK|15579|22097|lyfalmen||||84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||15579||15579|22097|
020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|||0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa||||1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel||||||
020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|||0|0|0|0|MES|0|0|0|100|XEU|2086|3639|vetorma||||8|0||Vistor hf|Merial SAS|||2086||2086|3639|
020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|||0|1|0|1|WTE|0|0|0|100|DKK|146711|186005|lyfsjukr||||4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||146711||146711|186005|
020861|QP52AF0202|Twinhip Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|||0|0|0|0|VEB|0|0|0|100|XEU|2440|4256|vetorma||||52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2440||2440|4256|
020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|||0|0|0|0|DAC|0|0|1|100|DKK|1897|3574|lyfalmen|V0174|3574||3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1897||1897|3574|
020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|||0|0|0|0|LLS|0|0|0|100|DKK|2828|4847|lyfalmen||||30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2828||2828|4847|
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|||0|0|0|0|GAN|0|0|0|100|SEK|2476|4366|lyfalmen||||60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2476||2476|4366|
021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|||0|0|0|0|DAC|0|0|1|100|IKR|827|1956|lyfalmen||||12|0|6,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1956|
021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|||0|0|0|0|DAC|0|0|1|100|IKR|1025|2381|lyfalmen|V0169|2367||12|0|10,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1025||1025|2381|
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|||0|0|E|0|ACA|0|0|1|100|IKR|453|1389|lyfalmen|V0188|1389||30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||300||300|1389|
021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|||0|0|E|0|GEM|0|0|0|100|XEU|955|2285|lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||955||955|2285|
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|||0|0|E|0|ACA|0|0|1|100|IKR|1187|2116|lyfalmen|V0189|2116||100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||831||831|2116|
021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|||0|0|E|0|BAP|0|0|0|100|SEK|17496|24503|lyfalmen||||4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||17496||17496|24503|31.08.2012
021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|||0|0|0|0|LVR|0|0|0|100|GBP|9516|13996|lyfalmen|V0437|13783||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9516||9516|13996|
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|||0|0|B|0|MSD|0|0|0|100|DKK|16095|22744|lyfalmen|V0490|9983||98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||16095||16095|22744|
021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|||0|0|0|0|LVR|0|0|0|100|GBP|6780|10254|lyfalmen|V0436|10254||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6780||6780|10254|
021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||||
021417|R01AD0504|Rhinocort (D.A.C.)|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|||0|0|E|0|DAC|0|0|1|100|SEK|1691|3241|lyfalmen||||120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||1654||1654|3241|31.08.2012
021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|||0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa||||6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl||||||
021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|||0|0|B|0|MSD|0|0|0|100|DKK|16350|23064|lyfalmen|V0491|18379||98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||16350||16350|23064|
021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|1484|2142|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Própófól||1484||1484|2142|
021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|4126|6623|lyfalmen||||30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4126||4126|6623|
021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|12628|18393|lyfalmen||||100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||12628||12628|18393|
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|||0|0|0|0|AZD|0|0|0|100|SEK|14412|20632|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14412||14412|20632|
021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|6673|10107|lyfalmen||||30|0|9,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||6673||6673|10107|
021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|||0|0|B|0|FER|0|0|0|100|DKK|14180|20341|lyfalmen||||60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14180||14180|20341|
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|14845|20513|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Própófól||14845||14845|20513|
021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|21257|29223|lyfalmen||||100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||21257||21257|29223|
021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|14845|20513|lyfsjukr||||500|0||Icepharma hf|Fresenius Kabi|Própófól||14845||14845|20513|
021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|22850|31222|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|rykmaurar||22850||22850|31222|
021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|||0|0|0|0|AZD|0|0|0|100|SEK|4492|7124|lyfalmen||||28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4492||4492|7124|
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|8536|12320|lyfsjukr||||500|0||Icepharma hf|Fresenius Kabi|Própófól||8536||8536|12320|
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|||0|0|0|1|PER|0|0|0|100|DKK|4308|6218|lyfsjukr||||50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4308||4308|6218|
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18293|25503|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18293||18293|25503|
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|3595|5897|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3595||3595|5897|
021950|B05AA0705|HyperHAES|irl|||250|ml|10|pokar||B05AA07|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|20264|27314|lyfsjukr||||2500|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||20264||20264|27314|
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|4968|7775|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4968||4968|7775|
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|17121|24032|lyfalmen||||98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||17121||17121|24032|
022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18293|25503|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18293||18293|25503|
022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|78771|100740|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||78771||78771|100740|
022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|||0|0|0|1|BAM|0|0|0|100|SEK|123237|156545|lyfsjukr||||1200|0||Icepharma hf|Baxter Medical AB|Albúmín||123237||123237|156545|
022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ||||||
022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|6760|10226|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||6760||6760|10226|
022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|7923|11817|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||7923||7923|11817|
022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|||0|0|0|0|MSD|0|0|0|100|DKK|24295|33035|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||24295||24295|33035|
022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|||0|0|*|0|SAA|0|0|0|100|NOK|5291|8217|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5291||5291|8217|
022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|8449|12537|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||8449||8449|12537|
022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|275669|347847|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||275669||275669|347847|
022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|304222|383681|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||304222||304222|383681|
022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|10603|18496|vetorma||||24|0||Icepharma hf|Bayer Animal Health GmbH|||10603||10603|18496|
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|||0|1|0|0|ALL|0|0|0|100|SEK|24557|33364|lyfalmen||||1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||24557||24557|33364|
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2132|3719|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||2132||2132|3719|
022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|1219|2646|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1219||1219|2646|
022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|ţpakki||QP52AA51|01.10.1991||L|||0|0|0|0|BAN|0|0|0|100|DKK|1298|2264|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||||1298|2264|
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|3601|2608|lyfalmen|V0056|1737||100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1191||1191|2608|
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|6329|3564|lyfalmen|V0057|2133||100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1890||1890|3564|
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2019|3522|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||2019||2019|3522|
022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|||0|0|B|0|ASP|0|0|1|100|XEU|591|1787|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||591||591|1787|
022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|||0|0|B|0|ASP|0|0|1|100|XEU|1771|3402|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1771||1771|3402|
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|1307|2280|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||1307||1307|2280|
022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|||0|0|0|0|NOH|0|0|0|100|DKK|4398|6995|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4398||4398|6995|
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|2129|2993|lyfalmen|V0321|2993||100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|2993|
022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|1554|2046|lyfalmen|V0321|1796||60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|2046|
022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||4541|
022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|25882|35027|lyfalmen||||8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||25882||25882|35027|
022802|L01XC0401|MabCampath|irţ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|||0|1|0|1|GEU|0|0|0|100|SEK|225694|285128|lyfsjukr||||3|0||Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||225694||225694|285128|
022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|12941|18786|lyfalmen||||4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||12941||12941|18786|
022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|spr|áfyllt sprauta|B01AX05|01.04.2012||R|||0|0|E|0|GGL|0|0|0|100|GBP|19432|26932|lyfalmen||||6|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||19432||19432|26932|
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2760|
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|||0|1|C|0|ACA|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827||30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2827|
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|||0|1|C|0|ACA|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196||30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4196|
022962|V01AA1104|Alutard SQ, hrossavćrur|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|22850|31222|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||22850||22850|31222|
022970|V01AA1104|Alutard SQ, hrossavćrur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18293|25503|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||18293||18293|25503|
023047|G04BD1001|Emselex|forđatfl|7,5|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|5318|8254|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5318||5318|8254|
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|||0|1|0|1|GIS|0|0|0|100|DKK|78765|100733|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||78765||78765|100733|
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|||0|1|0|0|SHI|0|0|0|100|DKK|24182|32894|lyfalmen||||90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||24182||24182|32894|
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|||0|1|0|0|SHI|0|0|0|100|DKK|37755|49928|lyfalmen||||90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||37755||37755|49928|
023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|19119|26539|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||19119||19119|26539|
023146|G04BD1001|Emselex|forđatfl|15|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|5371|8326|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5371||5371|8326|
023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|19313|26783|lyfalmen||||98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||19313||19313|26783|
023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|4847|4726|lyfalmen|V0250|4404||100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||2739||2739|4726|
023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|3629|5943|lyfalmen|V0251|3919||100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||3629||3629|5943|
023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|||0|0|0|0|DED|0|0|1|100|XEU|17336|24302|lyfalmen||||34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||17336||17336|24302|
023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|6957|10041|lyfsjukr||||0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||6957||6957|10041|
023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|26753|35458|lyfsjukr||||0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||26753||26753|35458|
023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|20259|27308|lyfsjukr||||0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||20259||20259|27308|
023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|48247|62432|lyfsjukr||||0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||48247||48247|62432|
023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|32602|42798|lyfsjukr||||0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||32602||32602|42798|
023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|8465|12217|lyfsjukr||||10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8465||8465|12217|
023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|97174|123836|lyfsjukr||||1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||97174||97174|123836|
023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|21164|28443|lyfsjukr||||25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||21164||21164|28443|
023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|13985|19434|lyfsjukr||||0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||13985||13985|19434|
023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|36807|48075|lyfsjukr||||50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||36807||36807|48075|
023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|73613|94267|lyfsjukr||||100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||73613||73613|94267|
023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|||0|1|0|1|AMG|0|0|0|100|DKK|169347|214413|lyfsjukr||||1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||169347||169347|214413|
023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|147228|186654|lyfsjukr||||200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||147228||147228|186654|
023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006|31.07.2012|R|||0|0|E|0|GGL|0|0|0|100|GBP|14354|20559|lyfalmen||||4|0|21,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||14354||14354|20559|
023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|127035|161311|lyfsjukr||||120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||127035||127035|161311|
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|||0|0|E|0|SBM|0|0|0|100|NOK|26050|30391|lyfalmen|V0029|7726||100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||22188||22188|30391|
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|||0|0|*|0|SAO|0|0|0|100|XEU|3387|5612|lyfalmen||||12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3387||3387|5612|
023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|||0|0|0|1|BAX|0|0|0|100|SEK|155191|196647|lyfsjukr||||1500|0||Icepharma hf|Baxter|Sevóflúran||155191||155191|196647|
023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|||0|1|0|1|ROC|0|0|0|100|DKK|53268|68734|lyfsjukr||||120|0|33,3300|Icepharma hf|Roche|Saquínavír||53268||53268|68734|
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|72118|92391|lyfsjukr||||90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||72118||72118|92391|
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|||0|0|E|0|MSD|0|0|0|100|DKK|2757|4750|lyfalmen||||100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2757||2757|4750|
024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007|31.07.2012|R|||0|0|0|1|WTE|0|0|0|100|DKK|79110|101166|lyfsjukr||||10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||79110||79110|101166|
024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|||1|0|E|0|JAS|0|0|0|100|SEK|2569|4493|lyfalmen||||5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2569||2569|4493|
024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|||0|0|E|0|TPG|0|0|0|100|DKK|18221|25412|lyfalmen||||30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||18221||18221|25412|
024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|||0|0|0|1|BAM|0|0|0|100|SEK|1813|2617|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1813||1813|2617|
024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|21316|28634|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||21316||21316|28634|
024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|13576|10275|lyfalmen|V0456|9109||28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||6796||6796|10275|
024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|||0|0|E|0|TPG|0|0|0|100|DKK|60097|77967|lyfalmen||||100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||60097||60097|77967|
024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|22850|31222|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||22850||22850|31222|
024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7193|10819|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7193||7193|10819|
024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|||0|0|B|0|AZD|0|0|0|100|SEK|434|1573|lyfalmen||||100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||434||434|1573|
024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7193|10819|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7193||7193|10819|
024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12120|17756|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12120||12120|17756|
024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12140|17781|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12140||12140|17781|
024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12265|17938|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12265||12265|17938|
024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|5186|8073|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5186||5186|8073|
024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|||0|1|0|0|NOE|0|0|0|100|DKK|65895|85243|lyfalmen||||100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||65895||65895|85243|
024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12265|17938|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12265||12265|17938|
024603|V04CL0001|Soluprick  Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|1477|2999|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1477||1477|2999|
024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|5186|8073|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5186||5186|8073|
024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7193|10819|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7193||7193|10819|
024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7193|10819|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7193||7193|10819|
024681|V04CL0002|Soluprick  Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|1477|2999|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1477||1477|2999|
024991|M01AE0111|Burana|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|355|1465|lyfalmen|V0563|1465||30|0|15,0000|Portfarma ehf|Orion Corporation|Íbúprófen||355||355|1465|
025009|M01AE0111|Burana|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.07.2012||L|||0|0|0|0|OPF|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Portfarma ehf|Orion Corporation|Íbúprófen||||||
025020|M01AE0111|Burana|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|712|1953|lyfalmen|V0562|1953||100|0|33,3300|Portfarma ehf|Orion Corporation|Íbúprófen||712||712|1953|
025053|M01AE0111|Burana|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|864|2161|lyfalmen|V0564|2161||100|0|50,0000|Portfarma ehf|Orion Corporation|Íbúprófen||864||864|2161|
025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|||0|0|B|0|ASP|0|0|1|100|XEU|598|1797|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||598||598|1797|
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18293|25503|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||18293||18293|25503|
025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húđ|D07AB02|01.04.1994||R|||0|0|B|0|ASP|0|0|1|100|XEU|1822|3471|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1822||1822|3471|
025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18293|25503|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||18293||18293|25503|
025306|M05BB0301|Fosavance|töflur|||12|stk|1|ţpakki|70mg+70mcg|M05BB03|01.10.2006||R|||0|0|0|0|MSD|0|0|0|100|DKK|12989|18846|lyfalmen||||12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||12989||12989|18846|
025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|79090|101140|lyfsjukr||||30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||79090||79090|101140|
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|73873|94593|lyfsjukr||||30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||73873||73873|94593|
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|||0|0|0|0|BOI|1|0|0|100|DKK|9065|17579|vetalmen||||20|0||Vistor hf|Boehringer Ingelheim|||9065||9065|17579|
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|||0|1|0|0|ALK|0|0|0|100|DKK|15691|22237|lyfalmen||||30|0||Vistor hf|ALK-Abello A/S|grasfrjó||15691||15691|22237|
025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|18624|25918|lyfalmen||||98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||18624||18624|25918|
025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|5957|9128|lyfalmen||||28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||5957||5957|9128|
025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2180|2819|lyfalmen|V0462|2819||90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||1345||1345|2819|
025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2372|2943|lyfalmen|V0471|2943||90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||1436||1436|2943|
025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010||R|||0|0|*|0|DAC|0|0|0|100|DKK|1783|3418|lyfalmen|V0369|2860||5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíđ||1783||1783|3418|
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|4964|7769|lyfalmen|V0205|1188||1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||4964||4964|7769|
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|13302|19239|lyfalmen|V0205|3564||3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||13302||13302|19239|
025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2550|3187|lyfalmen|V0472|3177||90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||1614||1614|3187|
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|||0|1|0|0|ALK|0|0|0|100|DKK|50403|65801|lyfalmen||||100|0||Vistor hf|ALK-Abello A/S|grasfrjó||50403||50403|65801|
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|||0|0|0|1|AZD|0|0|0|100|SEK|7391|10667|lyfsjukr||||25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7391||7391|10667|
025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|22850|31222|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||22850||22850|31222|
025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|||0|1|0|1|CEE|0|0|0|100|XEU|54417|70176|lyfsjukr||||28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||54417|70176|
025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|||0|0|B|0|POF|0|0|0|100|XEU|12617|18379|lyfalmen|V0492|18379||98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||12617||12617|18379|
025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991|31.08.2012|R|||0|0|E|0|MYL|0|0|1|100|SEK|1022|2377|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1022||1022|2377|
025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|||0|0|B|0|POF|0|0|0|100|XEU|15303|18379|lyfalmen|V0491|18379||98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||12617||12617|18379|
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|||0|0|0|0|MEF|0|0|0|100|XEU|4447|7758|vetorma||||1|0||Vistor hf|Merial (MSD)|||4447||4447|7758|
025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009|31.08.2012|R|||0|0|E|0|MYL|0|0|1|100|SEK|531|1705|lyfalmen||||25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||531||531|1705|
025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|||0|0|B|0|POF|0|0|0|100|XEU|12906|10002|lyfalmen|V0490|9983||98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||6596||6596|10002|
025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991|31.07.2012|R|||0|0|E|0|MYL|0|0|1|100|SEK|2698|3534|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1868||1868|3534|
025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|||0|0|0|0|POF|0|0|0|100|IKR|||lyflausa||||20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ||||||
026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|||0|0|0|0|VIR|0|0|0|100|SEK|2659|5278|vetalmen||||10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2659||2659|5278|
026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|||0|0|E|0|POF|0|0|0|100|IKR|820|2101|lyfalmen|V0447|2101||100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2101|
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|||0|0|0|0|MEF|0|0|0|100|XEU|8762|15285|vetorma||||2|0||Vistor hf|Merial (MSD)|||8762||8762|15285|
026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|21844|19035|lyfalmen|V0475|18351||28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||13139||13139|19035|
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18293|25503|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||18293||18293|25503|
026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|||0|1|0|1|PFM|0|0|0|100|DKK|40348|52519|lyfsjukr||||2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||40348||40348|52519|
026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|||0|1|0|1|PFM|0|0|0|100|DKK|201764|255096|lyfsjukr||||10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||201764||201764|255096|
026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|1719|3330|lyfalmen||||14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1719|3330|
026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|6514|9890|lyfalmen||||56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||6514|9890|
026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|3396|5624|lyfalmen||||14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3396|5624|
026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|13451|19426|lyfalmen||||56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||13451|19426|
026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|20156|27841|lyfalmen||||56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||20156|27841|
026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|26862|36257|lyfalmen||||56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||26862|36257|
026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|1453|2967|lyfalmen||||100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1453||1453|2967|
026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||||||
026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|||0|0|0|0|DAC|0|0|1|100|SEK|1621|3196|lyfalmen|V0160|3196||30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1621||1621|3196|
026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|||0|0|0|0|DAC|0|0|1|100|SEK|1152|2495|lyfalmen|V0159|2495||20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1108||1108|2495|
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|432|1570|lyfalmen||||50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||432||432|1570|
027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|||0|0|B|0|SGM|0|0|0|100|DKK|2554|4473|lyfalmen|V0199|3306||50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2554||2554|4473|
027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|||0|0|*|0|ALA|0|0|0|100|USD|2453|4334|lyfalmen||||5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2453||2453|4334|
027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|||0|0|*|0|MYL|0|0|0|100|SEK|7103|10695|lyfalmen||||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||7103||7103|10695|
027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|||0|0|E|0|ACA|0|0|0|100|XEU|27930|14490|lyfalmen|V0341|13192||100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||9877||9877|14490|
027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|||0|0|E|0|ACA|0|0|0|100|XEU|31345|15777|lyfalmen|V0342|14479||100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||10818||10818|15777|
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|7338|11017|lyfalmen||||56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||7338||7338|11017|
027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|9669|14206|lyfalmen||||56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||9669||9669|14206|
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|||0|0|B|0|NYC|0|0|0|100|DKK|795|2066|lyfalmen|V0153|2066||100|0|33,3300|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||795||795|2066|
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|||0|0|B|0|NYC|0|0|0|100|DKK|794|2065|lyfalmen|V0154|1949||100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||794||794|2065|
027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|||0|1|0|1|SPE|0|0|0|100|DKK|95075|121202|lyfsjukr||||105|0|5,2500|Vistor hf|SP Europe|Posacónazól||95075||95075|121202|
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|||0|0|0|0|OTS|0|1|0|100|DKK|19399|26891|lyfalmen||||28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19399||19399|26891|
027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|30187|39767|lyfsjukr||||1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||30187|39767|
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|||0|0|0|0|OTS|0|1|0|100|DKK|22421|30683|lyfalmen||||28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22421||22421|30683|
027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|44480|57705|lyfsjukr||||1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||44480||44480|57705|
027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|56032|72203|lyfsjukr||||1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||56032|72203|
028045|G03AB0001|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB|01.11.2009||R|||0|0|0|0|BAP|0|0|0|100|SEK|5066|7909|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5066||5066|7909|
028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||||||
028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|||0|0|*|0|MSD|0|0|0|100|DKK|22962|31362|lyfalmen|V0386|31362||196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||22962||22962|31362|
028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|3622|4742|lyfalmen|V0364|4742||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||2751||2751|4742|
028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|ţpakki|150/12,5 mg|C09XA52|01.06.2009|31.07.2012|R|||0|0|0|0|NOE|0|0|0|100|DKK|4040|6505|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||4040|6505|
028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|17766|24841|lyfalmen|V0120|24841||196|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||17766|24841|
028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|53631|69189|lyfsjukr||||1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||53631||53631|69189|
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|2390|4248|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2390||2390|4248|
028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|20064|27725|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||20064||20064|27725|
028360|J07BG0101|Rabies - Imovax|bóluefni|||1|ml|1|hgl||J07BG01|01.01.1996||R|||0|0|0|0|MEX|0|0|0|100|SEK|10399|15204|lyfalmen||||1|0||Icepharma hf|Aventis Pasteur MSD A/S|Hundaćđi, dauđ veira||10399||10399|15204|
028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1895|3571|lyfalmen|V0202|3571||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1895||1895|3571|
028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|2124|3884|lyfalmen|V0428|3369||50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2124||2124|3884|
028498|C08DB0102|Cardizem Retard|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|||0|0|B|0|FRO|0|0|0|100|DKK|4975|7784|lyfalmen||||60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||4975||4975|7784|
028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|1278|2727|lyfalmen||||56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2727|
028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|5812|5233|lyfalmen|V0245|4595||98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||3110||3110|5233|
028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|10358|10172|lyfalmen|V0232|9238||98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||6720||6720|10172|
028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|753|1125|lyfalmen|V0266|1095||30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||107||107|1125|
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|||0|0|0|0|OCO|1|0|0|100|DKK|7523|14618|vetalmen||||10|0||Icepharma hf|Orion Corporation (I)|||7523||7523|14618|
028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|||0|0|B|0|POF|0|0|0|100|XEU|4337|6912|lyfalmen||||28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||4337||4337|6912|
028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|4901|2716|lyfalmen|V0267|2466||100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||1270||1270|2716|
028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|17670|9483|lyfalmen|V0269|9483||100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||6217||6217|9483|
028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|1362|2842|lyfalmen|V0179|1824||7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||1362||1362|2842|
028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|4998|7816|lyfalmen|V0179|7816||30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||4998||4998|7816|
028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|577|1768|lyfalmen|V0180|875||1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1768|
028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|563|1749|lyfalmen|V0180|1749||2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1749|
028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|2031|3757|lyfalmen|V0180|3498||4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||2031||2031|3757|
029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|||0|0|E|0|GSK|0|0|1|100|GBP|1095|2477|lyfalmen||||16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1095|2477|
029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|||0|0|0|0|SEV|0|1|0|100|DKK|7181|10802|lyfalmen||||28|0|28,0000|Icepharma hf|Servier|Agómelatín||7181||7181|10802|
029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|||0|0|0|0|SEV|0|1|0|100|DKK|20484|28253|lyfalmen||||84|0|84,0000|Icepharma hf|Servier|Agómelatín||20484||20484|28253|
029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|2740|4727|lyfalmen||||30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2740||2740|4727|
029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|||0|0|E|0|AUK|0|0|0|100|GBP|256|1329|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||256|1329|
029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|ţpakki||C10AA01|01.09.2005||R|||0|0|0|0|LVR|0|0|0|100|XEU|7155|8799|lyfalmen|V0109|1798||98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||5717||5717|8799|
029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|||0|1|0|1|EIS|0|0|0|100|SEK|65143|83637|lyfsjukr||||2|0||Vistor hf|Eisai Ltd|Eribulin||65143||65143|83637|
029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|||0|1|0|1|AGP|0|0|0|100|XEU|21318|28637|lyfsjukr||||50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||21318||21318|28637|
029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|||0|1|0|1|AGP|0|0|0|100|XEU|5512|7955|lyfsjukr||||5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||5512||5512|7955|
029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|||0|1|0|1|AGT|0|0|0|100|XEU|4234|6111|lyfsjukr||||5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4234||4234|6111|
029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|5147|8020|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5147|8020|
029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|16164|22831|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16164|22831|
029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|5147|8020|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5147|8020|
029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|16164|22831|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16164|22831|
029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|||0|0|0|0|GAN|0|0|1|100|SEK|6548|9936|lyfalmen||||56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6548||6548|9936|
029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|94990|121095|lyfsjukr||||1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||94990||94990|121095|
029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|189980|240307|lyfsjukr||||1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||189980||189980|240307|
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|4871|3969|lyfalmen|V0148|3837||90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||2186||2186|3969|
030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|22980|31385|lyfalmen||||98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||22980||22980|31385|
030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.07.2006||L|||0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa||||60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín||||||
030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|||0|0|*|0|NOH|0|1|0|100|DKK|8743|12939|lyfalmen|V0277|12938||100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||8743||8743|12939|
030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|||0|0|*|0|NOH|0|1|0|100|DKK|2789|4794|lyfalmen||||100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||2789||2789|4794|
030754|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|770|l|1|hylki|kćlt|V03AN01|01.03.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||770|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
030765|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|11000|l|1|hylki|kćlt|V03AN01|01.03.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||11000|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|15259|26619|vetorma||||40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||15259|26619|
030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|||0|0|B|0|MYL|0|0|0|100|SEK|1404|2900|lyfalmen|V0051|2900||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||1404||1404|2900|
031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|||0|0|B|0|MYL|0|0|0|100|SEK|2219|4014|lyfalmen||||100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||2219||2219|4014|
031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|||0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen||||2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2575|
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|||0|0|*|0|ELD|0|0|0|100|XEU|2984|5061|lyfalmen||||10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2984||2984|5061|
031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|62096|79813|lyfsjukr||||20|0||Vistor hf|Schering-Plough|Temozolomid||62096||62096|79813|
031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|75654|96828|lyfsjukr||||5|0||Vistor hf|Schering-Plough|Temozolomid||75654||75654|96828|
031394|L01AX0301|Temodal|hylki|250|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|166794|211209|lyfsjukr||||5|0||Vistor hf|Schering-Plough|Temozolomid||166794||166794|211209|
031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|||0|0|B|0|REP|0|0|0|100|SEK|2131|3894|lyfalmen||||100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2131||2131|3894|
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|5627|8676|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5627||5627|8676|
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|||0|0|0|1|FEL|0|0|0|100|DKK|22036|29538|lyfsjukr||||5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||22036||22036|29538|
031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|2033|3760|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||2033||2033|3760|
032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|9127|13173|lyfsjukr||||4|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||9127|13173|
032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|13340|18624|lyfsjukr||||10|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||13340|18624|
032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|46159|59812|lyfsjukr||||50|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||46159|59812|
032190|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||1|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032202|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||2|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032236|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||4|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032247|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||5|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032258|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||10|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032270|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||20|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032281|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||50|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032304|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||600|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|||0|0|*|0|OTS|0|1|0|100|DKK|20001|27646|lyfalmen||||150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20001||20001|27646|
032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|3599|6278|vetorma||||50|0||Vistor hf|Merial (MSD)|||3599||3599|6278|
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|14044|24499|vetorma||||200|0||Vistor hf|Merial (MSD)|||14044||14044|24499|
033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|||0|1|*|0|FER|0|0|0|100|DKK|20273|27988|lyfalmen||||1|0|29,6300|Vistor hf|Ferring|Degarelix||||20273|27988|
033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|||0|1|*|0|FER|0|0|0|100|DKK|40433|53289|lyfalmen||||2|0|88,8900|Vistor hf|Ferring|Degarelix||||40433|53289|
033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||L|||0|0|0|0|NOB|1|0|0|100|XEU|1160|2024|vetorma||||7|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||||1160|2024|
033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|8684|16847|vetalmen||||100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||8684|16847|
033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|||0|0|E|0|ALC|0|0|1|100|USD|1262|2705|lyfalmen||||5|0||K.Pétursson hf|Alcon|Dexametasón||1262||1262|2705|
033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|||0|0|*|0|WIH|0|0|0|100|XEU|44181|23138|lyfalmen|V0185|20925||100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||16409||16409|23138|
033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|81766|104499|lyfsjukr||||60|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||81766||81766|104499|
033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|106651|135730|lyfsjukr||||60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||106651||106651|135730|
034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|2352|4679|vetalmen||||10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2352|4679|
034157|J07AM5104|Diftavax|bóluefni|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|||0|0|0|0|SPM|0|0|1|100|XEU|708|1947|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||708||708|1947|
034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|23526|31408|lyfsjukr||||25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||23526||23526|31408|
034423|J07BA0201|Ixiaro|stl|6|mcg|0,5|ml|1|spr|dreifa|J07BA02|01.01.2012||R|||0|0|0|0|IAG|0|0|0|100|SEK|15226|21654|lyfalmen||||0|0||Intercell AG|Intercell AG|Japönsk heilabólguveira óvirk||15226||15226|21654|
034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|||0|0|E|0|ELD|0|0|0|100|XEU|7708|11523|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7708|11523|
034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|||0|0|E|0|ELD|0|0|0|100|XEU|7708|11523|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7708|11523|
034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|72803|93250|lyfsjukr||||40|0||Vistor hf|Orion Corporation|Dexmedetómid||72803||72803|93250|
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|1738|3356|lyfalmen|V0367|2529||6|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||1738||1738|3356|
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|2981|5057|lyfalmen|V0367|5057||12|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||2981||2981|5057|
034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|||0|1|0|1|MSE|0|0|0|100|SEK|175977|222734|lyfsjukr||||2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||175977||175977|222734|
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|||0|0|0|1|LEP|0|0|0|100|DKK|7081|10220|lyfsjukr||||25|0||Vistor hf|LEO Pharma A/S|Prótamín||7081||7081|10220|
035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|2151|3104|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2151||2151|3104|
035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|||0|0|B|0|FER|0|0|0|100|DKK|15178|21594|lyfalmen||||300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15178||15178|21594|
035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|3616|5925|lyfalmen|V0079|5925||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3616|5925|
035494|C07AB0211|Metoprolol ratiopharm|forđatfl|23,75|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|1047|2411|lyfalmen||||100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1047||1047|2411|30.06.2012
035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|||0|0|E|0|ACA|0|0|0|100|IKR|1844|2668|lyfalmen|V0244|2668||56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1235||1235|2668|
035528|C07AB0211|Metoprolol ratiopharm|forđatfl|47,5|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|1265|2709|lyfalmen|V0048|2709||100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1265||1265|2709|
035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006|31.07.2012|R|||0|1|0|1|PER|0|0|0|100|DKK|124059|157577|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Pegaptaníb||124059||124059|157577|
035563|C07AB0211|Metoprolol ratiopharm|forđatfl|95|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|2258|4068|lyfalmen|V0049|4068||100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2258||2258|4068|
035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|10369|15163|lyfalmen|V0080|11843||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10369||10369|15163|
035597|C07AB0211|Metoprolol ratiopharm|forđatfl|190|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|4935|7061|lyfalmen|V0054|7061||100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||4446||4446|7061|
036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|||0|0|0|0|GZE|0|0|0|100|XEU|28989|35425|lyfalmen||||180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||26199||26199|35425|
036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|||0|1|0|1|MSE|0|0|0|100|SEK|144291|182968|lyfsjukr||||2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||144291||144291|182968|
036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|||0|0|E|0|MAS|0|0|1|100|SEK|6029|9226|lyfalmen||||60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6029||6029|9226|
036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|2959|5027|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2959||2959|5027|
036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|8617|12767|lyfalmen|V0081|10004||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8617||8617|12767|
036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|||0|1|0|1|ABL|0|0|0|100|DKK|5762|8316|lyfsjukr||||30|0|2,5000|Vistor hf|Abbott Laboratories A/S|Ritonavír||5762||5762|8316|
036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|186906|236450|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||186906||186906|236450|
036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|372800|469747|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||372800||372800|469747|
036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|744033|935644|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||744033||744033|935644|
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|||0|0|0|0|REP|0|0|1|100|SEK|825|2107|lyfalmen||||20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||825||825|2107|
036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|||0|0|0|0|REP|0|0|1|100|SEK|1450|2962|lyfalmen||||60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1450||1450|2962|
036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|||0|0|0|0|GSC|0|0|0|100|IKR|||lyflausa||||30|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Silíkonsambönd||||||
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|||0|0|0|0|REP|0|0|1|100|SEK|2862|4894|lyfalmen||||125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2862||2862|4894|
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|||0|0|0|0|REP|0|0|1|100|SEK|868|2166|lyfalmen||||30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||868||868|2166|
037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|12186|17839|lyfalmen||||84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12186||12186|17839|
037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|22371|30621|lyfalmen||||84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||22371||22371|30621|
037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|43749|57450|lyfalmen||||84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||43749||43749|57450|
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|||0|0|E|0|ROC|0|0|0|100|DKK|2387|4244|lyfalmen|V0434|4244||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2387||2387|4244|
037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|1092|2473|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1092||1092|2473|
037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|||0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen||||100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2188|
037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|||0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen||||250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3514|
037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|8491|12594|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8491|12594|
038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|||0|0|0|0|GSK|0|1|0|100|IKR|664|1499|lyfalmen||||20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1499|
038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|ţpakki||N06AB05|01.04.1993|31.07.2012|R|||0|0|B|0|GSK|0|1|0|100|IKR|1766|2374|lyfalmen||||60|0|60,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1020||1020|2374|
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|||0|0|B|0|GSK|0|1|0|100|IKR|2667|3155|lyfalmen|V0321|2993||100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3155|
038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|||0|0|0|0|SON|0|0|1|100|DKK|988|2330|lyfalmen||||50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||988||988|2330|
038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|2607|4545|lyfalmen||||28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2607||2607|4545|
038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|||0|1|0|1|AEU|0|0|0|100|DKK|165811|209975|lyfsjukr||||1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||165811||165811|209975|
038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|||0|1|0|1|WTE|0|0|0|100|DKK|71667|91825|lyfsjukr||||4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||71667||71667|91825|
039005|L01XA0301|Eloxatin|irţ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|||0|1|0|1|SNO|0|0|0|100|NOK|40469|52671|lyfsjukr||||10|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||40469||40469|52671|
039014|L01XA0301|Eloxatin|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|||0|1|0|1|SNO|0|0|0|100|NOK|67650|86783|lyfsjukr||||20|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||67650||67650|86783|
039141|B01AX0601 |Xarelto|filmhtfl|15|mg|42|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|15766|22331|lyfalmen|V0031|20780||42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||15766|22331|
039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|||0|0|0|0|GLB|0|0|0|100|GBP|7107|10596|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7030||7030|10596|
039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||15|0||D.A.C. ehf|D.A.C. ehf|Terbínafín||||||
039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|||0|1|0|0|SAA|0|0|0|100|NOK|4502|7137|lyfalmen||||20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||4502|7137|
039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|||0|1|0|0|SAA|0|0|0|100|NOK|22057|30227|lyfalmen||||100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||22057|30227|
039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|glas||N06AX03|01.06.2010||R|||0|0|B|0|MYL|0|1|0|100|SEK|3348|5559|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||3348||3348|5559|
039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|||0|0|B|0|MYL|0|0|0|100|SEK|579|1588|lyfalmen|V0541|1544||98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||445||445|1588|
039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|||0|0|B|0|MYL|0|0|0|100|SEK|651|1637|lyfalmen|V0542|1591||98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||481||481|1637|
039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|||0|0|0|0|PER|0|0|1|100|DKK|1225|2655|lyfalmen||||15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1225||1225|2655|
039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|||0|0|0|0|PER|0|0|1|100|DKK|1766|3395|lyfalmen||||22|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1766||1766|3395|
039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|||0|1|0|1|BAM|0|0|0|100|SEK|668|964|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||668||668|964|
039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|1630|2551|lyfalmen|V0110|2314||98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||1149||1149|2551|
039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|||0|0|E|0|AGP|0|0|1|100|GBP|8526|8765|lyfalmen|V0182|8765||42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||5692||5692|8765|
039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|||0|1|0|1|BAM|0|0|0|100|SEK|1082|1562|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1082||1082|1562|
039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|||0|0|E|0|AGP|0|0|1|100|GBP|1847|2065|lyfalmen|V0033|2065||10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||794||794|2065|
040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|||0|1|0|1|BAM|0|0|0|100|SEK|2512|3625|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||2512||2512|3625|
040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2012||R|||0|0|E|0|APC|0|0|1|100|XEU|1236|2670|lyfalmen|V0366|2332||30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1236||1236|2670|
040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|||0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1723|
040822|C10AA0504|Atorvastatin Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|4539|2527|lyfalmen|V0112|2527||100|0|50,0000|Portfarma ehf|Portfarma|Atorvastatín||1132||1132|2527|
041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006||R|||0|0|0|0|BYP|0|0|0|100|SEK|3348|5559|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3348||3348|5559|
041490|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|||0|0|B|0|BLU|0|1|0|100|XEU|2351|3615|lyfalmen|V0318|3615||100|0|100,0000|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Cítalópram||1927||1927|3615|
041704|QI09AX0001|Improvac|stl|300|mcg|20|ml|12|fl||QI09AX00|01.08.2010||R|||0|0|0|0|IPF|1|0|0|100|DKK|26534|46287|vetorma||||240|0||Icepharma hf|Pfizer Limited|GnRF hliđstćđa samtengd próteini||||26534|46287|
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|||0|0|0|0|IBV|0|0|0|100|DKK|4155|7248|vetorma||||100|0||Vistor hf|Intervet International BV|||4155||4155|7248|
041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||100|0||D.A.C. ehf|D.A.C. ehf|Díklófenak||||||
041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|||0|0|B|0|MYL|0|1|0|100|SEK|1198|2618|lyfalmen||||90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1198|2618|
041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|||0|0|0|0|APC|0|0|0|100|XEU|3803|1768|lyfalmen|V0005|1768||28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||577||577|1768|
041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|||0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa||||20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum||||||
042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|||0|0|B|0|AZD|0|0|0|100|SEK|1540|3086|lyfalmen||||25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1540||1540|3086|
042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|12959|18146|lyfsjukr||||500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||12959||12959|18146|
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2399|3462|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2399||2399|3462|
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2900|4185|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2900||2900|4185|
042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|4106|5926|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4106||4106|5926|
042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|4208|6073|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||4208||4208|6073|
042357|N07BA0141|Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín||||||
042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|5361|7737|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5361||5361|7737|
042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|6616|9549|lyfsjukr||||4000|0||Icepharma hf|Fresenius Kabi|Kolvetni||6616||6616|9549|
042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|3585|5174|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3585||3585|5174|
042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2744|3960|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2744||2744|3960|
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2097|3026|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2097||2097|3026|
042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2625|3789|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2625||2625|3789|
042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|3445|4972|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3445||3445|4972|
042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2353|3396|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2353||2353|3396|
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|1695|2446|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1695||1695|2446|
042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|5753|8303|lyfsjukr||||4000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||5753||5753|8303|
042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|1920|2771|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1920||1920|2771|
042549|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|1|dćla|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|730|1978|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||730||730|1978|
042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|||0|0|0|1|FRP|0|0|0|100|DKK|2718|3923|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2718||2718|3923|
042556|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|dćlur|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|13957|20061|lyfalmen||||10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||13957||13957|20061|
042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|1268|2522|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1268||1268|2522|
042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|1890|3760|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1890||1890|3760|
042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|2534|5038|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2534||2534|5038|
042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|5070|9908|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5070||5070|9908|
042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|5830|11367|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5830||5830|11367|
042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2288|3302|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2288||2288|3302|
042669|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|||1|0|0|0|MYL|0|0|0|100|SEK|535|1711|lyfalmen||||30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||535||535|1711|
043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|3210|4633|lyfsjukr||||100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||3210||3210|4633|
043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|22563|16743|lyfalmen|V0516|16359||100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||11524||11524|16743|
043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|||0|0|B|0|GSK|0|0|1|100|GBP|4917|5975|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3652||3652|5975|
043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|5935|8566|lyfsjukr||||100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||5935||5935|8566|
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|||0|0|0|0|PER|0|0|1|100|DKK|533|1708|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||533||533|1708|
043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|||0|0|E|0|ORG|0|0|0|100|DKK|1158|2563|lyfalmen||||30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1158||1158|2563|
043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
043935|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa||||100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat||||||
044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|||0|0|E|0|LVR|0|0|1|100|CHF|12376|18077|lyfalmen|V0034|18077||25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíđ (sykurflétta)||12376||12376|18077|
044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|360156|453878|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||360156|453878|
044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|508244|639729|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||508244|639729|
044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|21872|29995|lyfalmen||||100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||21872||21872|29995|
044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|83542|107390|lyfalmen||||100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||83542||83542|107390|
044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|2531|4441|lyfalmen||||10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2531||2531|4441|
044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|||0|0|0|0|OCO|0|0|0|100|DKK|1972|3923|vetalmen||||3|0||Icepharma hf|Orion Corporation (I)|||1972||1972|3923|
045385|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|10|dćlur|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|6977|10523|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||6977||6977|10523|
045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|1050|1982|lyfalmen|V0109|1798||98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||733||733|1982|
045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|868|1822|lyfalmen|V0108|1663||98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||616||616|1822|
045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|||0|0|0|1|VIL|0|0|0|100|NOK|2833|4089|lyfsjukr||||10|0|2,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||2833||2833|4089|
045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|||0|0|0|1|VIL|0|0|0|100|NOK|5665|8176|lyfsjukr||||10|0|5,0000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||5665||5665|8176|
045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|||0|0|0|0|AGT|0|0|1|100|XEU|355|1465|lyfalmen||||10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||355||355|1465|
046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|||0|0|0|0|PFV|0|0|0|100|DKK|19988|38553|vetalmen||||10|0||Icepharma hf|Pfizer vet.|||19988||19988|38553|
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|||0|0|B|0|ACA|0|0|0|100|XEU|971|2307|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||971||971|2307|
046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|||0|0|E|0|VIS|0|0|0|100|DKK|3716|6062|lyfalmen|V0382|6062||10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3716||3716|6062|
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|639|1853|lyfalmen|V0021|1853||90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||639||639|1853|
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|1050|2415|lyfalmen|V0022|2382||90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1050||1050|2415|
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|1321|2786|lyfalmen|V0023|2765||90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1321||1321|2786|
046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|||0|0|E|0|VIS|0|0|0|100|DKK|6189|9445|lyfalmen|V0383|9445||20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6189||6189|9445|
046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|||0|0|E|0|POF|0|0|0|100|GBP|5050|5641|lyfalmen|V0530|5641||84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||3408||3408|5641|
046767|N04BC0405|Ropinirol Portfarma|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|||0|0|E|0|POF|0|0|0|100|GBP|6336|6676|lyfalmen|V0531|6676||84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||4165||4165|6676|
046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|9844|9036|lyfalmen|V0283|8475||28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||5890||5890|9036|
046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|||0|0|E|0|POF|0|0|0|100|XEU|10227|3564|lyfalmen|V0205|3564||3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||1890||1890|3564|
046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|3176|2336|lyfalmen|V0279|2336||28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||992||992|2336|
047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|1027|2384|lyfalmen||||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1027||1027|2384|
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr||||10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684|
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr||||50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564|
047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|||0|1|0|1|WTE|0|0|0|100|DKK|138923|176231|lyfsjukr||||4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||138923||138923|176231|
047941|N03AX2101|Trobalt|filmhtfl|300|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|25698|34796|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||25698||25698|34796|
047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|11909|7916|lyfalmen|V0420|7313||30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||5071||5071|7916|
047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|22553|18627|lyfalmen|V0421|17841||30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||12814||12814|18627|
048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|||0|0|0|1|BAM|0|0|0|100|SEK|5334|7698|lyfsjukr||||250|0||Icepharma hf|Baxter Medical AB|Albúmín||5334||5334|7698|
048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|8269|11934|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8269||8269|11934|
048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|||0|0|0|1|BAM|0|0|0|100|SEK|8419|12151|lyfsjukr||||100|0||Icepharma hf|Baxter Medical AB|Albúmín||8419||8419|12151|
048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|2551|3150|lyfalmen|V0324|2466||100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1587||1587|3150|
048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|0|0|APC|0|1|0|100|XEU|2369|3462|lyfalmen|V0035|3462||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1815||1815|3462|
048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|7355|5272|lyfalmen|V0325|4753||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3138||3138|5272|
048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|7225|5054|lyfalmen|V0326|4623||100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2979||2979|5054|
048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|0|0|APC|0|1|0|100|XEU|3706|4277|lyfalmen|V0246|4277||28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2411||2411|4277|
048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|14448|5054|lyfalmen|V0327|4623||100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2979||2979|5054|
048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|||0|0|E|0|MAB|0|0|0|100|DKK|1107|2493|lyfalmen||||100|0||Vistor hf|Meda AB|Klídín og geđlyf||1107||1107|2493|
048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|||0|0|0|0|MSD|0|0|0|100|DKK|13148|19046|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||13148||13148|19046|
048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|||0|0|B|0|REP|0|0|0|100|SEK|4160|6670|lyfalmen||||100|0|66,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||4160||4160|6670|
048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1986||R|||0|0|0|0|ORG|0|0|0|100|DKK|1696|3299|lyfalmen||||63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1696||1696|3299|
048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|||0|1|*|0|ROC|0|0|0|100|DKK|58302|72508|lyfalmen|V0187|37502||150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||55747||55747|72508|
048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|||0|1|0|1|GZE|0|0|0|100|XEU|932639|1172344|lyfsjukr||||1|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||932639||932639|1172344|
048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|||0|0|0|0|GSH|0|0|1|100|DKK|456|1603|lyfalmen|V0230|1517||100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||456||456|1603|
049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|||0|0|E|0|ACA|0|0|0|100|XEU|2310|4139|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2310||2310|4139|
049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|16399|23126|lyfalmen||||3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||16399||16399|23126|
049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|||0|0|E|0|BOI|0|0|0|100|DKK|2267|4080|lyfalmen||||100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2267||2267|4080|
049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|||0|0|0|0|GAN|0|0|1|100|CHF|6318|9622|lyfalmen||||5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||6318||6318|9622|
049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|1059|1805|lyfalmen|V0108|1663||98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||604||604|1805|
049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|1154|1961|lyfalmen|V0109|1798||98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||718||718|1961|
049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|1827|2551|lyfalmen|V0110|2361||100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1149||1149|2551|
049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|||0|0|0|0|NOH|0|0|0|100|IKR|8006|4999|lyfalmen|V0123|3370||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4999|
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|||0|0|B|0|ACA|0|0|0|100|XEU|1129|2511|lyfalmen||||100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1120||1120|2511|
049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|||0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa||||30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||||
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|||0|0|B|0|ACA|0|0|0|100|XEU|2327|3492|lyfalmen||||100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1837||1837|3492|
049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól||||||
049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól||||||
049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen||||10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1417|
049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|||0|1|*|0|ROC|0|0|0|100|DKK|58302|75714|lyfalmen|V0470|71781||300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||58302||58302|75714|
050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|||0|1|0|1|BAP|0|0|0|100|SEK|571141|718664|lyfsjukr||||112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||571141||571141|718664|
050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|67884|87077|lyfsjukr||||7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||67884|87077|
050483|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|7108|3086|lyfalmen|V0012|2864||56|0|74,6700|Portfarma ehf|Portfarma|Esómeprazól||1540||1540|3086|
050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|||0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||||
050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|3131|5262|lyfalmen||||14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3131||3131|5262|
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|12266|17939|lyfalmen||||56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||12266||12266|17939|
050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|||0|0|E|0|PER|0|0|0|100|DKK|5206|4932|lyfalmen|V0042|4456||100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||2890||2890|4932|
050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|||0|0|0|0|AGT|0|0|0|100|XEU|4615|6646|lyfalmen|V0002|6646||100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4143||4143|6646|
050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|||0|0|E|0|AGT|0|0|0|100|XEU|4435|4385|lyfalmen|V0006|4217||100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2490||2490|4385|
050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|||0|0|E|0|AGT|0|0|0|100|XEU|10597|5077|lyfalmen||||100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2996||2996|5077|
051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|1609|3180|lyfalmen||||100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1609||1609|3180|
051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|||0|0|B|0|DAC|0|0|0|100|DKK|6522|8129|lyfalmen||||60|0||D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||5227||5227|8129|
051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|1662|3252|lyfalmen||||100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1662||1662|3252|
051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1437|2592|lyfalmen|V0363|2592||30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1179||1179|2592|
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|3908|5486|lyfalmen|V0365|5486||100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3295||3295|5486|
051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|||0|0|0|1|UCB|0|0|0|100|DKK|28695|37895|lyfsjukr||||50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||28695||28695|37895|
051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|||0|0|B|0|POF|0|0|0|100|XEU|1488|1900|lyfalmen|V0056|1737||100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||673||673|1900|
051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|||0|0|B|0|POF|0|0|0|100|XEU|2518|2133|lyfalmen|V0057|2133||100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||844||844|2133|
051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|sk|1|stauk||R03AC03|01.07.2012||R|||0|0|B|0|AZD|0|0|1|100|SEK|992|2336|lyfalmen||||100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||992||992|2336|
052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|215|1273|lyfalmen|V0047|1273||20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||215||215|1273|
052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|508|1674|lyfalmen|V0305|996||50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||508||508|1674|
052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|324727|409415|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||324727||324727|409415|
052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|360|1471|lyfalmen|V0439|1471||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||360|1471|
052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|1154|2558|lyfalmen||||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1154||1154|2558|
052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|740|1991|lyfalmen|V0305|1991||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||740||740|1991|
052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|678355|853218|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||678355||678355|853218|
052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|601237|756435|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||601237||601237|756435|
052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|||0|0|*|0|ALL|0|0|0|100|SEK|3803|6181|lyfalmen||||3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3803||3803|6181|
052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||2|0||D.A.C. ehf|D.A.C. ehf|Acíklóvír||||||
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|35119|45957|lyfsjukr||||8212|0||Icepharma hf|Fresenius Kabi|Blöndur||35119||35119|45957|
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|28550|37713|lyfsjukr||||7698|0||Icepharma hf|Fresenius Kabi|Blöndur||28550||28550|37713|
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|30140|39708|lyfsjukr||||7680|0||Icepharma hf|Fresenius Kabi|Blöndur||30140||30140|39708|
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|25216|33529|lyfsjukr||||7200|0||Icepharma hf|Fresenius Kabi|Blöndur||25216||25216|33529|
052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|33912|44442|lyfsjukr||||7880|0||Icepharma hf|Fresenius Kabi|Blöndur||33912||33912|44442|
052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|31489|41401|lyfsjukr||||7616|0||Icepharma hf|Fresenius Kabi|Blöndur||31489||31489|41401|
052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|||0|0|*|0|NAS|0|0|0|100|DKK|14659|20942|lyfalmen||||6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||14659||14659|20942|
052979|J01CF0103|Dicloxacillin Arrow|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.06.2012||R|||0|0|0|0|PCO|0|0|1|100|DKK|1820|3421|lyfalmen||||30|1|3,7500|Distica|Distica - óskráđ lyf|Díkloxacillín||1785||1785|3421|
053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|||0|0|0|0|MYL|0|0|0|100|SEK|2401|4090|lyfalmen|V0313|4036||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2274||2274|4090|
053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|||0|0|0|0|BAP|0|0|0|100|SEK|2258|4068|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2258||2258|4068|
053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|||0|1|0|1|ABT|0|0|0|100|DKK|59048|75988|lyfsjukr||||120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||59048||59048|75988|
053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|||0|0|B|0|SNO|0|0|0|100|NOK|5443|8425|lyfalmen||||100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||5443||5443|8425|
053231|J07BB0201|Fluarix|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|6156|9400|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||6156||6156|9400|
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|||0|1|*|0|SDE|0|0|0|100|NOK|38412|50752|lyfalmen|V0453|41267||100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||38412||38412|50752|
053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|||0|1|*|0|SDE|0|0|0|100|NOK|32243|43010|lyfalmen|V0454|37217||100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||32243||32243|43010|
053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|||0|0|0|0|MYL|0|0|1|100|SEK|640|1749|lyfalmen|V0060|1039||20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||563||563|1749|
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|||1|0|0|0|MAP|0|0|0|100|GBP|15729|22285|lyfalmen||||10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||15729||15729|22285|
053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|||0|0|0|0|OTS|0|1|0|100|DKK|1469|2988|lyfalmen||||1|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1469||1469|2988|
053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|1095|2477|lyfalmen||||30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1095||1095|2477|
054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|7406|10187|lyfalmen|V0490|10187||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||6731||6731|10187|
054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|||0|0|0|0|MEX|0|0|0|100|XEU|2474|4363|lyfalmen||||0|0||Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2474||2474|4363|
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||||
054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|||0|0|0|0|LEP|0|0|1|100|DKK|2589|4521|lyfalmen||||15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2589||2589|4521|
054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|||0|0|0|0|LEP|0|0|1|100|DKK|3570|5862|lyfalmen||||20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3570||3570|5862|
054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|||0|1|0|1|ROA|0|0|0|100|DKK|61301|78815|lyfsjukr||||56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||61301||61301|78815|
054376|B05AA0113|Albunorm 20%|irl|200|g/líter|100|ml|1|fl|lausn|B05AA01|01.06.2012||R|||0|0|0|1|OCT|0|0|0|100|DKK|9345|13487|lyfsjukr||||100|0||Vistor hf|Octapharma AB|Albúmín||9345||9345|13487|
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|||0|0|0|0|UCN|0|0|1|100|SEK|1103|2488|lyfalmen||||200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1103||1103|2488|
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|||0|0|0|0|ACA|0|1|0|100|XEU|1612|3184|lyfalmen|V0061|3184||30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1612||1612|3184|
054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|||1|0|0|0|REB|0|0|0|100|DKK|4555|8919|vetalmen||||10|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Buprenorphinhýdróklóríđ||||4555|8919|
054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|||0|0|0|0|PAL|1|0|0|100|DKK|7376|12867|vetorma||||20|0||Icepharma hf|Pfizer Oy Animal Health|||7376||7376|12867|
055164|S01AX2201|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AX22|01.08.2010||R|||0|0|0|0|ALA|0|0|1|100|USD|1746|3367|lyfalmen||||5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxasín hýdróklóríđ||||1746|3367|
055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|||0|0|0|0|REP|0|0|1|100|SEK|787|2055|lyfalmen||||20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||787||787|2055|
055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|||1|0|E|0|PER|0|0|0|100|DKK|8836|13066|lyfalmen||||100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||8836||8836|13066|
055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|2064|2980|lyfalmen|V0467|2843||56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1463||1463|2980|
055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|E|0|ACA|0|0|0|100|IKR|4539|2527|lyfalmen|V0112|2527||100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2527|
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|0|0|ACA|0|0|0|100|IKR|6185|3246|lyfalmen|V0113|3246||100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1657||1657|3246|
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|0|0|ACA|0|0|0|100|IKR|7867|6047|lyfalmen|V0114|6047||100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|6047|
056183|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|18477|25734|lyfalmen|V0459|24704||100|0|50,0000|Vistor hf|AstraZeneca AB|Ticagrelor||18477||18477|25734|
056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|||0|0|0|0|CES|1|0|0|100|XEU|25837|45071|vetorma||||10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||25837||25837|45071|
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|||0|0|0|0|REP|0|0|1|100|SEK|1281|2731|lyfalmen||||40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1281||1281|2731|
056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til skömmtunar|N06AX16|01.10.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|3562|5852|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3562|5852|
056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|til skömmtunar|N06AX16|01.10.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|3562|5852|lyfalmen||||100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3562|5852|
056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|||0|0|E|0|MAB|0|0|1|100|DKK|2874|4910|lyfalmen||||15|0||Vistor hf|Meda AB|Pímekrólímus||2874||2874|4910|
056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|||0|1|0|1|EPI|0|0|0|100|XEU|222846|281554|lyfsjukr||||15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||222846||222846|281554|
056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|||0|1|0|1|POF|0|0|0|100|DKK|55637|71707|lyfsjukr||||30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||55637||55637|71707|
057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|11504|16716|lyfalmen|V0095|13034||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||11504||11504|16716|
057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|11266|16021|lyfsjukr||||5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||11266||11266|16021|
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|6478|9349|lyfsjukr||||5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||6478||6478|9349|
057367|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl|lausn|J06BA02|01.10.2011||R|||0|0|0|1|BAA|0|0|0|100|SEK|245635|310154|lyfsjukr||||300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||245635||245635|310154|
057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|23511|27473|lyfalmen|V0350|27473||84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||19863||19863|27473|
057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|||0|0|0|1|FRP|0|0|0|100|DKK|4687|6765|lyfsjukr||||200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||4687||4687|6765|
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|3572|5155|lyfsjukr||||5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||3572||3572|5155|
057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|358718|452074|lyfsjukr||||50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||358718||358718|452074|
057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|||0|1|0|1|JAS|0|0|0|100|SEK|550728|693046|lyfsjukr||||120|0||Vistor hf|Janssen-Cilag AB|Abírateron||550728||550728|693046|
057703|J01DD0401|Rocephalin|irţ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|23745|31682|lyfsjukr||||5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||23745||23745|31682|
058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|||0|0|0|0|IPI|0|0|1|100|DKK|19329|26803|lyfalmen||||112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||19329|26803|
058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|||0|0|E|0|BOI|0|0|0|100|DKK|409|1538|lyfalmen||||5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||409||409|1538|
058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|129772|164746|lyfsjukr||||30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||129772||129772|164746|
058283|QI01AD040|Avipro Thymovac|frţlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|||0|0|0|0|LOH|0|0|0|100|XEU|155226|270784|vetorma||||5000|0||Icepharma hf|Lohmann Animal Health|||||155226|270784|
058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|||0|0|0|0|LOH|0|0|0|100|XEU|235803|411347|vetorma||||10000|0||Icepharma hf|Lohmann Animal Health|||||235803|411347|
058397|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|||0|0|0|0|SPM|0|0|0|100|XEU|16668|23463|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||16668||16668|23463|
058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|1037|2397|lyfalmen||||100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1037||1037|2397|
058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|96124|122518|lyfsjukr||||210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||96124||96124|122518|
058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|42071|55344|lyfalmen||||1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||42071||42071|55344|
058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|1229|2660|lyfalmen||||100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1229||1229|2660|
058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|2292|4114|lyfalmen||||100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2292||2292|4114|
058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07CA06|01.03.1999|31.08.2012|R|||0|0|0|0|GSK|0|0|0|100|GBP|4540|7189|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4540||4540|7189|
059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|||0|0|0|0|AGT|0|0|0|100|XEU|2374|2972|lyfalmen|V0006|2362||56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1457||1457|2972|
059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|||0|0|B|0|REP|0|0|0|100|SEK|1526|3066|lyfalmen||||250|0|20,8300|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1526||1526|3066|
059295|S01AA0104|Kloramfenikol - Lyfjaver|augnsm|1|%|5|g|1|túpa||S01AA01|01.06.2012||R|||0|0|E|0|LAL|0|0|1|100|IKR|2297|4121|lyfalmen||||5|1||Lyfjaver ehf|Lyfjaver ehf|Klóramfeníkól||2297||2297|4121|
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|||0|1|*|0|ASP|0|0|0|100|XEU|94998|121768|lyfalmen||||2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||94998||94998|121768|
059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|10|spr||J07CA06|01.01.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|33248|44271|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||33248||33248|44271|
059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|||0|1|0|1|POF|0|0|0|100|DKK|86809|110828|lyfsjukr||||30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||86809||86809|110828|
059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|||0|0|E|0|BPC|0|0|0|100|SEK|41088|47385|lyfalmen||||30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||35729||35729|47385|
059870|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.11.2010||R|||0|1|*|0|APE|0|0|0|100|XEU|52684|68664|lyfalmen||||50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||52684||52684|68664|
060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|||0|1|0|0|NOE|0|0|0|100|DKK|361038|455648|lyfalmen||||84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||361038||361038|455648|
060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|||0|1|0|0|NOE|0|0|0|100|DKK|180534|229115|lyfalmen||||84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||180534||180534|229115|
060848|N06AA0402|Anafranil Retard|forđatfl|75|mg|100|stk|1|ţpakki||N06AA04|01.10.1989||R|||0|0|B|0|NOH|0|1|0|100|DKK|5402|8369|lyfalmen||||100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||5402||5402|8369|
061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|||0|0|0|0|PFA|0|0|0|100|DKK|2633|5228|vetalmen||||4|0||Icepharma hf|Pfizer Animal Health|||||2633|5228|
061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|||0|0|0|0|PFA|0|0|0|100|DKK|1379|2743|vetalmen||||4|0||Icepharma hf|Pfizer Animal Health|||||1379|2743|
061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|||0|0|0|0|PFA|1|0|0|100|DKK|8148|15818|vetalmen||||20|0||Icepharma hf|Pfizer Animal Health|||||8148|15818|
061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|||0|0|E|0|DAC|0|0|0|100|DKK|6692|10133|lyfalmen|V0133|10133||84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||6692||6692|10133|
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|||0|0|0|0|PER|0|0|1|100|IKR|||lyflausa||||50|0||Icepharma hf|Pfizer ApS|Píroxíkam||||||
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|||0|0|E|0|ORG|0|0|0|100|DKK|6693|10135|lyfalmen|V0133|10133||84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||6693||6693|10135|
061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|1|spr||QP52AF02|01.04.1992||L|||0|0|0|0|PAL|0|0|0|100|DKK|1631|2845|vetorma||||26|0||Icepharma hf|Pfizer Oy Animal Health|||||1631|2845|
061715|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.05.2008||R|||0|1|0|1|IPI|0|0|0|100|DKK|153192|194138|lyfsjukr||||1|0||Icepharma hf|Pfizer Limited|Temsirolímus||153192||153192|194138|
061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|||0|0|0|1|NOH|0|0|0|100|DKK|4253|6138|lyfsjukr||||10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4253||4253|6138|
061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|||0|1|0|1|NOE|0|0|0|100|DKK|15186|20941|lyfsjukr||||1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||15186||15186|20941|
061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|||0|1|0|1|NOE|0|0|0|100|DKK|21380|28714|lyfsjukr||||1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||21380||21380|28714|
062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|440|1581|lyfalmen|V0307|1445||30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||440||440|1581|
062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|||0|1|*|0|AGP|0|0|0|100|XEU|57061|37502|lyfalmen|V0187|37502||150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||27854||27854|37502|
062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|1580|3140|lyfalmen||||10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1580||1580|3140|
062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|6374|9199|lyfsjukr||||20|0||Icepharma hf|Pfizer ApS|Metótrexat||6374||6374|9199|
062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|435|628|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Metótrexat||435||435|628|
062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|0|100|DKK|887|2192|lyfalmen|V0308|1924||60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||887||887|2192|
062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|||0|0|E|0|AGT|0|0|1|100|XEU|1769|3399|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1769||1769|3399|
062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|||0|0|0|0|BAN|0|0|0|100|DKK|17245|30083|vetorma||||1000|0||Icepharma hf|Bayer Animal Health GmbH|||17245||17245|30083|
062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|40581|52812|lyfsjukr||||2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||40581||40581|52812|
062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|49546|64063|lyfsjukr||||2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||49546||49546|64063|
062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|||0|0|0|0|GLB|0|0|0|100|GBP|16482|16305|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||11204||11204|16305|
063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|||0|0|E|0|NOH|0|0|1|100|DKK|4032|6494|lyfalmen||||10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4032||4032|6494|
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|||0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen||||500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2864|
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|||0|0|0|0|ACA|0|0|0|100|XEU|2427|3679|lyfalmen|V0123|3370||28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1974||1974|3679|
063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|||0|0|E|0|DAC|0|0|1|100|XEU|4328|6010|lyfalmen|V0458|6010||100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||3678||3678|6010|
063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|7452|10755|lyfsjukr||||2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7452||7452|10755|
063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|||0|0|0|0|PAS|0|0|0|100|XEU|2425|4230|vetorma||||12|0||Vistor hf|Pfizer Oy Animal Health|||2425||2425|4230|
063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|932|2254|lyfalmen|V0309|1986||30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||932||932|2254|
063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|0|100|DKK|1952|3649|lyfalmen|V0310|3102||60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1952||1952|3649|
064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|1037989|1304559|lyfsjukr||||20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1037989|1304559|
064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|415195|522952|lyfsjukr||||20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||415195|522952|
064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|2049|3782|lyfalmen|V0311|3164||30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2049||2049|3782|
064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|4151959|5212591|lyfsjukr||||20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4151959|5212591|
064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|2075980|2607237|lyfsjukr||||20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2075980|2607237|
064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|||0|0|E|0|BOI|0|0|0|100|DKK|2012|3731|lyfalmen||||100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2012||2012|3731|
064733|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|||0|0|0|0|SPM|0|0|0|100|XEU|788|2057|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||788||788|2057|
064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|||0|0|0|1|OCT|0|0|0|100|DKK|56058|72235|lyfsjukr||||1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||56058||56058|72235|
065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|||0|0|0|0|SLL|0|0|0|100|DKK|1870|3537|lyfalmen||||25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1870||1870|3537|
065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól||||||
065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól||||||
065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|15100|20833|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jódixanól||15100||15100|20833|
065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|||0|0|*|0|PER|0|0|0|100|DKK|2397|3608|lyfalmen|V0376|2062||2|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1922||1922|3608|
065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.06.2011||R|||0|1|*|0|LVR|0|0|0|100|SEK|61330|76945|lyfalmen|V0451|76945||1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||59283||59283|76945|
065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|||0|0|*|0|PER|0|0|0|100|DKK|7186|10378|lyfalmen|V0376|6185||8|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||6871||6871|10378|
065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|4683|6759|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4683||4683|6759|
066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|||0|0|0|0|DOR|1|0|0|100|DKK|3911|7682|vetalmen||||100|0||Icepharma hf|Dopharma Reserch B.V|||3911||3911|7682|
066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|6399|9732|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||6399||6399|9732|
066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|||0|0|0|1|FRP|0|0|0|100|DKK|31521|41441|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||31521||31521|41441|
066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|||0|0|0|0|GOG|0|0|1|100|DKK|811|2088|lyfalmen||||51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||811||811|2088|
066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr||||120|0||Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603|
066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|||0|0|B|0|DAC|0|0|0|100|NOK|1494|3023|lyfalmen|V0036|3023||30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1494||1494|3023|
066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|||0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||||
066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|||0|1|0|1|AGP|0|0|0|100|XEU|14629|20242|lyfsjukr||||50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||14629||14629|20242|
067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|8270|11936|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8270||8270|11936|
067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|||0|0|0|0|UCN|0|0|0|100|SEK|1471|2991|lyfalmen||||100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1471||1471|2991|
067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|||0|0|*|0|APC|0|0|0|100|DKK|1776|2488|lyfalmen|V0376|2062||2|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1103||1103|2488|
067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|1567|2842|lyfalmen|V0179|1824||7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1362||1362|2842|
067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|5748|7816|lyfalmen|V0179|7816||30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||4998||4998|7816|
067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|664|1768|lyfalmen|V0180|875||1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1768|
067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|612|1749|lyfalmen|V0180|1749||2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1749|
067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|2031|3757|lyfalmen|V0180|3498||4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||2031||2031|3757|
067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|14199|13437|lyfalmen|V0419|13437||30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||9107||9107|13437|
068043|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|2|glas|sk-úđari|R01AA07|01.02.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|||1|0|0|0|VEQ|1|0|0|100|XEU|5837|11380|vetalmen||||50|0||Icepharma hf|Vétoquinol AG|||5837||5837|11380|
068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|107616|136941|lyfsjukr||||15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||107616||107616|136941|
068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|||0|1|0|1|GTS|0|0|0|100|GBP|79163|101232|lyfsjukr||||14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||79163||79163|101232|
068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|||0|1|B|0|MEB|0|0|0|100|SEK|1801|3443|lyfalmen||||20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1801||1801|3443|
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|||0|1|B|0|MEB|0|0|0|100|SEK|5963|9136|lyfalmen||||100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||5963||5963|9136|
068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|||0|0|E|0|MED|0|0|0|100|XEU|25330|14189|lyfalmen|V0342|14189||98|0|130,6600|Medical ehf|Medical ehf|Dónepezíl||9657||9657|14189|
068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|2405|3471|lyfsjukr||||400|0||Actavis Group hf|Braun|Natríumklóríđ||2405||2405|3471|
068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|2993|4320|lyfsjukr||||400|0||Actavis Group hf|Braun|Kalíumklóríđ||2993||2993|4320|
068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
068951|V07AB09|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
068960|V07AB09|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
069106|H01BA0201|Minirin|frţ.tfl|240|mcg|30|stk|1|ţpakki||H01BA02|01.08.2012||R|||0|0|E|0|FEL|0|0|0|100|DKK|13550|19550|lyfalmen||||30|0|18,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13550||13550|19550|
069115|H01BA0201|Minirin|frţ.tfl|240|mcg|100|stk|1|ţpakki||H01BA02|01.08.2012||R|||0|0|E|0|FEL|0|0|0|100|DKK|42768|56219|lyfalmen||||100|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||42768||42768|56219|
069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||||
069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|411|1365|lyfalmen|V0448|1365||100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||282||282|1365|
070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|18566|25845|lyfalmen||||1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||18566|25845|
070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|26853|36246|lyfalmen||||1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||26853|36246|
070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|34776|46189|lyfalmen||||1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||34776|46189|
070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|NOK|45751|59300|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||45751||45751|59300|
070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|||0|0|0|0|PAB|1|0|0|100|IKR|10511|20355|vetalmen||||100|0||Vistor hf|Pharmaxim AB|||10511||10511|20355|
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|||0|0|*|0|JAS|0|1|0|100|SEK|12619|18382|lyfalmen||||100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||12619||12619|18382|
071076|QA12CE9902|Selevitan, vet.|kyrni|||1250|g|1|plbrús||QA12CE99|01.12.2006||R|||0|0|0|0|PAB|0|0|0|100|SEK|6341|12348|vetalmen||||1250|0||Vistor hf|Pharmaxim AB|||6341||6341|12348|
071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|||0|0|*|0|ACA|0|1|0|100|XEU|667|1891|lyfalmen||||100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||667||667|1891|
071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|||0|1|0|1|EIS|0|0|0|100|SEK|66954|85910|lyfsjukr||||1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||66954||66954|85910|
071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|||0|1|0|1|EIS|0|0|0|100|SEK|334771|422020|lyfsjukr||||5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||334771||334771|422020|
071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|8703|12884|lyfalmen||||30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||8703|12884|
071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|10395|9027|lyfalmen|V0144|8585||12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||5883||5883|9027|
071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|||0|1|0|1|GZE|0|0|0|100|SEK|90196|115078|lyfsjukr||||20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||90196|115078|
072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|||0|0|E|0|PSA|0|0|0|100|XEU|3014|2001|lyfalmen|V0009|2001||30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||747||747|2001|
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|||0|0|0|0|ORF|1|0|0|100|DKK|6722|13080|vetalmen||||5|0||Vistor hf|Orion-Farmos|||6722||6722|13080|
072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|||0|0|E|0|PSA|0|0|0|100|XEU|9478|7921|lyfalmen|V0029|7726||100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||5075||5075|7921|
072520|V01AA1104|Alutard SQ, hrossavćrur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18293|25503|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||18293||18293|25503|
072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr||||20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946|
072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr||||20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946|
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|||1|0|0|1|JAS|0|0|0|100|SEK|657|948|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||657||657|948|
072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|||0|1|0|1|ABB|0|0|0|100|DKK|141853|179908|lyfsjukr||||2|0|27,5900|Vistor hf|Abbott|Adalimumab||141853||141853|179908|
072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|||0|0|*|0|ELD|0|0|0|100|XEU|15794|22367|lyfalmen||||1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||15794||15794|22367|
072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|||0|0|*|0|ELD|0|0|0|100|XEU|15794|22367|lyfalmen||||2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||15794||15794|22367|
073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|75234|96301|lyfsjukr||||60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||75234||75234|96301|
073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1009|2359|lyfalmen||||100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1009||1009|2359|
073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|||0|0|E|0|GSK|0|0|0|100|GBP|3802|6180|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||3802||3802|6180|
073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1571|3128|lyfalmen||||100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1571||1571|3128|
073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|48917|23138|lyfalmen|V0185|20925||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||16409||16409|23138|
073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|684|1551|lyfalmen|V0066|1551||100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||418||418|1551|
073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|1|100|DKK|292|1378|lyfalmen|V0047|1273||20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||292||292|1378|
073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|718|1961|lyfalmen|V0305|996||50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||718||718|1961|
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|917|2233|lyfalmen|V0305|1991||100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||917||917|2233|
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|1|100|DKK|494|1655|lyfalmen|V0439|1471||20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||494||494|1655|
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|1341|2813|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1341||1341|2813|
073935|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA03|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|3558|6207|vetorma||||1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3558||3558|6207|
073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|||0|0|*|0|APT|0|0|0|100|GBP|1351|2827|lyfalmen||||50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||1351||1351|2827|
074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.12.2009||R|||0|0|0|0|DAC|0|0|0|100|DKK|4442|7055|lyfalmen|V0142|7055||4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4442||4442|7055|
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|||0|0|0|0|NOE|0|0|0|100|DKK|3435|5678|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3435||3435|5678|
074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007|30.06.2012|R|||0|0|0|0|NOE|0|0|0|100|DKK|4839|7598|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4839||4839|7598|
074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|||0|0|E|0|DAC|0|0|1|100|GBP|424|1553|lyfalmen||||28|0|350,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||420||420|1553|31.08.2012
074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|17288|23579|lyfsjukr||||50|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||17288||17288|23579|
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|458|1605|lyfalmen||||25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||458||458|1605|
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|||0|0|0|0|AGT|0|0|1|100|DKK|655|1875|lyfalmen||||50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||655||655|1875|
074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|||0|0|0|0|AGT|0|0|0|100|DKK|1031|2389|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1031||1031|2389|
074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|||0|0|0|0|SCA|1|0|0|100|DKK|19807|34552|vetorma||||25|0||Vistor hf|Scan Vet Animal Health AS|||19807||19807|34552|
074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|||0|0|B|0|AUK|0|1|0|100|GBP|416|1548|lyfalmen|V0510|1506||98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||416||416|1548|
074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|||0|0|B|0|AUK|0|1|0|100|GBP|760|1978|lyfalmen|V0512|1943||98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||730||730|1978|
074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|||0|0|B|0|AEG|0|0|0|100|GBP|963|2296|lyfalmen||||60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||963||963|2296|
074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|||0|0|B|0|APT|0|0|0|100|GBP|514|1682|lyfalmen||||100|0|100,0000|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Digoxín||514||514|1682|
075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|||0|0|*|0|APT|0|0|0|100|GBP|2573|4455|lyfalmen||||100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||2541||2541|4455|
075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|4677|7377|lyfalmen||||30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4677||4677|7377|
075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|14030|20153|lyfalmen||||90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14030||14030|20153|
075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|ţpakki||J02AB02|01.01.1985||R|||0|0|0|0|JAS|0|0|1|100|SEK|1786|3422|lyfalmen||||10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1786||1786|3422|
075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|4677|7377|lyfalmen||||30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4677||4677|7377|
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|1931|2741|lyfalmen|V0363|2592||30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1288||1288|2741|
075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|14030|20153|lyfalmen||||90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14030||14030|20153|
075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|||1|0|0|0|ACA|0|0|1|100|XEU|1786|3422|lyfalmen||||300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1786||1786|3422|
075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|||1|0|0|0|ACA|0|0|1|100|NOK|3030|5124|lyfalmen||||300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||3030||3030|5124|
075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|||0|0|0|0|NBV|0|0|0|100|XEU|2490|4385|lyfalmen||||4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2490|4385|
075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|||0|0|E|0|LVR|0|0|1|100|DKK|12703|18487|lyfalmen|V0196|18487||100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||12703||12703|18487|
075356|G04BD0703|Detrusitol SR (Lyfjaver)|forđahlk|4|mg|84|stk|1|ţpakki||G04BD07|01.07.2011||R|||0|0|E|0|LVR|0|0|0|100|DKK|17078|23978|lyfalmen||||84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Tólteródín||||17078|23978|
075382|V04CL0030|Soluprick SQ, rauđölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075413|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|||0|0|E|0|LVR|0|0|0|100|XEU|19057|26462|lyfalmen|V0441|26462||90|0|180,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||19057||19057|26462|
075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075425|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|||0|0|E|0|LVR|0|0|0|100|XEU|15517|22019|lyfalmen|V0440|22019||90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||15517||15517|22019|
075440|V04CL0026|Soluprick SQ, hesliviđur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|||0|0|E|0|POF|0|0|0|100|XEU|3921|5258|lyfalmen|V0445|5258||98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||3128||3128|5258|
075465|V04CL0024|Soluprick SQ, haliđagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|||0|1|0|1|AVS|0|0|0|100|NOK|30591|40274|lyfsjukr||||1|0||Vistor hf|Aventis Pharma SA|Docetaxel||30591||30591|40274|
075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|||0|1|0|1|AVS|0|0|0|100|NOK|114819|145980|lyfsjukr||||4|0||Vistor hf|Aventis Pharma SA|Docetaxel||114819||114819|145980|
075507|V04CL0018|Soluprick SQ, axhnođapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075689|V04CL0027|Soluprick SQ, hrossavćrur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
075724|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|93601|119352|lyfsjukr||||1000|0|2,2200|Icepharma hf|Wyeth Europe|Storkuţáttur IX||93601||93601|119352|
075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|||0|0|0|0|DEC|0|0|0|100|DKK|915|1820|vetalmen||||20|0||Vistor hf|Dechra Veterinary Products A/S|||915||915|1820|
075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|5791|8358|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5791||5791|8358|
075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|5791|8358|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5791||5791|8358|
075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|5791|8358|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5791||5791|8358|
075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|||0|0|0|0|AUK|0|0|0|100|GBP|446|1589|lyfalmen||||28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||446||446|1589|
075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|||0|0|0|0|AEA|0|0|1|100|XEU|430|1567|lyfalmen||||20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||430||430|1567|
075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|853|1816|lyfalmen|V0449|1816||100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||612||612|1816|
076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|||0|0|*|0|MSD|0|0|0|100|DKK|6268|9553|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6268||6268|9553|
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|||0|0|*|0|MSD|0|0|0|100|DKK|21347|29336|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||21347||21347|29336|
076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.12.2009||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||2|0||Ísaga ehf|AGA AB|Súrefni||||||
076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|0|0|POF|0|1|0|100|IKR|445|1588|lyfalmen|V0045|1588||20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1588|
076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|*|0|POF|0|1|0|100|IKR|1986|3099|lyfalmen|V0290|3099||60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3099|
076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|*|0|POF|0|1|0|100|IKR|1946|3373|lyfalmen|V0291|3373||60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1750||1750|3373|
076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|843|2132|lyfalmen||||100|0|6,6667|Vistor hf|Schering-Plough Europe|Perfenazín||843||843|2132|
076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|1179|2592|lyfalmen||||100|0|13,3333|Vistor hf|Schering-Plough Europe|Perfenazín||||1179|2592|
076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|1681|3278|lyfalmen||||100|0|26,6667|Vistor hf|Schering-Plough Europe|Perfenazín||||1681|3278|
076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|6813|11885|vetorma||||100|0||Vistor hf|Merial (MSD)|||6813||6813|11885|
076814|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009||R|||0|0|0|0|GLB|0|0|0|100|GBP|7107|10596|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7030||7030|10596|
076871|G01AF0202|Canesten (D.A.C.)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa||||1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól||||||
077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|||0|0|0|0|ACA|0|0|1|100|XEU|220|1280|lyfalmen||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||220||220|1280|
077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|||0|0|0|0|ACA|0|0|1|100|XEU|648|1865|lyfalmen||||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||648||648|1865|
077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.07.2010||R|||0|0|E|0|APC|0|0|0|100|XEU|9477|7921|lyfalmen|V0029|7726||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||5075||5075|7921|
077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|||0|0|E|0|GSK|0|0|0|100|GBP|796|2068|lyfalmen||||10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||796||796|2068|
078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||30|0||D.A.C. ehf|D.A.C. ehf|Ekónazól||||||
078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||20|0||D.A.C. ehf|D.A.C. ehf|Klótrímazól||||||
078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009||L|||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa||||4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín||||||
078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||120|0||D.A.C. ehf|D.A.C. ehf|Ketókónazól||||||
078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|11524|12606|lyfalmen|V0419|12541||28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12606|
078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|535|1711|lyfalmen||||20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||535||535|1711|
078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|814|2092|lyfalmen||||40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||814||814|2092|
078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|||0|0|0|0|FPL|0|0|1|100|XEU|1331|2800|lyfalmen|V0560|2800||100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1331||1331|2800|
078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|||0|0|0|0|FPL|0|0|1|100|XEU|1903|3582|lyfalmen|V0561|3582||100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1903||1903|3582|
078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|||0|1|0|1|SAG|0|0|0|100|SEK|124281|157855|lyfsjukr||||15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||124281||124281|157855|
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|||0|0|0|0|MSD|0|0|0|100|DKK|8499|5856|lyfalmen|V0069|2359||98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3565||3565|5856|
079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|2790|4027|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||2790||2790|4027|
079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|4727|6822|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||4727||4727|6822|
079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|8793|12690|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||8793||8793|12690|
079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|||0|0|0|0|RRL|0|0|0|100|DKK|3483|5743|lyfalmen||||10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3483||3483|5743|
079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|||0|0|*|0|SPL|0|1|0|100|DKK|17596|24628|lyfalmen||||10|0|154,5714|Vistor hf|Schering-Plough Europe|Perfenazín||17596||17596|24628|
079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
079370|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.05.2010|31.08.2012|L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|||0|0|B|0|ACA|0|1|0|100|XEU|3329|5533|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3329||3329|5533|
079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|||0|0|0|1|BRS|0|0|0|100|DKK|1976|2852|lyfsjukr||||5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||1976||1976|2852|
080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|||0|0|0|0|ACA|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517||10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1517|
080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|||0|0|0|0|ACA|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852||20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1852|
080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|||0|0|0|0|ACA|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864||10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1864|
080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|||0|0|0|0|ACA|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577||20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2577|
080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|||0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen||||20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745|
080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|||0|0|0|0|ANI|1|0|0|100|XEU|3821|7509|vetalmen||||10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3821|7509|
080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|||0|0|*|0|LYF|0|0|0|100|XEU|16784|17841|lyfalmen|V0421|17841||30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||12188||12188|17841|
080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól||||||
080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|||0|0|0|0|BAN|1|0|0|100|DKK|9734|16980|vetorma||||24|0||Icepharma hf|Bayer Animal Health GmbH|||9734||9734|16980|
080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|||0|0|*|0|RAT|0|0|0|100|XEU|15793|9483|lyfalmen|V0170|9483||30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||6217||6217|9483|
080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|||0|0|*|0|RAT|0|0|0|100|XEU|34898|20925|lyfalmen|V0185|20925||100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||14645||14645|20925|
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|||0|0|B|0|LBK|0|1|0|100|DKK|2143|3910|lyfalmen||||100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2143||2143|3910|
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|||0|0|0|0|GSK|0|1|0|100|GBP|5976|9154|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||5976||5976|9154|
080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|2527|3441|lyfalmen|V0143|2352||4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1800||1800|3441|
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|||0|0|0|0|GSK|0|1|0|100|GBP|3103|5224|lyfalmen||||30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3103||3103|5224|
080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|32515|56721|vetorma||||500|0||Vistor hf|Merial (MSD)|||32515||32515|56721|
080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|7141|7055|lyfalmen|V0143|7055||12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||4442||4442|7055|
080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|2789|3531|lyfalmen|V0144|2862||4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1866||1866|3531|
080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|14261|19780|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||14261||14261|19780|
080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|10396|9027|lyfalmen|V0144|8585||12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||5883||5883|9027|
080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|28115|37167|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||28115||28115|37167|
081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.07.2012||R|||0|0|E|0|ASA|0|0|0|100|SEK|37659|49807|lyfalmen|V0209|49807||12|0|34,7222|Vistor hf|Astra Zeneca A/S|Natríumhýalúrónat||37659||37659|49807|
081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||10|0||Ísaga ehf|AGA AB|Súrefni||||||
081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||20|0||Ísaga ehf|AGA AB|Súrefni||||||
081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||50|0||Ísaga ehf|AGA AB|Súrefni||||||
081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||5|0||Ísaga ehf|AGA AB|Súrefni||||||
081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||600|0||Ísaga ehf|AGA AB|Súrefni||||||
081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||1|0||Ísaga ehf|AGA AB|Súrefni||||||
081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
081624|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.05.2010|31.08.2012|L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||2|0||Ísaga ehf|AGA AB|Súrefni||||||
081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||4|0||Ísaga ehf|AGA AB|Súrefni||||||
081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|7654|5645|lyfalmen|V0515|5515||100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3411||3411|5645|
081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|4394|6990|lyfalmen||||21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4394||4394|6990|
081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||4|0||Ísaga ehf|AGA AB|Súrefni||||||
081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|1741|2513|lyfsjukr||||10|0|3,3333|Icepharma hf|Roche|Mídazólam||1741||1741|2513|
081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.04.2010||R|||0|0|*|0|DAC|0|1|0|100|XEU|18639|14814|lyfalmen|V0456|9109||28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||10114||10114|14814|
081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|||0|0|*|0|SAA|0|0|0|100|NOK|5752|8847|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5752||5752|8847|
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|||0|0|*|0|SDE|0|0|0|100|NOK|8641|12799|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8641||8641|12799|
082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|36139|15482|lyfalmen|V0184|14033||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||10602||10602|15482|
082040|D07XC0101|Diprosalic|áburđur|||100|ml|1|glas||D07XC01|01.01.1987||R|||0|0|B|0|SPL|0|0|1|100|DKK|2138|3904|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2138||2138|3904|
082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kćlt|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||36|0||Ísaga ehf|AGA AB|Súrefni||||||
082685|R03BA0502|Flixotide Diskus|innúđadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|3198|4875|lyfalmen||||60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2848||2848|4875|
082719|R03BA0502|Flixotide Diskus|innúđadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|5667|8731|lyfalmen||||60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5667||5667|8731|
082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|||0|0|0|0|MYL|0|0|1|100|SEK|933|2255|lyfalmen||||125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||933||933|2255|
082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|||0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól||||||
082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|4751|7478|lyfalmen||||20|0|1,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4751||4751|7478|
082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|5616|8661|lyfalmen||||20|0|3,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5616||5616|8661|
082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|8549|12085|lyfalmen|V0080|12085||100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||8119||8119|12085|
082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|||0|0|E|0|NOH|0|0|0|100|DKK|12491|18221|lyfalmen||||56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||12491||12491|18221|
083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|||0|0|*|0|AZA|0|0|0|100|SEK|19017|26411|lyfalmen|V0186|7055||28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||19017||19017|26411|
083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|||0|0|E|0|NOH|0|0|0|100|DKK|13046|18918|lyfalmen|V0344|13172||56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13046||13046|18918|
083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|7422|11132|lyfalmen||||20|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7422||7422|11132|
083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|||0|1|0|1|ABL|0|0|0|100|DKK|72905|93378|lyfsjukr||||450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||72905||72905|93378|
083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|||0|0|E|0|NOH|0|0|0|100|DKK|28309|38073|lyfalmen|V0346|28278||112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||28309||28309|38073|
083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|||0|1|0|1|SNO|0|0|0|100|NOK|8233|11882|lyfsjukr||||11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8233||8233|11882|
084097|C09CA0105|Losartan LYFIS|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|2008|2359|lyfalmen|V0069|2359||98|0|98,0000|LYFIS ehf|LYFIS ehf|Lósartan||1009||1009|2359|
084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|255|1328|lyfalmen||||10|0|2,5000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||255||255|1328|
084192|N05BA1206|Alprazolam Krka|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|1|100|XEU|1929|3164|lyfalmen|V0311|3164||30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1597||1597|3164|
084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|492|1652|lyfalmen||||20|0|5,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||492||492|1652|
084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|69471|89069|lyfsjukr||||4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||69471||69471|89069|
084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|58115|74817|lyfsjukr||||0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||58115||58115|74817|
084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|75761|96963|lyfsjukr||||0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||75761||75761|96963|
084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|93726|119509|lyfsjukr||||0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||93726||93726|119509|
084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|19372|26194|lyfsjukr||||0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||19372||19372|26194|
084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|30256|39854|lyfsjukr||||0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||30256||30256|39854|
084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|38743|50505|lyfsjukr||||0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||38743||38743|50505|
084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|11998|16940|lyfsjukr||||0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||11998|16940|
084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|45737|59282|lyfsjukr||||0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||45737|59282|
084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|140867|178671|lyfsjukr||||1|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||140867|178671|
084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|948|2276|lyfalmen||||10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||948||948|2276|
084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|11247|16364|lyfalmen||||60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||11247||11247|16364|
084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|36601|48479|lyfalmen||||100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||36601||36601|48479|
085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|||1|0|E|0|PER|0|0|0|100|DKK|14687|20977|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||14687||14687|20977|
085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|||0|1|*|0|GAN|0|0|0|100|NOK|42700|56134|lyfalmen||||2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||42700||42700|56134|
085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|||0|0|0|0|SAO|0|0|1|100|XEU|2487|4381|lyfalmen||||15|0||Icepharma hf|Santen Oy|Levófloxacín||2487||2487|4381|
085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|||0|0|E|0|NOH|0|0|0|100|DKK|28309|38073|lyfalmen|V0345|28278||112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||28309||28309|38073|
085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|||0|0|0|0|GSK|0|0|1|100|IKR|821|2102|lyfalmen||||20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||821||821|2102|
085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|||0|1|E|0|FEL|0|0|0|100|DKK|19265|26723|lyfalmen|V0412|22232||375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||19265||19265|26723|
085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|||0|1|E|0|FEL|0|0|0|100|DKK|33401|44463|lyfalmen|V0412|44463||750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||33401||33401|44463|
085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|||0|1|0|1|ELD|0|0|0|100|XEU|89211|113842|lyfsjukr||||56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||89211||89211|113842|
085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|||0|0|0|0|AEU|0|0|0|100|DKK|37820|50009|lyfalmen||||1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||37820||37820|50009|
085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|||0|0|*|0|API|0|0|0|100|SEK|2966|5036|lyfalmen|V0465|4323||3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||2966||2966|5036|
085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|||0|0|*|0|API|0|0|0|100|SEK|8766|12970|lyfalmen|V0465|12970||9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||8766||8766|12970|
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|4011|5090|lyfalmen|V0364|4742||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3005||3005|5090|
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|5432|5901|lyfalmen|V0365|5486||100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3598||3598|5901|
086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|||0|0|0|1|GSK|0|0|0|100|GBP|8288|11962|lyfsjukr||||5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8288||8288|11962|
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|||0|0|0|1|GSK|0|0|0|100|GBP|14407|19963|lyfsjukr||||5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||14407||14407|19963|
086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|28628|38473|lyfalmen||||600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||28628||28628|38473|
086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|57256|74401|lyfalmen||||1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||57256||57256|74401|
086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|||0|1|0|1|BSP|0|0|0|100|DKK|50802|65639|lyfsjukr||||1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||50802||50802|65639|
086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|||0|0|0|0|BOY|0|0|0|100|SEK|18338|25559|lyfalmen||||1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||18338||18338|25559|
086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|||0|0|0|1|ROA|0|0|0|100|DKK|47644|61676|lyfsjukr||||100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||47644||47644|61676|
087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998||R|||0|0|E|0|ORG|0|0|0|100|DKK|2826|4845|lyfalmen||||28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||2826||2826|4845|
087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd||||||
087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|ţpakki||N05CF02|01.08.2012||R|||0|0|0|0|SNO|0|0|0|100|NOK|424|1559|lyfalmen|V0060|1559||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||424||424|1559|
087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|||0|1|0|1|VII|0|0|0|100|DKK|152529|193306|lyfsjukr||||60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||152529||152529|193306|
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|287|1372|lyfalmen|V0312|441||10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||287||287|1372|
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|0|100|NOK|252|1324|lyfalmen|V0312|1324||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||252||252|1324|
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|0|100|NOK|2126|3887|lyfalmen||||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2126||2126|3887|
087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen||||500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3586|
087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|||0|0|E|0|MEC|0|0|0|100|SEK|883|2187|lyfalmen||||5|0|27,7778|Icepharma hf|Merck AB|Klómífen||883||883|2187|
087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|||0|0|E|0|APC|0|0|0|100|XEU|3314|1934|lyfalmen|V0009|1868||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||698||698|1934|
087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|||0|0|*|0|AGP|0|0|0|100|XEU|10159|7916|lyfalmen|V0420|7313||30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||5071||5071|7916|
087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|||0|0|0|0|CHP|0|0|0|100|XEU|29784|51957|vetorma||||104|0||Icepharma hf|Chanelle Pharmaceuticals|||29784||29784|51957|
087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa||||20|0||Vistor hf|Nordic Drugs AB|Algínsýra||||||
087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|||0|0|0|0|VIR|0|0|0|100|DKK|4212|8260|vetalmen||||76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4212||4212|8260|
088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|||0|0|0|0|CES|1|0|0|100|SEK|28204|49200|vetorma||||10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||28204||28204|49200|
088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|||0|0|E|0|GGL|0|0|1|100|GBP|1346|2820|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1346||1346|2820|
088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|1538|3083|lyfalmen||||20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1538||1538|3083|
088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|5935|9098|lyfalmen||||100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||5935||5935|9098|
088393|A03FA0101|Primperan|eţ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|389|1511|lyfalmen||||6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||389||389|1511|
088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|||0|0|B|0|LEP|0|0|0|100|DKK|4801|7546|lyfalmen||||30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4801||4801|7546|
088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|||0|0|B|0|LEP|0|0|0|100|DKK|9274|13665|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9274||9274|13665|
088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|||0|0|B|0|LEP|0|0|0|100|DKK|14229|20403|lyfalmen||||120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||14229||14229|20403|
088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|ţpakki||L01XE07|01.11.2008|31.07.2012|R|||0|1|0|1|GGL|0|0|0|100|GBP|178960|226477|lyfsjukr||||70|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||||178960|226477|
088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|||0|0|*|0|AGP|0|0|0|100|XEU|21553|18627|lyfalmen|V0421|17841||30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||12814||12814|18627|
088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|||0|0|*|0|POF|0|0|0|100|DKK|6037|6185|lyfalmen|V0376|6185||8|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||3806||3806|6185|
088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|||0|0|0|0|PER|0|0|0|100|DKK|1658|3247|lyfalmen||||63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og östrógen||1658||1658|3247|
089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen||||120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5674|
089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|||0|1|0|1|VII|0|0|0|100|DKK|152529|193306|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||152529||152529|193306|
089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|||0|0|E|0|MYD|0|0|0|100|SEK|4033|6496|lyfalmen||||100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||4033||4033|6496|
089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.05.2012||L|||0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín||||||
089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.05.2012||L|||0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín||||||
089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.05.2012||R|||0|0|E|0|LYF|0|0|1|100|XEU|1529|2176|lyfalmen|V0362|2176||100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín||875||875|2176|
090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|||0|0|B|0|FRO|0|0|0|100|DKK|2201|3990|lyfalmen||||100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2201||2201|3990|
090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|||0|0|0|0|PAD|0|0|1|100|DKK|1505|3038|lyfalmen||||20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1505||1505|3038|
090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|||0|0|0|0|PAD|0|0|1|100|DKK|2989|5068|lyfalmen||||40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||2989||2989|5068|
090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|||0|0|0|0|PAD|0|0|1|100|DKK|898|2207|lyfalmen||||100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||898||898|2207|
090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|||0|0|0|1|NOM|0|0|0|100|DKK|5501|7939|lyfsjukr||||10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||5501||5501|7939|
090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|||0|0|E|0|SNO|0|0|1|100|NOK|1750|3373|lyfalmen||||16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1750||1750|3373|
090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|||0|1|0|1|ACK|0|0|0|100|USD|16435|22508|lyfsjukr||||60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||16435|22508|
091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|2699|3895|lyfsjukr||||2|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2699||2699|3895|
091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|4666|6734|lyfsjukr||||5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4666||4666|6734|
091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|13691|19065|lyfsjukr||||18|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||13691||13691|19065|
091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|||1|0|0|0|NOH|0|0|0|100|DKK|3179|5328|lyfalmen||||30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3179||3179|5328|
091649|L01DB0105|Doxorubicin Actavis|sts|10|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|||0|1|0|1|APC|0|0|0|100|XEU|1696|2448|lyfsjukr||||1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||1696|2448|
091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|||0|1|0|1|APC|0|0|0|100|XEU|6940|10016|lyfsjukr||||1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||6940|10016|
091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|||0|0|E|0|CHA|0|0|1|100|DKK|3750|6109|lyfalmen||||30|0||Vistor hf|CCS Healthcare AB|Dexametasón||3750||3750|6109|
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|1239|1860|lyfalmen|V0021|1853||90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríđ||644||644|1860|
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|2142|2382|lyfalmen|V0022|2382||90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1026||1026|2382|
091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|590|1786|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||590||590|1786|
092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|||0|0|0|0|LBK|0|0|0|100|DKK|3653|5976|lyfalmen||||15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||3653|5976|
092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|||0|0|0|0|PAL|1|0|0|100|DKK|8659|16799|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||8659||8659|16799|
092241|J01AA0209|Doxycyclin Actavis Disper|töflur|100|mg|8|stk|1|ţpakki|0|J01AA02|01.02.2012|31.08.2012|R|||0|0|0|0|AGT|0|0|1|100|XEU|446|1589|lyfalmen||||8|0|8,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||446||446|1589|
092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|||0|0|E|0|SBM|0|0|0|100|NOK|7791|10616|lyfalmen|V0009|1868||28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7045||7045|10616|
092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092609|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.08.2010|31.08.2012|L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|||0|0|E|0|NAS|0|0|0|100|DKK|2145|3913|lyfalmen||||18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2145||2145|3913|
092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|||0|0|*|0|DAC|0|1|0|100|DKK|8742|12938|lyfalmen|V0277|12938||100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||8742||8742|12938|
092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|ţpakki|320/25 mg|C09DA03|01.11.2008||R|||0|0|0|0|NOH|0|0|0|100|DKK|22633|30950|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||22633||22633|30950|
092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|||0|0|E|0|AUK|0|0|1|100|GBP|434|1573|lyfalmen||||28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||434||434|1573|
092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|||0|0|E|0|AUK|0|0|1|100|GBP|564|1750|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||564||564|1750|
092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|3162|3530|lyfalmen|V0203|3530||12|0|84,0000|Portfarma ehf|Portfarma|Alendrónsýra||1865||1865|3530|
093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|1083|2460|lyfalmen||||28|0|1,8700|Icepharma hf|Norpharma a/s|Oxýcódon||||1083|2460|
093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|2485|4378|lyfalmen||||28|0|3,7300|Icepharma hf|Norpharma a/s|Oxýcódon||||2485|4378|
093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|4830|7586|lyfalmen||||28|0|7,4700|Icepharma hf|Norpharma a/s|Oxýcódon||||4830|7586|
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|||0|0|E|0|GSK|0|0|0|100|GBP|6863|10367|lyfalmen||||1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||6863||6863|10367|
093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|||0|0|B|0|NOH|0|0|0|100|DKK|1385|2874|lyfalmen||||160|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1385||1385|2874|
093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|||0|0|0|0|PAL|1|0|0|100|DKK|24956|43534|vetorma||||100|0||Icepharma hf|Pfizer Oy Animal Health|||24956||24956|43534|
093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|||0|1|*|0|DAC|0|0|0|100|SEK|61331|78313|lyfalmen|V0451|76945||1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||60373||60373|78313|
093747|C09AA0503|Ramipril Actavis (DAC)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|||0|0|B|0|DAC|0|0|0|100|XEU|1185|2600|lyfalmen||||100|0|200,0000|D.A.C. ehf|D.A.C. ehf|Ramipríl||1185||1185|2600|31.08.2012
093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|15219|21645|lyfalmen||||28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||15219||15219|21645|
093770|L02AE0304|Zoladex (D.A.C.)|vefjalyf|3,6|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|||0|1|*|0|DAC|0|0|0|100|SEK|22733|31075|lyfalmen|V0183|31075||1|0|27,9070|D.A.C. ehf|D.A.C. ehf|Góserelín||22733||22733|31075|
093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|42949|56446|lyfalmen||||98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||42949||42949|56446|
093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|552385|695126|lyfsjukr||||0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||552385||552385|695126|
093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|594890|748469|lyfsjukr||||1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||594890||594890|748469|
094111|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|||0|0|E|0|ALM|0|0|0|100|SEK|5132|7999|lyfalmen|V0236|7588||6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5132||5132|7999|
094122|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|||0|0|E|0|ALM|0|0|0|100|SEK|7605|11382|lyfalmen|V0236|11382||9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7605||7605|11382|
094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|||0|0|0|0|BOI|0|0|0|100|DKK|1681|3344|vetalmen||||15|0||Vistor hf|Boehringer Ingelheim|||1681||1681|3344|
094287|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|12260|17931|lyfalmen||||50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||12260||12260|17931|
094296|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|17561|24584|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||17561||17561|24584|
094305|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|79019|101714|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||79019||79019|101714|
094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|||0|1|0|1|VII|0|0|0|100|GBP|80791|103275|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||80791||80791|103275|
094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|||0|0|0|0|APE|0|0|1|100|XEU|44652|58583|lyfalmen||||1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||44652|58583|
094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|6092|10627|vetorma||||50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6092||6092|10627|
095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|||0|0|0|0|PCO|0|0|0|100|IKR|1577|3136|lyfalmen||||100|1|50,0000|Distica|Distica - óskráđ lyf|Magnesíum hýdroxíđ||1577||1577|3136|
095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|4760|5017|lyfalmen|V0143|4703||8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2952||2952|5017|
095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|||0|0|E|0|AGT|0|0|0|100|DKK|5461|8449|lyfalmen||||50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||5461||5461|8449|
095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|0|0|JCI|0|1|0|100|SEK|17938|25057|lyfalmen||||28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17938||17938|25057|
095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|0|0|JCI|0|1|0|100|SEK|17938|25057|lyfalmen||||28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17938||17938|25057|
095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|||0|0|0|0|POF|0|0|0|100|XEU|1807|3451|lyfalmen||||100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1807||1807|3451|
095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|||0|0|0|0|POF|0|0|0|100|XEU|2831|4852|lyfalmen||||200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||2831||2831|4852|
095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|*|0|JCI|0|1|0|100|SEK|17938|25057|lyfalmen||||28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17938||17938|25057|
095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|||0|0|0|1|POF|0|0|0|100|XEU|2373|3425|lyfsjukr||||50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2373|3425|
095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|||0|0|0|1|POF|0|0|0|100|XEU|3283|4738|lyfsjukr||||100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3283|4738|
095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|||0|0|E|0|AGP|0|0|1|100|XEU|1003|1473|lyfalmen|V0225|1473||100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||361||361|1473|
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|3430|6759|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3430||3430|6759|
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|4527|8865|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4527||4527|8865|
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|8243|16000|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||8243||8243|16000|
096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|||0|0|0|1|BAM|0|0|0|100|SEK|7504|10830|lyfsjukr||||60|0||Icepharma hf|Baxter Medical AB|Mesna||7504||7504|10830|
096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|12061|17019|lyfsjukr||||10|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||12061||12061|17019|
096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|94289|120215|lyfsjukr||||100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||94289||94289|120215|
096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.05.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|2257|2651|lyfalmen|V0088|2598||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1222||1222|2651|
096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.05.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|2349|2681|lyfalmen|V0089|2627||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1244||1244|2681|
096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|||0|0|0|0|GGL|0|0|1|100|GBP|2035|3763|lyfalmen||||5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2035||2035|3763|
096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|15165|21577|lyfalmen||||30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15165||15165|21577|
096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|646130|812776|lyfsjukr||||21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||646130||646130|812776|
096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|684932|861472|lyfsjukr||||21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||684932||684932|861472|
096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|720380|905959|lyfsjukr||||21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||720380||720380|905959|
096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|790592|994075|lyfsjukr||||21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||790592||790592|994075|
096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|15165|21577|lyfalmen||||30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15165||15165|21577|
096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|||0|0|E|0|SEV|0|0|0|100|DKK|1398|2891|lyfalmen||||30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1398||1398|2891|
096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|30332|40612|lyfalmen||||60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||30332||30332|40612|
096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|||0|1|E|0|SNO|0|0|0|100|NOK|18209|25397|lyfalmen||||20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||18209||18209|25397|
096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008|31.07.2012|R|||0|1|0|1|IPI|0|0|0|100|DKK|90844|115892|lyfsjukr||||1|0|1,0000|Icepharma hf|Pfizer Limited|Anidulafungin||90844||90844|115892|
097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|25627|34044|lyfsjukr||||10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||25627||25627|34044|
097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|||0|0|0|0|AUW|1|0|0|100|XEU|7612|14789|vetalmen||||10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||7612|14789|
097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|||0|0|0|0|DAC|0|0|1|100|DKK|2065|3787|lyfalmen|V0461|3787||20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2053||2053|3787|
097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|||0|0|E|0|SCP|0|0|1|100|DKK|1039|2400|lyfalmen||||120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1039||1039|2400|
097531|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2012||R|||0|0|0|0|PER|0|1|0|100|DKK|10458|15285|lyfalmen|V0334|5733||98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10458||10458|15285|
097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|||0|0|0|0|PER|0|1|0|100|DKK|19856|27464|lyfalmen|V0335|5733||98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||19856|27464|
097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|||0|0|0|0|PCO|0|0|1|100|DKK|2284|4103|lyfalmen||||100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2284||2284|4103|
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|3075|2765|lyfalmen|V0023|2765||90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1306||1306|2765|
097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|||0|0|E|0|AGP|0|0|0|100|IKR|2738|2780|lyfalmen|V0233|2681||12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1317||1317|2780|
097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|||0|0|E|0|AGP|0|0|0|100|IKR|1917|2407|lyfalmen|V0234|2246||6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1044||1044|2407|
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|0|0|AGP|0|1|0|100|XEU|1034|2373|lyfalmen|V0329|2373||30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1019||1019|2373|
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|||0|0|B|0|ACA|0|0|0|100|XEU|6186|3003|lyfalmen|V0072|3003||98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1480||1480|3003|
098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|||0|0|B|0|ACA|0|0|0|100|XEU|7927|3073|lyfalmen|V0073|3073||98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1531||1531|3073|
098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|||0|0|B|0|BIG|0|0|1|100|SEK|603|1804|lyfalmen||||30|0||Icepharma hf|Bioglan AB|Flúócínólón||603||603|1804|
098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|||0|0|B|0|BIG|0|0|1|100|SEK|603|1804|lyfalmen||||30|0||Icepharma hf|Bioglan AB|Flúócínólón||603||603|1804|
098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa||||250|0||Icepharma hf|Bioglan AB|Klórhexidín||||||
098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|933|1943|lyfalmen|V0243|1943||50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||705||705|1943|
098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|1590|2404|lyfalmen|V0244|2382||50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1042||1042|2404|
098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|4490|4689|lyfalmen|V0245|4689||100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||2712||2712|4689|
098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|8044|9427|lyfalmen|V0232|9427||100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||6176||6176|9427|
098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|17551|23909|lyfsjukr||||25|0||Actavis Group hf|Braun|Flúmazeníl||17551||17551|23909|
098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|16498|23250|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||16498||16498|23250|
099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|||0|1|0|1|ASZ|0|0|0|100|SEK|98106|125006|lyfsjukr||||10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||98106||98106|125006|
099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|*|0|MYL|0|1|0|100|IKR|6128|3749|lyfalmen|V0284|3455||100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||2025||2025|3749|
099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|*|0|MYL|0|1|0|100|IKR|14070|15000|lyfalmen|V0285|12803||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||10250||10250|15000|
099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|*|0|MYL|0|1|0|100|IKR|23001|30017|lyfalmen|V0286|25570||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||21890||21890|30017|
099705|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|2761|3813|lyfalmen|V0247|3813||60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2072||2072|3813|
099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|3818|5768|lyfalmen|V0248|5768||60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3501||3501|5768|
099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|7755|9597|lyfalmen|V0249|9597||60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||6300||6300|9597|
099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|703|1941|lyfalmen|V0414|1941||98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||703||703|1941|
100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|||0|0|0|0|LIL|0|0|0|100|XEU|12360|18057|lyfalmen||||28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12360|18057|
100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|||0|0|0|0|LIL|0|0|0|100|XEU|12360|18057|lyfalmen||||28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12360|18057|
100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|||0|0|B|0|ACA|0|1|0|100|XEU|1784|3419|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1784||1784|3419|
101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|11804|12574|lyfalmen||||100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||8476||8476|12574|
101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|16326|23034|lyfalmen||||100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||16326||16326|23034|
101691|C08CA0502|Adalat Oros|forđatfl|20|mg|28|stk|1|ţpakki||C08CA05|01.10.1999||R|||0|0|B|0|BAP|0|0|0|100|SEK|1993|3705|lyfalmen||||28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||1993||1993|3705|
101709|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.10.1999||R|||0|0|B|0|BAP|0|0|0|100|SEK|6433|9779|lyfalmen||||98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||6433||6433|9779|
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|0|0|AGP|0|1|0|100|XEU|1274|2722|lyfalmen|V0330|2722||30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1274||1274|2722|
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|B|0|AGP|0|1|0|100|XEU|2898|4943|lyfalmen|V0331|4943||96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2898||2898|4943|
101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|||0|0|B|0|APC|0|0|0|100|XEU|3636|2651|lyfalmen|V0088|2651||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1222||1222|2651|
101760|N06AX1104|Miron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|||0|0|0|0|AGP|0|1|0|100|XEU|5190|8079|lyfalmen|V0332|8079||96|0|144,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||5190||5190|8079|
101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|||0|0|B|0|APC|0|0|0|100|XEU|4217|2681|lyfalmen|V0089|2681||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1244||1244|2681|
101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007||R|||0|0|E|0|DAC|0|0|1|100|DKK|4833|7590|lyfalmen|V0227|7076||100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||4833||4833|7590|
101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|||0|0|0|0|BOI|0|0|0|100|SEK|17323|33435|vetalmen||||250|0||Vistor hf|Boehringer Ingelheim|||||17323|33435|
101825|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.09.2011||R|||0|0|E|0|APR|0|0|0|100|DKK|3012|5099|lyfalmen||||100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||||3012|5099|
101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|ţpakki||G03DB08|01.05.2012||R|||0|0|0|0|BAB|0|0|0|100|SEK|6738|10196|lyfalmen||||28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||6738||6738|10196|
101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|ţpakki||G03DB08|01.05.2012||R|||0|0|0|0|BAB|0|0|0|100|SEK|20212|27911|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||20212||20212|27911|
102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|3738|6092|lyfalmen|V0041|3582||98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3738||3738|6092|
102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|||0|0|0|1|AZA|0|0|0|100|SEK|1873|2703|lyfsjukr||||50|0||Vistor hf|AstraZeneca AB|Própófól||1873||1873|2703|
102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|||0|0|0|1|AZA|0|0|0|100|SEK|3045|4395|lyfsjukr||||50|0||Vistor hf|AstraZeneca AB|Própófól||3045||3045|4395|
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|3266|2651|lyfalmen|V0088|2598||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1222||1222|2651|
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|4133|2681|lyfalmen|V0089|2627||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1244||1244|2681|
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|2789|2359|lyfalmen|V0069|2359||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1009||1009|2359|
103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|||0|0|E|0|POF|0|0|1|100|GBP|2540|2065|lyfalmen|V0033|2065||10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||794||794|2065|
103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|||0|0|E|0|POF|0|0|1|100|GBP|10049|8395|lyfalmen|V0182|8348||40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||5421||5421|8395|
103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|||0|0|B|0|POF|0|1|0|100|XEU|4153|5850|lyfalmen|V0334|5850||100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3561||3561|5850|
103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|||0|0|B|0|POF|0|1|0|100|XEU|6665|5850|lyfalmen|V0335|5850||100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3561||3561|5850|
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|||0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen||||25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1854|
103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|||0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa||||1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl||||||
104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|13334|18617|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jódixanól||13334||13334|18617|
104047|C09CA0304|Valsartan LYFIS|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|2871|3073|lyfalmen|V0073|3073||98|0|196,0000|LYFIS ehf|LYFIS ehf|Valsartan||1531||1531|3073|
104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|||0|0|E|0|FEL|0|0|0|100|DKK|2958|5025|lyfalmen||||2|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||2958||2958|5025|
104498|N05CH0101|Circadin|forđatfl|2|mg|21|stk|1|ţpakki||N05CH01|01.11.2007||R|||0|0|0|0|NER|0|0|1|100|DKK|2034|3761|lyfalmen|V0574|3177||21|0|21,0000|Vistor hf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2034||2034|3761|
104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|||0|0|B|0|FER|0|0|0|100|DKK|7799|11648|lyfalmen||||28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7799||7799|11648|
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|||0|0|B|0|FER|0|0|0|100|DKK|4380|6971|lyfalmen|V0017|6971||700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4380||4380|6971|
104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|||0|0|B|0|FER|0|0|0|100|DKK|4957|7760|lyfalmen||||100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4957||4957|7760|
104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|121116|153883|lyfsjukr||||2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||121116|153883|
105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|4308|5987|lyfalmen|V0004|1671||28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3661||3661|5987|
105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|13108|16222|lyfalmen|V0011|5114||100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||11143||11143|16222|
105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|17431|19282|lyfalmen|V0012|5114||100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13336||13336|19282|
105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|||0|0|0|0|DAC|0|0|0|100|SEK|1226|2656|lyfalmen|V0545|2656||63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||1226||1226|2656|
105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|3719|6066|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||3719||3719|6066|
105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|12930|18772|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||12930||12930|18772|
105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|4287|6843|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4287||4287|6843|
105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|14913|21261|lyfalmen||||98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||14913||14913|21261|
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2430|4303|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2430||2430|4303|
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2873|4909|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2873||2873|4909|
106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|||0|0|0|0|RRL|0|0|0|100|DKK|1736|3354|lyfalmen||||10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1736||1736|3354|
106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|||0|0|0|0|RRL|0|0|0|100|DKK|3471|5727|lyfalmen||||10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3471||3471|5727|
106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|||0|0|0|0|ABS|0|0|1|100|DKK|2511|4414|lyfalmen||||14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2511||2511|4414|
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|||0|0|0|1|GSK|0|0|0|100|GBP|18672|25316|lyfsjukr||||5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||18672||18672|25316|
106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|||0|0|0|1|GSK|0|0|0|100|GBP|10326|14842|lyfsjukr||||5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10326||10326|14842|
107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|1908|1787|lyfalmen|V0278|1787||28|0|7,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||591||591|1787|
107138|C07AG0203|Carvedilol Actavis|filmhtfl|6,25|mg|100|stk|1|ţpakki||C07AG02|01.05.2012||R|||0|0|B|0|ADG|0|0|0|100|XEU|1196|2615|lyfalmen||||100|0|16,6600|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1196||1196|2615|
107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|||0|0|B|0|PER|0|0|0|100|DKK|1481|3005|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1481||1481|3005|
107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|||0|0|0|0|CRO|0|0|0|100|XEU|1451|2531|vetorma||||6|0||Portfarma ehf|Cross Vetpharm Group Ltd.|||||1451|2531|
107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|||0|0|E|0|ACA|0|0|0|100|XEU|870|2169|lyfalmen||||60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||870||870|2169|
108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.01.1991||R|||0|0|B|0|BAP|0|0|0|100|SEK|2843|4868|lyfalmen||||100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2843||2843|4868|
108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|3106|5228|lyfalmen||||30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3106||3106|5228|
108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|9217|13587|lyfalmen||||90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9217||9217|13587|
108802|N05AH0310|Zalasta (LYFIS)|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|12950|6906|lyfalmen|V0282|6752||56|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||4333||4333|6906|
108845|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|||0|0|E|0|AZD|0|0|1|100|SEK|1175|2586|lyfalmen||||120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1175||1175|2586|
108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|||0|0|E|0|AZD|0|0|1|100|SEK|1630|3209|lyfalmen||||120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1630||1630|3209|
109357|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|||0|0|0|0|APC|0|0|0|100|XEU|2059|1671|lyfalmen|V0004|1671||28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||506||506|1671|
109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|22850|31222|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|rykmaurar||22850||22850|31222|
109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18293|25503|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18293||18293|25503|
109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7102|10694|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7102||7102|10694|
109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|ţpakki||N02BE01|01.12.1983||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól||||||
109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.07.1992||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól||||||
109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|ţpakki||N02BE01|01.11.1981||R|||0|0|0|0|ACA|0|0|1|100|XEU|393|1517|lyfalmen|V0230|1517||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||393||393|1517|
110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||R06AE07|01.09.2012||L|||0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín||||||
110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|||0|0|*|0|SAO|0|0|0|100|XEU|487|1645|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||487||487|1645|
110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.04.2008||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||3|0||Ísaga ehf|AGA AB|Súrefni||||||
110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1990||R|||0|0|0|0|ORG|0|0|0|100|DKK|1449|2961|lyfalmen||||63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1449||1449|2961|
110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|||0|0|B|0|ORC|0|0|0|100|DKK|3705|6047|lyfalmen||||100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3705||3705|6047|
110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|106195|135157|lyfsjukr||||60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||106195||106195|135157|
111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|5523|6946|lyfalmen|V0373|6946||15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4362||4362|6946|
111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|||0|0|0|0|GSH|0|0|1|100|DKK|705|1943|lyfalmen||||100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||705||705|1943|
112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|||0|0|0|0|ORG|0|0|0|100|DKK|20473|28239|lyfalmen||||1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||20473||20473|28239|
112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.04.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|7728|3651|lyfalmen|V0203|3530||12|0|84,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alendrónsýra||1953||1953|3651|
113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|8008|11933|lyfalmen|V0024|10806||60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8008||8008|11933|
113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|23804|32419|lyfalmen|V0024|32419||180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||23804||23804|32419|
113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|8112|12076|lyfalmen|V0025|10922||60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8112||8112|12076|
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|3682|6016|lyfalmen||||2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3682||3682|6016|
113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|24081|32767|lyfalmen|V0025|32767||180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||24081||24081|32767|
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|6308|9608|lyfalmen||||4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6308||6308|9608|
113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|||0|1|0|1|NOE|0|0|0|100|DKK|627260|789094|lyfsjukr||||112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||627260||627260|789094|
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|718|1961|lyfalmen||||20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||718||718|1961|
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|913|2228|lyfalmen||||30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||913||913|2228|
113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|1393|2884|lyfalmen||||40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1393||1393|2884|
114033|R03AC0210|Ventolin Diskus|innúđadu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|||0|0|B|0|GSK|0|0|1|100|IKR|999|2345|lyfalmen||||60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||999||999|2345|
114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|||0|1|0|1|WIL|0|0|0|100|XEU|49389|63866|lyfsjukr||||5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||49389||49389|63866|
114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|||0|0|E|0|MSD|0|0|1|100|DKK|3889|6299|lyfalmen||||28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3889||3889|6299|
114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999||R|||0|0|*|0|MSD|0|0|0|100|DKK|2219|4014|lyfalmen|V0373|2315||5|0|25,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2219||2219|4014|
114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.11.2010||R|||0|0|0|0|GAN|0|0|1|100|XEU|2082|3827|lyfalmen||||4|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2082||2082|3827|
114664|D10AD5301|Epiduo|hlaup|||30|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011|30.06.2012|R|||0|0|0|0|GAN|0|0|0|100|SEK|3275|5459|lyfalmen||||30|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||3275||3275|5459|
114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|||0|0|0|0|GAN|0|0|0|100|SEK|6228|9498|lyfalmen||||60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6228||6228|9498|
115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|1793|3432|lyfalmen||||10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1793||1793|3432|
115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|IKR|9164|13226|lyfsjukr||||10|0||Actavis Group hf|Braun|Naloxón||9164||9164|13226|
115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|||0|0|0|0|MYL|0|0|1|100|SEK|1569|3125|lyfalmen||||20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1569||1569|3125|
115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|10753|15688|lyfalmen||||60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10753||10753|15688|
115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|1793|3432|lyfalmen||||10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1793||1793|3432|
115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|10753|15688|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10753||10753|15688|
115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|||0|0|*|0|MSD|0|0|0|100|DKK|1785|3421|lyfalmen|V0369|2860||5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1785||1785|3421|
115931|R03AC1202|Serevent Diskus|innúđadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|3709|6053|lyfalmen||||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3709||3709|6053|
115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|||0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa||||55|0||Icepharma hf|Norpharma |Malatíón||||||
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|||0|0|0|1|GSK|0|0|0|100|GBP|3725|5376|lyfsjukr||||5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3725||3725|5376|
116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|||0|0|0|1|GSK|0|0|0|100|GBP|1947|2810|lyfsjukr||||5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1947||1947|2810|
116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|1114|1737|lyfalmen|V0056|1737||100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||554||554|1737|
116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|1763|2133|lyfalmen|V0057|2133||100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||844||844|2133|
116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|||0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa||||10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum||||||
116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|2446|4325|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||2446||2446|4325|
116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|2810|4823|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||2810||2810|4823|
116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen||||||
116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen||||||
116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|ţpakki||M01AE01|01.08.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|713|1954|lyfalmen|V0562|1953||100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||713||713|1954|
116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|355|1465|lyfalmen|V0563|1465||30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||355||355|1465|
116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|ţpakki||M01AE01|01.05.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|865|2162|lyfalmen|V0564|2161||100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||865||865|2162|
116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|16669|23465|lyfalmen||||84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||16669||16669|23465|
116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|7104|10208|lyfalmen|V0081|10208||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||6747||6747|10208|
116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|5680|8749|lyfalmen||||28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5680||5680|8749|
116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|6099|9322|lyfalmen||||28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6099||6099|9322|
116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|18007|25144|lyfalmen||||84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||18007||18007|25144|
116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|||0|0|0|0|PFF|0|0|0|100|DKK|7769|11607|lyfalmen||||0|0||Icepharma hf|Pfizer Limited|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||7769||7769|11607|
117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX00|01.04.2004||R|||0|0|0|0|KEL|1|0|0|100|NOK|10323|19994|vetalmen||||6000|0||Icepharma hf|Kela Laboratoria NV|||10323||10323|19994|
117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|3167|5311|lyfalmen||||100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3167||3167|5311|
117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|||0|0|E|0|ROC|0|0|0|100|DKK|4268|6817|lyfalmen|V0435|6717||100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4268||4268|6817|
117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|14809|21130|lyfalmen||||100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||14809|21130|
117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|26172|35391|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||26172|35391|
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|||0|0|E|0|ROC|0|0|0|100|DKK|1512|3047|lyfalmen||||100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1512||1512|3047|
117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|4526|7170|lyfalmen||||10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4526|7170|
117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|45256|59341|lyfalmen||||100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||45256|59341|
117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|52345|68238|lyfalmen||||100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||52345|68238|
117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|66600|85466|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||66600||66600|85466|
117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|||0|0|0|0|BAN|0|0|0|100|DKK|9150|15962|vetorma||||250|0||Icepharma hf|Bayer Animal Health GmbH|||9150||9150|15962|
117788|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|2321|4154|lyfalmen||||28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2321||2321|4154|
117796|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|5548|8568|lyfalmen||||98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||5548||5548|8568|
117820|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|8308|12344|lyfalmen||||98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||8308||8308|12344|
117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|||0|0|0|0|KEL|0|0|0|100|NOK|7211|14019|vetalmen||||1200|0||Icepharma hf|Kela Laboratoria NV|||7211||7211|14019|
117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|||0|0|0|0|KEL|0|0|0|100|NOK|12647|24457|vetalmen||||6000|0||Icepharma hf|Kela Laboratoria NV|||12647||12647|24457|
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|3758|1787|lyfalmen|V0278|1787||28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||591||591|1787|
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|5342|2336|lyfalmen|V0279|2336||28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||992||992|2336|
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|20715|6906|lyfalmen|V0282|6752||56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4333||4333|6906|
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|15825|9036|lyfalmen|V0283|8475||28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5890||5890|9036|
118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|||0|0|0|0|GSK|0|0|1|100|GBP|2218|4013|lyfalmen||||100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2218||2218|4013|
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr||||4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728|
118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín||||||
118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|ţpakki||A02BA02|01.04.1994|31.08.2012|R|||0|0|E|0|ACA|0|0|0|100|XEU|932|2254|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||932||932|2254|
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|16286|8546|lyfalmen|V0280|8546||56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5532||5532|8546|
118570|A07EC0203|Pentasa Sachets|forđakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|||0|0|B|0|FER|0|0|0|100|DKK|7090|10678|lyfalmen|V0015|9955||50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7090||7090|10678|
118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|||0|0|B|0|FER|0|0|0|100|DKK|21768|29864|lyfalmen|V0015|29864||150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||21768||21768|29864|
118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|||0|0|B|0|AEG|0|0|0|100|XEU|460|1608|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||460||460|1608|
119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|||0|1|0|1|AEU|0|0|0|100|DKK|72826|93279|lyfsjukr||||5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||72826||72826|93279|
119825|N05BA1206|Alprazolam Krka|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|1|100|XEU|906|1986|lyfalmen|V0309|1986||30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||736||736|1986|
119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|||0|0|0|0|POF|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen||||||
119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|||0|1|0|1|GGL|0|0|0|100|GBP|444856|560177|lyfsjukr||||30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||444856||444856|560177|
120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|||0|1|0|1|GGL|0|0|0|100|GBP|444856|560177|lyfsjukr||||30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||444856||444856|560177|
120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|||0|0|E|0|SAL|0|0|0|100|USD|976|2314|lyfalmen||||10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||976||976|2314|
120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|||0|1|0|1|LIL|0|0|0|100|XEU|45286|58716|lyfsjukr||||1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||45286||45286|58716|
120392|M01AE0110|Ibuprofen Actavis|filmhtfl|200|mg|24|stk|1|ţpakki||M01AE01|01.01.2012||L|||0|0|0|0|AHF|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Actavis Group PTC ehf|Actavis Group hf|Íbúprófen||||||
120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|29924|39437|lyfsjukr||||2|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||29924||29924|39437|
120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.05.2008||R|||0|0|0|0|LVR|0|0|0|100|DKK|16779|23603|lyfalmen|V0253|8411||100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||16779||16779|23603|
121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|||0|0|0|0|AZD|0|0|0|100|SEK|5633|8685|lyfalmen||||28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5633||5633|8685|
121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|||0|0|0|1|ORG|0|0|0|100|DKK|8928|12885|lyfsjukr||||50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||8928||8928|12885|
121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|||0|0|B|0|GSK|0|0|1|100|IKR|467|1618|lyfalmen||||200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||467||467|1618|
121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|E|0|POF|0|0|0|100|XEU|7578|5144|lyfalmen|V0011|5012||98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3045||3045|5144|
121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|||0|0|E|0|AUK|0|0|1|100|GBP|407|1532|lyfalmen||||28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||404||404|1532|
121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|||0|0|B|0|NOH|0|1|0|100|DKK|1659|3248|lyfalmen|V0314|2285||100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1659||1659|3248|
121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|272|1351|lyfalmen||||28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||272||272|1351|
122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|||0|0|0|0|BIV|0|0|0|100|IKR|9600|16747|vetorma||||50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9600||9600|16747|
122577|A04AA0105|Ondansetron BMM Pharma|filmhtfl|4|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|||0|0|E|0|BMM|0|0|0|100|XEU|2936|4946|lyfalmen|V0381|4946||10|0|2,5000|BMM Pharma AB|BMM Pharma AB|Ondansetrón||2900||2900|4946|
122610|A04AA0105|Ondansetron BMM Pharma|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|||0|0|E|0|BMM|0|0|0|100|XEU|3353|4908|lyfalmen|V0384|4908||10|0|5,0000|BMM Pharma AB|BMM Pharma AB|Ondansetrón||2872||2872|4908|
123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|||0|0|0|0|AGT|0|0|1|100|DKK|519|1689|lyfalmen||||10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||519||519|1689|
123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|||0|0|0|0|AGT|0|0|1|100|DKK|810|2087|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||810||810|2087|
123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|||0|0|0|0|ICE|0|0|0|100|USD|26772|46702|vetorma||||100|0||Icepharma hf|Icepharma hf|||26772||26772|46702|
123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|230|1294|lyfalmen||||100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||230|1294|
123954|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|||0|0|B|0|BLU|0|1|0|100|XEU|2166|3823|lyfalmen|V0317|3823||100|0|50,0000|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Cítalópram||2079||2079|3823|
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|||0|0|E|0|AVS|0|0|0|100|NOK|44762|58721|lyfalmen||||56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||44762||44762|58721|
124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|||0|0|0|0|CHP|0|0|0|100|XEU|1713|3407|vetalmen||||42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1713|3407|
124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|||0|0|0|0|SBM|0|0|0|100|NOK|37361|49433|lyfalmen||||30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||37361|49433|
124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|1797|2246|lyfalmen|V0234|2246||6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||926||926|2246|
124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|2566|2681|lyfalmen|V0233|2681||12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1244||1244|2681|
124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|||0|0|E|0|NOH|0|0|0|100|DKK|941|2266|lyfalmen||||30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||941||941|2266|
124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|||0|0|B|0|ACA|0|0|0|100|XEU|481|1637|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||481||481|1637|
124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|10463|15292|lyfalmen|V0464|15292||8|0|75,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||10463||10463|15292|
124936|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.11.1999||R|||1|0|0|1|RBP|0|0|0|100|DKK|1199|1730|lyfsjukr||||7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1199||1199|1730|
125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|||0|0|B|0|ACA|0|0|0|100|XEU|791|1551|lyfalmen|V0066|1551||100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||418||418|1551|
125973|D01BA0205|Terbinafin BMM Pharma|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.08.2012||R|||0|0|0|0|BMM|0|0|0|100|XEU|2333|3370|lyfalmen|V0123|3370||28|0|28,0000|BMM Pharma AB|BMM Pharma AB|Terbínafín||1748||1748|3370|
126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ||||||
126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|||0|1|0|1|SKB|0|0|0|100|GBP|113260|144024|lyfsjukr||||10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||113260|144024|
126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|||0|1|0|1|SKB|0|0|0|100|GBP|29066|38360|lyfsjukr||||10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||29066|38360|
126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|||0|0|0|1|INN|0|0|0|100|XEU|23850|31814|lyfsjukr||||1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||23850||23850|31814|
126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|||0|0|0|1|INN|0|0|0|100|XEU|7949|11472|lyfsjukr||||1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||7949||7949|11472|
126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|47032|60908|lyfsjukr||||50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||47032||47032|60908|
126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|94088|119963|lyfsjukr||||100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||94088||94088|119963|
126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|188110|237961|lyfsjukr||||200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||188110||188110|237961|
126926|B01AX0601 |Xarelto|filmhtfl|15|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|37394|49475|lyfalmen|V0031|49475||100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||37394|49475|
126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|||0|0|E|0|MCS|0|0|0|100|SEK|1034|2393|lyfalmen|V0447|2101||100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1034||1034|2393|
127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|*|0|ELD|0|1|0|100|XEU|8198|5891|lyfalmen|V0279|2336||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3591||3591|5891|
128131|QG51BE0002|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51BE00|01.03.2009||R|||0|0|0|0|BID|1|0|0|100|DKK|11571|22391|vetalmen||||30|0||Vistor hf|Boehringer Ingelheim Danmark|||11571||11571|22391|
128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|||0|0|E|0|LEP|0|0|0|100|DKK|1160|2566|lyfalmen||||100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1160||1160|2566|
128777|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.07.1988||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||60|0|10,0000|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole||||||
128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|||0|0|0|1|BAM|0|0|0|100|SEK|3980|5744|lyfsjukr||||100|0||Icepharma hf|Baxter Medical AB|Mesna||3980||3980|5744|
129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|0|0|ELD|0|1|0|100|XEU|29555|28427|lyfalmen|V0280|8546||56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||20623||20623|28427|
129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|*|0|ELD|0|1|0|100|XEU|32123|21954|lyfalmen|V0282|6752||56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||15465||15465|21954|
129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|228|1291|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||228||228|1291|
129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|||0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen||||100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3210|
129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|||0|0|B|0|BOI|0|0|0|100|DKK|4122|6618|lyfalmen||||60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||4122||4122|6618|
130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|18526|22832|lyfalmen|V0285|12803||100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||16165||16165|22832|
130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|29325|34661|lyfalmen|V0286|25570||100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||25590||25590|34661|
130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|2329|4165|lyfalmen||||10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||2329||2329|4165|
130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|DKK|13158|25438|vetalmen||||2|0||Vistor hf|Virbac S.A|Deslorelín||13158||13158|25438|
130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|3762|6125|lyfalmen||||125|0|31,2500|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||3762||3762|6125|
130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|1820|3469|lyfalmen||||10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||1820||1820|3469|
130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|||0|0|0|0|IPI|0|0|1|100|DKK|10706|15624|lyfalmen||||53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||10706|15624|
130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|||0|0|0|0|PHA|0|0|0|100|NOK|63196|103104|veteldis||||500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||63196|103104|
131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|3337|5544|lyfalmen||||10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríđ||||3337|5544|
131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|471|1623|lyfalmen||||100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||471||471|1623|
131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|741|1993|lyfalmen||||100|0|15,0000|Vistor hf|Recip AB|Fenemal||741||741|1993|
131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|988|2330|lyfalmen||||100|0|50,0000|Vistor hf|Recip AB|Fenemal||988||988|2330|
131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|1094|2475|lyfalmen||||100|0|100,0000|Vistor hf|Recip AB|Fenemal||1094||1094|2475|
131450|B01AC0405|Clopidogrel Qualigen (Lyfjaver)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2011||R|||0|0|E|0|LVR|0|0|0|100|XEU|2455|2806|lyfalmen|V0009|1868||28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Klópídógrel||1336||1336|2806|
131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|5636|8689|lyfalmen|V0132|8689||26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5636||5636|8689|
131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|3729|6080|lyfalmen|V0032|5427||10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||3729||3729|6080|
131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|11187|16282|lyfalmen|V0032|16282||30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||11187||11187|16282|
131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|37146|49163|lyfalmen||||100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||37146||37146|49163|
132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|ţpakki||N06AA09|01.04.2008|31.08.2012|R|||0|0|B|0|AUK|0|1|0|100|GBP|264|1258|lyfalmen||||28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||204||204|1258|
132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|7967|10683|lyfalmen|V0348|10683||28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||7094||7094|10683|
132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|||0|0|0|0|AGP|0|0|0|100|XEU|8714|3849|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2098||2098|3849|
132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|||0|0|0|0|AGP|0|0|0|100|XEU|6983|3849|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2098||2098|3849|
132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|||1|0|E|0|REP|0|0|1|100|SEK|1479|3002|lyfalmen||||100|0|25,0000|Vistor hf|Recip AB|Kódein||1479||1479|3002|
132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|||1|0|0|0|JAS|0|0|0|100|SEK|7741|11568|lyfalmen||||30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7741||7741|11568|
132761|D08AG0201|Betadine|áburđur|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|||0|0|0|0|SAL|0|0|0|100|USD|1112|2500|lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1112||1112|2500|
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|||0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa||||100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol||||||
132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|ţpakki||G03AB04|01.01.1993||R|||0|0|0|0|JAS|0|0|0|100|SEK|1378|2864|lyfalmen||||84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1378||1378|2864|
133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|28158|37221|lyfsjukr||||0|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||28158||28158|37221|
133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|37456|48890|lyfsjukr||||1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||37456||37456|48890|
133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|48941|63303|lyfsjukr||||2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||48941|63303|
133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Meda AB (V)|Makrógól 3350||||||
133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||20|0||Vistor hf|Meda AB (V)|Makrógól 3350||||||
133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||50|0||Vistor hf|Meda AB (V)|Makrógól 3350||||||
133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|||0|0|E|0|SAD|0|0|0|100|DKK|8214|12215|lyfalmen||||100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8214||8214|12215|31.08.2012
134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|ţpakki||J02AC03|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|86765|110773|lyfsjukr||||14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||86765||86765|110773|
134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|||0|0|0|0|ABS|0|0|1|100|DKK|1424|2927|lyfalmen||||50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1424||1424|2927|
134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|||0|0|*|0|SAO|0|0|0|100|XEU|3757|6118|lyfalmen|V0378|5462||9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||3757||3757|6118|
134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|||0|0|*|0|SAO|0|0|0|100|XEU|11262|16385|lyfalmen|V0378|16385||27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||11262||11262|16385|
134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|||0|1|0|1|AGT|0|0|0|100|XEU|4437|6404|lyfsjukr||||25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||4437||4437|6404|
134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|||0|1|0|1|BRS|0|0|0|100|DKK|66042|84765|lyfsjukr||||30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||66042||66042|84765|
134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|||0|1|0|1|GSI|0|0|0|100|DKK|122365|155451|lyfsjukr||||30|0|30,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||122365||122365|155451|
135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|49742|64309|lyfsjukr||||1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||49742||49742|64309|
135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|||0|0|B|0|ADG|0|0|0|100|XEU|1998|3712|lyfalmen||||100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1998||1998|3712|
135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|||0|0|B|0|MYL|0|0|0|100|SEK|1007|2356|lyfalmen||||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1007||1007|2356|
135434|R03BA0502|Flixotide Diskus|innúđadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|2241|4044|lyfalmen||||60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2241||2241|4044|
136168|G03AB0401|Trinovum|töflur|||63|stk|1|ţpakki||G03AB04|01.10.1988||R|||0|0|0|0|JAS|0|0|0|100|SEK|1658|3247|lyfalmen||||63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1658||1658|3247|
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|||0|0|0|0|REP|0|0|0|100|SEK|6907|10427|lyfalmen||||100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||6907||6907|10427|
136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|69471|89069|lyfsjukr||||4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||69471||69471|89069|
136658|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|1|100|XEU|431|1445|lyfalmen|V0307|1445||30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||341||341|1445|
136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|2260|3262|lyfsjukr||||5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2260||2260|3262|
136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|7078|10215|lyfsjukr||||17|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7078||7078|10215|
136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|5217|7529|lyfsjukr||||25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5217||5217|7529|
136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|8132|11737|lyfsjukr||||50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||8132||8132|11737|
137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|||0|1|0|1|HUK|0|0|0|100|XEU|5566|8033|lyfsjukr||||20|0||Icepharma hf|Hospira UK Ltd|Oxalíplatín||5566||5566|8033|
137513|S01XA2011|Oculac|augndr|||10|ml|1|glas|međ rotvörn|S01XA20|01.10.1999||L|||0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen||||10|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||1633|
137521|S01XA2011|Oculac|augndr|||0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|||0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen||||8|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||1990|
137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|SEK|20805|27993|lyfsjukr||||25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||20805||20805|27993|
137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|XEU|5888|8498|lyfsjukr||||10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||5888||5888|8498|
137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|XEU|9884|14265|lyfsjukr||||10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||9884||9884|14265|
137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|SEK|5971|8618|lyfsjukr||||10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||5971||5971|8618|
137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|||0|0|0|1|HOS|0|0|0|100|XEU|697|1006|lyfsjukr||||500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||697||697|1006|
138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|||0|0|0|1|HOS|0|0|0|100|DKK|1418|2047|lyfsjukr||||1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1418||1418|2047|
138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1589|3153|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1589||1589|3153|
139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|4424|6946|lyfalmen|V0373|6946||15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4362||4362|6946|
139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||L|||0|0|0|0|NEH|0|0|1|100|IKR|||lyflausa||||100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín||||||
140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|||0|1|0|1|ORG|0|0|0|100|DKK|128472|163115|lyfsjukr||||20|0||Vistor hf|N.V. Organon|Sugammadex||128472||128472|163115|
140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|||0|1|0|1|ORG|0|0|0|100|DKK|321077|404834|lyfsjukr||||50|0||Vistor hf|N.V. Organon|Sugammadex||321077||321077|404834|
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|1360|2839|lyfalmen|V0266|1095||30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1360||1360|2839|
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|||0|0|0|1|LBK|0|1|0|100|DKK|11006|15695|lyfsjukr||||10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11006||11006|15695|
140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|||0|0|0|1|DES|0|0|0|100|DKK|596|860|lyfsjukr||||5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||596||596|860|
140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|||0|0|0|0|SRR|1|0|0|100|NOK|91547|175957|vetalmen||||1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||91547||91547|175957|
140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín||||||
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|||0|0|B|0|PER|0|0|1|100|DKK|1162|2568|lyfalmen|V0413|2304||2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1162||1162|2568|
141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|4144|5819|lyfsjukr||||1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4032||4032|5819|
141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|19681|26582|lyfsjukr||||1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||19681||19681|26582|
141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|3608|5207|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3608||3608|5207|
141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|2572|4497|lyfalmen||||30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||2572||2572|4497|
141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|20212|27911|lyfalmen||||0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||20212||20212|27911|
141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|||0|0|0|0|BAB|0|0|0|100|SEK|4713|7426|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||4713||4713|7426|
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|8061|12006|lyfalmen|V0267|2466||100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8061||8061|12006|
142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|||0|0|E|0|MYL|0|0|1|100|SEK|2673|3562|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1888||1888|3562|
142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|||0|0|0|1|SNO|0|0|0|100|NOK|3208|4630|lyfsjukr||||30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3208||3208|4630|
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|||0|0|B|0|SNO|0|0|0|100|NOK|1051|2417|lyfalmen||||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1051||1051|2417|
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|||0|0|0|0|MEB|0|0|1|100|SEK|2868|4902|lyfalmen||||100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2868||2868|4902|
143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|||0|0|B|0|PER|0|0|1|100|DKK|1352|2828|lyfalmen||||1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1352||1352|2828|
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|||0|0|0|1|PER|0|0|0|100|DKK|2124|3065|lyfsjukr||||1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2124||2124|3065|
143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|||0|0|0|0|GLB|0|0|0|100|GBP|3806|6185|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3806||3806|6185|
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|||0|0|0|0|SAL|0|0|0|100|USD|919|2236|lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||919||919|2236|
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|||0|0|0|0|PER|0|0|1|100|DKK|1380|2867|lyfalmen||||2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1380||1380|2867|
143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|||0|0|E|0|BOI|0|0|0|100|DKK|1244|2681|lyfalmen||||100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1244||1244|2681|
143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|||0|0|*|0|MSD|0|0|0|100|DKK|7891|11773|lyfalmen|V0386|8961||56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||7891||7891|11773|
143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|||0|0|B|0|ASP|0|0|1|100|XEU|566|1753|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||566||566|1753|
143800|N05AN0101|Litarex|forđatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|||0|0|*|0|AGT|0|1|0|100|DKK|1127|2521|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1127||1127|2521|
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|||0|0|0|0|PER|0|0|1|100|DKK|1897|3574|lyfalmen|V0174|3574||3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1897||1897|3574|
144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|||0|0|E|0|MSD|0|0|0|100|DKK|1956|3655|lyfalmen||||100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1956||1956|3655|
144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|21505|29534|lyfalmen||||60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||21505||21505|29534|
144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|75522|96663|lyfsjukr||||2|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||75522||75522|96663|
144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|56445|72721|lyfsjukr||||2|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||56445||56445|72721|
144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|35072|45898|lyfsjukr||||2|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||35072||35072|45898|
144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|||0|0|B|0|ASP|0|0|1|100|XEU|612|1816|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||612||612|1816|
144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008|30.06.2012|R|||0|0|0|0|AGT|0|0|1|100|XEU|332|1433|lyfalmen||||24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||332||332|1433|
144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008|30.06.2012|R|||0|0|0|0|AGT|0|0|1|100|XEU|551|1733|lyfalmen||||24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||551||551|1733|
145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|79862|102109|lyfsjukr||||1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||79862||79862|102109|
145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2078|3822|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2078||2078|3822|
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Recip AB|Pýrvín||||||
145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|ţpakki||P02CX01|01.01.1995||L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||32|0||Vistor hf|Recip AB|Pýrvín||||||
145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|0|0|ELD|0|1|0|100|XEU|19229|18899|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13031||13031|18899|
146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|30656|40356|lyfsjukr||||1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||30656||30656|40356|
146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|||0|1|0|1|HUK|0|0|0|100|XEU|2843|4103|lyfsjukr||||2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||2843||2843|4103|
146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|||0|1|0|1|HUK|0|0|0|100|XEU|5776|8336|lyfsjukr||||5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||5776||5776|8336|
146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|||0|1|0|0|ELI|0|0|0|100|XEU|16831|23668|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||16831||16831|23668|
146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|856|2150|lyfalmen|V0351|1076||10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||856||856|2150|
147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|||0|1|0|1|HOP|0|0|0|100|XEU|2357|3402|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2357||2357|3402|
147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|||0|1|0|1|HOP|0|0|0|100|XEU|1461|2109|lyfsjukr||||10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1461||1461|2109|
147343|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.02.2012||L|||0|0|0|0|LVR|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól||||||
148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|||0|0|0|0|ROA|0|0|1|100|DKK|105866|135407|lyfalmen||||75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||105866||105866|135407|
148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|ţpakki||J01CA08|01.09.2012||R|||0|0|0|0|OPF|0|0|1|100|DKK|1132|2527|lyfalmen|V0577|2527||20|0|6,6667|Portfarma ehf|Orion Corporation|Pívmecillínam||1132||1132|2527|
148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|ţpakki||J01CA08|01.09.2012||R|||0|0|0|0|OPF|0|0|1|100|DKK|1684|3283|lyfalmen||||30|0|10,0000|Portfarma ehf|Orion Corporation|Pívmecillínam||1684||1684|3283|
148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|||0|0|0|0|OPF|0|0|1|100|DKK|6037|9237|lyfalmen||||100|0|33,3300|Portfarma ehf|Orion Corporation|Pívmecillínam||6037||6037|9237|
148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|||0|1|0|0|BLT|0|0|0|100|DKK|78132|100601|lyfalmen||||30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||78132||78132|100601|
148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|||0|1|0|0|BLT|0|0|0|100|DKK|78132|100601|lyfalmen||||30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||78132||78132|100601|
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|||0|0|*|0|LFS|0|1|0|100|DKK|800|2073|lyfalmen||||100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||800||800|2073|
148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|62097|79814|lyfsjukr||||5|0||Ísaga ehf|AGA AB|Tvínituroxíđ og súrefni||62097||62097|79814|
148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|||0|1|0|1|HOP|0|0|0|100|SEK|6301|9094|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||6301||6301|9094|
148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|||0|1|0|1|HOP|0|0|0|100|SEK|13209|18460|lyfsjukr||||10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||13209||13209|18460|
148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|||0|1|0|1|HOS|0|0|0|100|SEK|28257|37345|lyfsjukr||||1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||28257||28257|37345|
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|||0|0|0|0|BAN|1|0|0|100|DKK|3409|6718|vetalmen||||25|0||Icepharma hf|Bayer Animal Health GmbH|||3409||3409|6718|
149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|||0|0|0|0|PCO|0|1|0|100|SEK|2102|3854|lyfalmen||||75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2102||2102|3854|
149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|||0|0|*|0|POF|0|0|0|100|DKK|2041|2488|lyfalmen|V0376|2062||2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1103||1103|2488|
150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993|31.08.2012|R|||0|0|E|0|SAD|0|0|0|100|DKK|16026|22658|lyfalmen||||100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16026||16026|22658|
150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|49210|63641|lyfsjukr||||2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||49210|63641|
150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|3555|5842|lyfalmen||||28|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||3555|5842|
150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|5897|9046|lyfalmen|V0120|7097||56|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||5897|9046|
150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|||0|0|0|0|GSK|0|0|0|100|GBP|3635|5951|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hreinsađir fjórgildir meningókokka polysakkaríđ mótefnavakar||||3635|5951|
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|||0|0|*|0|LBK|0|1|0|100|DKK|6163|9410|lyfalmen||||10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6163||6163|9410|
151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|1154|2558|lyfalmen||||10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1154||1154|2558|
151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|||0|0|E|0|LBK|0|0|0|100|DKK|14967|21329|lyfalmen||||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14967|21329|
151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|||0|0|E|0|LBK|0|0|0|100|DKK|46213|57780|lyfalmen||||98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||44012||44012|57780|
151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|5085|7935|lyfalmen||||0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5085||5085|7935|
151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|||0|0|E|0|MYL|0|0|0|100|SEK|5353|3969|lyfalmen|V0148|3837||90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||2186||2186|3969|
151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|||0|0|B|0|PER|0|1|0|100|DKK|1478|3001|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1478||1478|3001|
151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|RAT|0|0|0|100|XEU|4209|4217|lyfalmen|V0006|4217||100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||2367||2367|4217|
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|1885|2721|lyfsjukr||||5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||1885||1885|2721|
152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|||0|0|0|0|DAC|0|0|0|100|XEU|2427|4293|lyfalmen|V0123|3370||28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||2423||2423|4293|
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|||0|0|0|0|PER|0|0|1|100|IKR|||lyflausa||||25|0||Icepharma hf|Pfizer ApS|Píroxíkam||||||
152397|R03BA0202|Pulmicort Turbuhaler|innúđadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|||0|0|B|0|AZD|0|0|0|100|SEK|3904|6319|lyfalmen||||200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3904||3904|6319|
152413|R03BA0202|Pulmicort Turbuhaler|innúđadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|5705|8783|lyfalmen||||200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5705||5705|8783|
152421|R03BA0202|Pulmicort Turbuhaler|innúđadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|||0|0|B|0|ASZ|0|0|0|100|SEK|10468|15299|lyfalmen||||200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||10468||10468|15299|
152635|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|||0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa||||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra||||||
152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|17669|9483|lyfalmen|V0269|9483||100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||6217||6217|9483|
152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|1247|2685|lyfalmen|V0181|1454||4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1247||1247|2685|
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín||||||
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|||0|0|0|0|AZD|0|0|1|100|SEK|1786|3422|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1786||1786|3422|
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín||||||
153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|37373|48786|lyfsjukr||||1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||37373|48786|
153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2256|4065|lyfalmen|V0561|3582||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2256||2256|4065|
153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|1578|3138|lyfalmen|V0560|2800||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1578||1578|3138|
153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||R|||0|0|E|0|ACA|0|0|1|100|XEU|2149|3919|lyfalmen|V0575|3332||100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2149||2149|3919|
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|||0|0|0|1|GIS|0|0|0|100|DKK|215053|271774|lyfsjukr||||10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||215053||215053|271774|
153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|512|1679|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||512|1679|
153507|L02BG0602|Exemestan Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|||0|0|*|0|APC|0|0|0|100|XEU|32981|43936|lyfalmen|V0452|43936||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||32981||32981|43936|
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|4306|6869|lyfalmen|V0181|5451||15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4306||4306|6869|
153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|301|1391|lyfalmen||||24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||301||301|1391|
153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|499|1662|lyfalmen||||24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||499||499|1662|
153601|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|1|lykja||B03BA03|01.06.2010||R|||0|0|E|0|SHS|0|0|1|100|DKK|1476|2998|lyfalmen||||1|0|50,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||1476||1476|2998|
154475|D05AX5203|Xamiol|hlaup|||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009|31.07.2012|R|||0|0|B|0|LEP|0|0|0|100|DKK|8265|12285|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8265||8265|12285|
154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|8855|13092|lyfalmen||||100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||8855||8855|13092|
154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|993|2337|lyfalmen||||20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||993||993|2337|
154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|27407|36278|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||27407||27407|36278|
154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|35907|46946|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||35907||35907|46946|
154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|39451|51394|lyfsjukr||||7880|0||Icepharma hf|Fresenius Kabi|Blöndur||39451||39451|51394|
154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|29199|38527|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||29199||29199|38527|
154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|35919|46961|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||35919||35919|46961|
154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|25732|34176|lyfsjukr||||4824|0||Icepharma hf|Fresenius Kabi|Blöndur||25732||25732|34176|
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|3563|5853|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3563||3563|5853|
154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|33551|43989|lyfsjukr||||7616|0||Icepharma hf|Fresenius Kabi|Blöndur||33551||33551|43989|
154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|0|0|AGP|0|0|0|100|XEU|1431|2936|lyfalmen|V0259|2936||28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1431||1431|2936|
154732|G04CA0102|Xatral Uno|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.01.2003||R|||0|0|E|0|SNO|0|0|0|100|NOK|7220|10855|lyfalmen|V0550|7271||90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7220||7220|10855|
154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|B|0|AGP|0|0|0|100|XEU|4069|5753|lyfalmen|V0334|5733||98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3490||3490|5753|
154750|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009|31.08.2012|R|||0|0|0|0|AGP|0|0|0|100|XEU|2373|2452|lyfalmen||||28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1077||1077|2452|
154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|B|0|AGP|0|0|0|100|XEU|6530|5753|lyfalmen|V0335|5733||98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3490||3490|5753|
154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|||0|1|0|0|INT|0|0|0|100|DKK|422966|533367|lyfalmen||||252|0||Vistor hf|InterMune Europe Ltd.|Pírfenidon||422966||422966|533367|
155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|||0|0|*|0|APT|0|0|0|100|XEU|1478|3001|lyfalmen||||25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Chlorambucíl||1478||1478|3001|
155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|2080|3813|lyfalmen|V0247|3813||60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2072||2072|3813|
155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|3506|5768|lyfalmen|V0248|5768||60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3501||3501|5768|
155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|6303|9597|lyfalmen|V0249|9597||60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||6300||6300|9597|
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1431|2936|lyfalmen||||100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1431||1431|2936|
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|613|1817|lyfalmen||||100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||613||613|1817|
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|6723|10176|lyfalmen|V0181|10176||28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6723||6723|10176|
156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|||0|0|*|0|ELD|0|0|0|100|XEU|5508|8514|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5508||5508|8514|
156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|||0|0|*|0|ELD|0|0|0|100|XEU|5554|8576|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5554||5554|8576|
156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|||0|0|0|0|REP|0|0|1|100|SEK|433|1571|lyfalmen||||15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||433||433|1571|
156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|2210|3190|lyfsjukr||||15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2210||2210|3190|
156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|1295|1869|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1295||1295|1869|
156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|6052|8735|lyfsjukr||||45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||6052||6052|8735|
156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|||0|0|0|0|ROC|0|0|0|100|DKK|8898|13151|lyfalmen||||84|0|28,0000|Icepharma hf|Roche|Orlístat||8898||8898|13151|
156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|||0|1|0|1|HOP|0|0|0|100|XEU|8106|11699|lyfsjukr||||60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||8106||8106|11699|
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|||0|0|0|0|JAS|0|0|0|100|SEK|869|2168|lyfalmen||||6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||869||869|2168|
156861|QJ01MA9002|Enrotron Flavour|töflur|50|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|||0|0|0|0|ANI|0|0|0|100|IKR|1898|3775|vetalmen||||10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||1898||1898|3775|
157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín||||||
157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|10|spr||QP52AF02|01.04.1992||R|||0|0|0|0|PAL|0|0|0|100|DKK|6856|11960|vetorma||||260|0||Icepharma hf|Pfizer Oy Animal Health|||6856||6856|11960|
157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|2552|2336|lyfalmen|V0279|2336||28|0|14,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||992||992|2336|
157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|||0|0|E|0|NOH|0|0|0|100|DKK|1433|2939|lyfalmen|V0239|2939||100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1433||1433|2939|
158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|1575|3133|lyfalmen||||10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1575|3133|
158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|29011|38954|lyfalmen||||100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||29011|38954|
158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|||0|0|E|0|NOH|0|0|0|100|DKK|894|2202|lyfalmen|V0239|1470||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||894||894|2202|
158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|97261|123945|lyfsjukr||||1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||97261|123945|
158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|194523|246009|lyfsjukr||||1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||194523|246009|
158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|551564|694095|lyfsjukr||||1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||551564|694095|
158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|||0|1|0|1|APG|0|0|0|100|XEU|49672|64221|lyfsjukr||||1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||49672|64221|
158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|||0|1|0|1|APG|0|0|0|100|XEU|70860|90812|lyfsjukr||||1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||70860||70860|90812|
158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|||0|0|E|0|DES|0|0|0|100|DKK|771|2034|lyfalmen||||5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||771||771|2034|
158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1029|2387|lyfalmen|V0469|2387||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1029|2387|
159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|3170|5315|lyfalmen|V0219|5315||5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3170||3170|5315|
159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|5457|8444|lyfalmen|V0220|8444||5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5457||5457|8444|
159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|7079|10663|lyfalmen|V0221|10663||5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||7079||7079|10663|
159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|8249|12263|lyfalmen|V0223|12263||5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||8249||8249|12263|
159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|4877|4451|lyfalmen|V0318|2024||56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2538||2538|4451|
159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|ţpakki||L02BG06|01.06.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|19091|26504|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Exemestan||19091||19091|26504|
159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|12505|11675|lyfalmen|V0320|3588||56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||7819||7819|11675|
159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|1768|2547|lyfalmen|V0062|1753||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1146||1146|2547|
159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|3061|3540|lyfalmen|V0067|1644||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1872||1872|3540|
159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|6308|4679|lyfalmen|V0071|2164||28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2705||2705|4679|
159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|||0|0|E|0|MYL|0|0|1|100|SEK|465|1615|lyfalmen||||25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||465||465|1615|
159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|||0|0|E|0|MYL|0|0|1|100|SEK|1599|3166|lyfalmen||||100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1599||1599|3166|
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|||0|0|0|1|APC|0|0|0|100|DKK|94808|120867|lyfsjukr||||2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||94808||94808|120867|
159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|3953|7763|vetalmen||||50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3953||3953|7763|
160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|2078|2980|lyfalmen|V0010|2980||56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1463||1463|2980|
160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|||0|0|0|1|AGT|0|0|0|100|DKK|2138|3086|lyfsjukr||||50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2138||2138|3086|
160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|35590|46548|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||35590||35590|46548|
160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|51820|66917|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||51820||51820|66917|
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|||0|0|*|0|SNO|0|1|0|100|NOK|977|2315|lyfalmen||||100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||977||977|2315|
160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|||0|0|0|0|BRS|0|0|0|100|DKK|2227|4025|lyfalmen||||50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2227||2227|4025|
160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|69131|88642|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||69131||69131|88642|
160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|||0|0|E|0|BOI|0|0|1|100|DKK|1131|2526|lyfalmen||||15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1131||1131|2526|
161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|75234|96301|lyfsjukr||||120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||75234||75234|96301|
161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|||0|0|B|0|PER|0|0|1|100|DKK|559|1744|lyfalmen||||1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||559||559|1744|
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|||0|0|0|1|PER|0|0|0|100|DKK|867|1251|lyfsjukr||||1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||867||867|1251|
161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|||0|0|0|1|PER|0|0|0|100|DKK|787|1136|lyfsjukr||||5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||787||787|1136|
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|571|1760|lyfalmen||||1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||571||571|1760|
161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|5007|7828|lyfalmen|V0131|7828||26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5007||5007|7828|
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|56777|73800|lyfalmen|V0452|43936||100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||56777||56777|73800|
161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|||1|1|0|1|RBP|0|0|0|100|DKK|13380|18569|lyfsjukr||||28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||13296||13296|18569|
162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|149622|189658|lyfsjukr||||8|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||149622||149622|189658|
162115|N06AA0906|Saroten|töflur|25|mg|100|stk|1|glas||N06AA09|01.12.2011||R|||0|0|B|0|LBK|0|1|0|100|DKK|734|1983|lyfalmen|V0512|1983||100|0|33,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||734||734|1983|
162149|N06AA0906|Saroten|töflur|10|mg|100|stk|1|glas||N06AA09|01.12.2011||R|||0|0|B|0|LBK|0|1|0|100|DKK|408|1537|lyfalmen|V0510|1537||100|0|13,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||408||408|1537|
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|||0|0|B|0|PER|0|0|0|100|DKK|1808|3452|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1808||1808|3452|
162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|||0|0|0|0|LEV|1|0|0|100|XEU|5118|10000|vetalmen||||5|0||Le Vet B.V.|Le Vet B.V.|||||5118|10000|
162808|C01DA1404|Fem-Mono Retard|forđatfl|60|mg|100|stk|1|ţpakki||C01DA14|01.03.2012||R|||0|0|B|0|GUK|0|0|0|100|SEK|1974|3679|lyfalmen|V0041|3655||100|0|150,0000|Actavis Group PTC ehf|Generics UK Ltd.|Ísósorbíđ mónónítrat||1974||1974|3679|
162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|||0|0|*|0|BLU|0|0|0|100|XEU|415|1522|lyfalmen|V0500|1522||100|0|25,0000|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Metformín||397||397|1522|
162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|||0|0|*|0|BLU|0|0|0|100|XEU|673|1900|lyfalmen||||100|0|42,5000|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Metformín||673||673|1900|
162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|ţpakki||A10BA02|01.09.2012||R|||0|0|*|0|BLU|0|0|0|100|XEU|830|2114|lyfalmen||||60|0|30,0000|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Metformín||830||830|2114|
162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|||0|0|E|0|BLU|0|0|0|100|XEU|718|1697|lyfalmen|V0108|1697||100|0|33,3400|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Simvastatín||525||525|1697|
162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|||0|0|E|0|BLU|0|0|0|100|XEU|808|1835|lyfalmen|V0109|1835||100|0|66,6700|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Simvastatín||626||626|1835|
162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|||0|0|E|0|BLU|0|0|0|100|XEU|1301|2361|lyfalmen|V0110|2361||100|0|133,3333|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Simvastatín||1010||1010|2361|
162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|1543|3025|lyfalmen|V0373|2315||5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1496||1496|3025|
162929|G04CA0205|Ranomax|forđahlk|0,4|mg|100|stk|1|ţpakki||G04CA02|01.04.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|4472|4263|lyfalmen|V0148|4263||100|0|100,0000|Artasan ehf|Ranbaxy (UK) Ltd|Tamsúlósín||2401||2401|4263|
162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|||0|0|B|0|GSK|0|0|0|100|GBP|2241|4044|lyfalmen||||120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2241||2241|4044|
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|||1|0|0|0|NOH|0|0|0|100|DKK|1079|2455|lyfalmen||||30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1079||1079|2455|
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|1645|3229|lyfalmen|V0351|3229||30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1645||1645|3229|
163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|||0|0|E|0|AEA|0|0|0|100|XEU|191|1240|lyfalmen||||20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||191|1240|
163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|||0|0|B|0|GSK|0|0|0|100|GBP|3314|4875|lyfalmen||||120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2848||2848|4875|
163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|||0|0|0|0|PCO|0|0|0|100|IKR|8140|12114|lyfalmen||||454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12114|
164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|347748|438306|lyfsjukr||||42|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||347748||347748|438306|
164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|||0|0|*|0|APT|0|0|0|100|XEU|3255|5432|lyfalmen||||25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Merkaptópúrín||3255||3255|5432|
164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|3659|5281|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3659||3659|5281|
164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|||0|0|E|0|MYL|0|0|0|100|SEK|3001|5084|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||3001|5084|
164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|9895|14515|lyfalmen||||100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||9895||9895|14515|
164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|||0|0|B|0|MYL|0|1|0|100|SEK|1035|2395|lyfalmen||||100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1035||1035|2395|
164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|||0|0|B|0|MYL|0|1|0|100|SEK|955|2285|lyfalmen|V0314|2285||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||||955|2285|
164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|7332|11009|lyfalmen|V0014|10884||60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7332||7332|11009|
165001|C05AA0102|Proctosedyl|eţ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|||0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa||||12|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||||
165019|C05AA0102|Proctosedyl|eţ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|||0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa||||30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||||
165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|788|2057|lyfalmen||||100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||788||788|2057|
165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|||0|0|0|0|LAS|1|0|0|100|XEU|6512|12677|vetalmen||||10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|||6512||6512|12677|
165431|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.01.1992|31.07.2012|R|||0|0|B|0|AZD|0|0|0|100|SEK|4538|7187|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4538||4538|7187|
165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|||0|0|B|0|AZD|0|0|0|100|SEK|5079|7927|lyfalmen|V0059|3766||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5079||5079|7927|
165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|||0|0|B|0|AZD|0|0|0|100|SEK|3278|5463|lyfalmen|V0058|2731||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3278||3278|5463|
165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|266901|336843|lyfsjukr||||8|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||266901||266901|336843|
165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|35590|46548|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||35590||35590|46548|
165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|51820|66917|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||51820||51820|66917|
165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|||0|0|E|0|UCN|0|0|1|100|SEK|703|1941|lyfalmen||||100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||703||703|1941|
165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|||0|0|E|0|UCN|0|0|1|100|SEK|203|1257|lyfalmen||||25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||203||203|1257|
165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|||0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa||||10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín||||||
165791|N06DA0206|Donepezil Medical|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|||0|0|E|0|MED|0|0|0|100|XEU|22928|12928|lyfalmen|V0341|12928||98|0|65,3300|Medical ehf|Medical ehf|Dónepezíl||8735||8735|12928|
165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|3866|5580|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3866||3866|5580|
165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|69131|88642|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||69131||69131|88642|
165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|234343|295983|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||234343||234343|295983|
166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|||0|0|0|0|IBV|0|0|0|100|DKK|4412|8644|vetalmen||||60|0||Vistor hf|Intervet International BV|||||4412|8644|
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|||0|0|B|0|SNO|0|0|0|100|NOK|1858|3521|lyfalmen||||100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1858||1858|3521|
166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|||0|1|E|0|PER|0|0|0|100|DKK|14328|20527|lyfalmen||||8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||14328||14328|20527|
166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|2224|4021|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2224||2224|4021|
166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|4210|6738|lyfalmen|V0428|6738||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4210||4210|6738|
166709|G04CA0103|Alfuzosin Ranbaxy|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.07.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|4600|7271|lyfalmen|V0550|7271||90|0|120,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alfúzósín||4600||4600|7271|
166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|||0|1|E|0|IPI|0|0|0|100|DKK|123288|157272|lyfalmen||||1|0||Icepharma hf|Pfizer Limited|Clostridíum||123288||123288|157272|
166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa||||100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra||||||
167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|0|0|AGP|0|0|0|100|XEU|423|1558|lyfalmen|V0333|1558||7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||423||423|1558|
168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|||0|0|E|0|AUK|0|0|0|100|GBP|624|1833|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||624|1833|
168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|||0|0|E|0|AGP|0|0|0|100|XEU|4452|5144|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3045||3045|5144|
168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|||0|0|E|0|NOH|0|0|0|100|DKK|2878|4916|lyfalmen|V0240|4914||200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||2878||2878|4916|
168815|N03AF0105|Tegretol Retard|forđatfl|400|mg|30|stk|1|ţpakki||N03AF01|01.07.1988|30.06.2012|R|||0|0|E|0|NOH|0|0|0|100|DKK|1261|2704|lyfalmen||||30|0|12,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1261||1261|2704|
168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|||0|0|E|0|NOH|0|0|0|100|DKK|5312|8245|lyfalmen|V0433|8244||200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5312||5312|8245|
168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|||0|1|0|1|PFP|0|0|0|100|SEK|54073|69744|lyfsjukr||||10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||54073||54073|69744|
169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|||0|1|0|1|PFP|0|0|0|100|SEK|235098|296930|lyfsjukr||||50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||235098||235098|296930|
169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|||0|0|0|1|ROA|0|0|0|100|DKK|20462|27562|lyfsjukr||||5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||20462||20462|27562|
169664|J07BK0101|Varilrix|bóluefni|||0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|5341|8285|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5341||5341|8285|
169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|||0|1|C|0|POF|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827||30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2827|
169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|||0|1|C|0|POF|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196||30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4196|
169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577||20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2577|
169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864||10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1864|
169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852||20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1852|
169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517||10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1517|
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2958|5025|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2958||2958|5025|
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|3184|5334|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3184||3184|5334|
170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|22907|30631|lyfsjukr||||4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||22907|30631|
170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|56853|73233|lyfsjukr||||10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||56853|73233|
170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|||0|0|0|0|GLB|0|0|0|100|GBP|5743|8835|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5743||5743|8835|
170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|107464|136750|lyfsjukr||||20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||107464||107464|136750|
170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.07.2012||R|||0|0|E|0|SAD|0|0|0|100|DKK|15131|21535|lyfalmen||||100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||15131||15131|21535|
170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|||0|1|B|0|ABS|0|0|0|100|DKK|3678|6010|lyfalmen||||100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||3678||3678|6010|
170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|||0|1|B|0|ABS|0|0|0|100|DKK|6438|9786|lyfalmen||||100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||6438||6438|9786|
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|2421|4291|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2421||2421|4291|
170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl|.|J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|10768|15396|lyfsjukr||||1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||10768||10768|15396|
170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|25904|34392|lyfsjukr||||1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||25904||25904|34392|
170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|38856|50647|lyfsjukr||||2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||38856||38856|50647|
170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|XEU|3162|3530|lyfalmen|V0203|3530||12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1865||1865|3530|
170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|||0|0|0|0|POF|0|0|0|100|IKR|12363|4397|lyfalmen|V0207|3113||12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||2499||2499|4397|
170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|54234|69946|lyfsjukr||||4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||54234||54234|69946|
171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|||0|0|0|0|DEC|1|0|0|100|DKK|2583|5132|vetalmen||||25|0||Vistor hf|Dechra Veterinary Products A/S|||2583||2583|5132|
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|3667|5995|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3667||3667|5995|
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|3951|6384|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3951||3951|6384|
171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|||0|0|B|0|LDR|0|0|0|100|NOK|1527|3068|lyfalmen||||100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1527||1527|3068|
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|4477|7103|lyfalmen|V0247|3813||60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4477||4477|7103|
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|7369|11059|lyfalmen|V0248|5768||60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7369||7369|11059|
171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|42587|55329|lyfsjukr||||75|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||42587||42587|55329|
172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|28392|37514|lyfsjukr||||50|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||28392||28392|37514|
172249|QJ01MA9002|Enrotron Flavour|töflur|150|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|||0|0|0|0|ANI|0|0|0|100|IKR|3289|6488|vetalmen||||10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||3289||3289|6488|
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|13308|19247|lyfalmen|V0249|9597||60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13308||13308|19247|
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|24975|33889|lyfalmen||||60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||24975||24975|33889|
172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|65301|83835|lyfsjukr||||100|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||65301||65301|83835|
172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|28269|28278|lyfalmen|V0346|28278||112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||20504||20504|28278|
172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|||0|1|*|0|APT|0|0|0|100|XEU|3288|5477|lyfalmen||||100|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Búsúlfan||3288||3288|5477|
172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|||0|0|B|0|AZD|0|0|0|100|SEK|11651|16917|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||11651||11651|16917|
172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|6000|9187|lyfalmen||||56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6000||6000|9187|
172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|11147|16227|lyfalmen||||56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||11147||11147|16227|
172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|19339|26816|lyfalmen||||56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||19339||19339|26816|
172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|IKR|830|2114|lyfalmen|V0207|1038||4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||830||830|2114|
172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|25219|34195|lyfalmen||||56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||25219||25219|34195|
173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|||0|0|0|0|MAB|0|0|1|100|DKK|404|1532|lyfalmen||||50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||404||404|1532|
173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|||0|0|E|0|MYL|0|0|1|100|SEK|2887|4928|lyfalmen||||100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||2887||2887|4928|
173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|||0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen||||60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3426|
173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|||0|0|E|0|MYL|0|0|1|100|SEK|6164|9411|lyfalmen||||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||6164||6164|9411|
173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|||0|1|0|1|AMG|0|0|0|100|DKK|15670|21427|lyfsjukr||||2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||15573||15573|21427|
173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|ţpakki||N05CF01|01.10.2001||R|||0|0|0|0|MYL|0|0|1|100|SEK|354|1463|lyfalmen||||30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||354||354|1463|
173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|14963|20661|lyfsjukr||||2|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||14963||14963|20661|
173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|||0|0|0|1|AGT|0|0|0|100|DKK|1298|1873|lyfsjukr||||20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1298||1298|1873|
174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|||0|0|0|0|REP|0|0|1|100|SEK|676|1904|lyfalmen||||14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||676||676|1904|
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|||0|0|0|0|REP|0|0|1|100|SEK|691|1924|lyfalmen||||14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||691||691|1924|
174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|||0|0|*|0|ALL|0|0|0|100|SEK|1785|3421|lyfalmen|V0368|2714||5|0|25,0000|Vistor hf|Allergan|Brímónidín||1785||1785|3421|
174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|||0|0|*|0|ALL|0|0|0|100|SEK|5236|8141|lyfalmen|V0368|8141||15|0|75,0000|Vistor hf|Allergan|Brímónidín||5236||5236|8141|
175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|||0|0|E|0|GSK|0|0|1|100|GBP|2540|2220|lyfalmen|V0033|2065||10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||907||907|2220|
176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|||0|0|0|0|ELD|0|1|0|100|XEU|6246|4730|lyfalmen|V0278|1787||28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2742||2742|4730|
177716|N05CH0101|Circadin|forđatfl|2|mg|30|stk|1|ţpakki||N05CH01|01.09.2012||R|||0|0|0|0|RAD|0|0|1|100|DKK|2602|4538|lyfalmen|V0574|4538||30|0|30,0000|Nycomed Danmark ApS|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2602||2602|4538|
178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|||0|0|E|0|PCO|0|0|1|100|IKR|723|1968|lyfalmen||||1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|1968|
178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|||0|0|B|0|BLU|0|1|0|100|XEU|5070|6407|lyfalmen|V0320|6407||100|0|200,0000|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Cítalópram||3968||3968|6407|
179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|157416|199440|lyfsjukr||||1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||157416||157416|199440|
179171|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.02.2012|30.06.2012|R|||1|0|0|1|AGP|0|0|0|100|XEU|5479|7908|lyfsjukr||||5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5479||5479|7908|
179333|R02AA0304|Strepsils Menthol|sogtfl|||24|stk|1|ţpakki||R02AA03|01.12.2005|31.08.2012|L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|12098|8411|lyfalmen|V0253|8411||100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||5433||5433|8411|
179552|B01AX0601 |Xarelto|filmhtfl|15|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|10511|15357|lyfalmen||||28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||10511|15357|
180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|||0|1|0|1|WIL|0|0|0|100|XEU|122601|155747|lyfsjukr||||5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||122601||122601|155747|
180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|||0|0|B|0|UCB|0|0|0|100|DKK|5285|8209|lyfalmen||||100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5285||5285|8209|
180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|||0|0|E|0|PER|0|0|1|100|DKK|752|2008|lyfalmen||||5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||752||752|2008|
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól||||||
181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DA32|01.10.1995||R|||0|0|0|0|PFV|0|0|0|100|DKK|7590|14747|vetalmen||||100|0||Icepharma hf|Pfizer vet.|||7590||7590|14747|
181750|L01BA0105|Methotrexate Wyeth Lederle|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|||0|1|0|1|PER|0|0|0|100|DKK|9227|13317|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Metótrexat||9227||9227|13317|
182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|||0|0|0|0|IBV|0|0|0|100|SEK|5884|11471|vetalmen||||100|0||Vistor hf|Intervet International BV|||5884||5884|11471|
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|||0|0|0|0|IBV|1|0|0|100|DKK|5088|9942|vetalmen||||50|0||Vistor hf|Intervet International BV|||5088||5088|9942|
183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|||0|0|B|0|ALK|0|0|1|100|DKK|5463|8452|lyfalmen||||1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5463|8452|
183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|1390981|1747564|lyfsjukr||||168|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1390981||1390981|1747564|
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|||0|0|B|0|BRS|0|0|0|100|DKK|1122|2514|lyfalmen||||100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1122||1122|2514|
183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|ţpakki||P01AB01|01.10.1995|31.08.2012|R|||0|0|0|0|SNO|0|0|1|100|NOK|848|2139|lyfalmen||||21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||848||848|2139|
184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|461|1610|lyfalmen||||100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||461||461|1610|
184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|IKR|1643|2121|lyfalmen||||100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2121|
184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|584|1778|lyfalmen||||15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||584||584|1778|
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|4934|7728|lyfalmen|V0017|6971||700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4934||4934|7728|
184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|||0|0|*|0|NOH|0|0|0|100|DKK|20506|28280|lyfalmen|V0170|9483||30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||20506||20506|28280|
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|||0|0|*|0|NOH|0|0|0|100|DKK|52115|67949|lyfalmen|V0185|20925||100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||52115||52115|67949|
184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|1112|2500|lyfalmen||||16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1112||1112|2500|
184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|||0|0|E|0|AZA|0|0|0|100|SEK|5337|8280|lyfalmen|V0235|7821||6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5337||5337|8280|
187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|||0|0|E|0|MAB|0|0|1|100|DKK|4849|7612|lyfalmen||||30|0||Vistor hf|Meda AB|Pímekrólímus||4849||4849|7612|
188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|||0|0|0|1|WTE|0|0|0|100|DKK|72834|93289|lyfsjukr||||10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||72834||72834|93289|
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|2762|4757|lyfalmen||||250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2762||2762|4757|
188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|||0|0|*|0|GPL|0|0|0|100|USD|1999|3713|lyfalmen||||100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíđ||1999||1999|3713|
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|||0|0|0|1|NOH|0|0|0|100|DKK|6756|9751|lyfsjukr||||10|0||Vistor hf|Novartis Healthcare A/S-|Deferoxamín||6756||6756|9751|
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|2354|4199|lyfalmen||||5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2354||2354|4199|
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|969|2304|lyfalmen|V0413|2304||2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||969||969|2304|
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|469|1620|lyfalmen||||1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||469||469|1620|
189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|||0|1|0|1|PER|0|0|0|100|DKK|435|628|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Metótrexat||435||435|628|
190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|||0|0|E|0|AGT|0|0|1|100|DKK|941|2266|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||941||941|2266|
190728|M01AB0101|Confortid|eţ-stíll|50|mg|10|stk|1|ţpakki||M01AB01|01.08.2012||R|||0|0|E|0|AGT|0|0|1|100|DKK|832|2117|lyfalmen||||10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||832||832|2117|
191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3645|5261|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3645||3645|5261|
191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3472|5011|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3472||3472|5011|
191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3583|5171|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3583||3583|5171|
191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
191742|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.08.2012||R|||0|0|B|0|AZD|0|0|0|100|SEK|4497|7131|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4497||4497|7131|
191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|||0|0|E|0|PER|0|0|1|100|DKK|492|1652|lyfalmen||||4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||492||492|1652|
192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|||0|0|B|0|AGP|0|1|0|100|XEU|3610|5917|lyfalmen||||96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3610||3610|5917|
192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|||0|0|E|0|LEP|0|0|0|100|DKK|1516|3053|lyfalmen||||100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1516||1516|3053|
192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|||25|stk|1|glas||C03AB01|01.12.1972||R|||0|0|E|0|LEP|0|0|0|100|DKK|423|1558|lyfalmen||||25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||423||423|1558|
193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|||0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen||||20|0|7,5500|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2233|
194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|1004|1449|lyfsjukr||||2|0||Icepharma hf|Pfizer ApS|Metótrexat||1004||1004|1449|
195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|||0|0|B|0|MYL|0|0|0|100|SEK|1838|3493|lyfalmen||||250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||1838||1838|3493|
195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|||0|0|E|0|AGT|0|0|1|100|DKK|2331|4168|lyfalmen||||5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2331||2331|4168|
195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|||0|0|E|0|AGT|0|0|1|100|DKK|741|1993|lyfalmen||||1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||741||741|1993|
195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|E|0|POF|0|0|0|100|XEU|12907|5144|lyfalmen|V0012|5012||98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||3045||3045|5144|
195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|88967|113536|lyfsjukr||||2|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||88967||88967|113536|
195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|157416|199440|lyfsjukr||||1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||157416||157416|199440|
195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|JAS|0|0|1|100|SEK|757|2014|lyfalmen||||15|0||Vistor hf|Janssen-Cilag AB|Blöndur||757||757|2014|
195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|||0|0|E|0|REP|0|0|1|100|SEK|388|1510|lyfalmen||||30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||388||388|1510|
195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|||0|0|E|0|REP|0|0|1|100|SEK|821|2102|lyfalmen||||100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||821||821|2102|
196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|||0|0|B|0|MYL|0|0|0|100|SEK|2348|4191|lyfalmen||||250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2348||2348|4191|
196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|||0|0|0|0|BAP|0|0|0|100|SEK|1463|2980|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1463||1463|2980|
196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|||0|0|0|0|APC|0|0|1|100|IKR|||lyflausa||||100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||||||
196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|||0|0|B|0|APT|0|0|0|100|GBP|5886|9031|lyfalmen||||100|0|0,8333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||5886||5886|9031|
196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|25074|33350|lyfsjukr||||2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||25074|33350|
197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|||0|0|0|0|IBV|1|0|0|100|DKK|2412|4798|vetalmen||||10|0||Vistor hf|Intervet International BV|||2412||2412|4798|
197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|||0|0|0|0|PER|0|0|1|100|DKK|803|2077|lyfalmen||||20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||803||803|2077|
197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|||0|0|0|0|PER|0|0|0|100|DKK|2629|4575|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2629||2629|4575|
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2173|3951|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2173||2173|3951|
198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|||0|1|*|0|APT|0|0|0|100|XEU|1987|3697|lyfalmen||||25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Melphalan||1987||1987|3697|
198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|||0|1|0|1|PER|0|0|0|100|DKK|6729|9712|lyfsjukr||||200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||6729||6729|9712|
198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|||0|0|0|1|LFS|0|1|0|100|DKK|382|551|lyfsjukr||||5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||382||382|551|
199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|||0|0|*|0|PER|0|0|0|100|DKK|33818|44987|lyfalmen||||100|0||Icepharma hf|Pfizer ApS|Estramústín||33818||33818|44987|
199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|7983|5645|lyfalmen|V0515|5515||100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3411||3411|5645|
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|||0|0|0|0|PER|0|0|1|100|DKK|593|1790|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||593||593|1790|
199584|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|||0|0|E|0|APC|0|0|0|100|XEU|7641|5144|lyfalmen|V0011|5012||98|0|65,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3045||3045|5144|
199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|88314|112717|lyfsjukr||||1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||88314|112717|
199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|||0|0|E|0|PER|0|0|0|100|DKK|4378|6968|lyfalmen|V0126|6968||8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4378||4378|6968|
199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|||0|0|0|1|JAB|0|0|0|100|XEU|52730|68059|lyfsjukr||||5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||52730||52730|68059|
199940|L01XC1101|Yervoy|stţ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|||0|1|0|1|BMS|0|0|0|100|DKK|2565583|3221689|lyfsjukr||||40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2565583||2565583|3221689|
300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|||0|0|E|0|PCO|0|0|0|100|GBP|5359|8139|lyfalmen||||60|1|12,0000|Distica|Distica - óskráđ lyf|Úrsódeoxýkól sýra||5234||5234|8139|
370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|||0|0|0|1|ROC|0|0|0|100|DKK|632|912|lyfsjukr||||1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||632||632|912|
370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|DKK|29061|55974|vetalmen||||2|0||Vistor hf|Virbac S.A|Deslorelín||29061||29061|55974|
370434|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|||0|0|E|0|APC|0|0|0|100|XEU|11531|5144|lyfalmen|V0012|5012||98|0|130,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3045||3045|5144|
370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|||0|0|0|1|NOM|0|0|0|100|DKK|550|794|lyfsjukr||||1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||550||550|794|
371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|||0|0|E|0|MAB|0|0|1|100|DKK|9647|14176|lyfalmen||||60|0||Vistor hf|Meda AB|Pímekrólímus||9647||9647|14176|
371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum||||||
371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum||||||
371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen||||1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||9953|
371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín||||||
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|||0|0|0|0|SNO|0|1|0|100|NOK|6222|9490|lyfalmen||||90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||6222||6222|9490|
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|||0|0|E|0|ROC|0|0|0|100|DKK|3430|5671|lyfalmen||||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3430||3430|5671|
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|||0|0|0|0|ORG|0|0|0|100|DKK|2352|4196|lyfalmen||||66|0|66,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2352||2352|4196|
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|||0|0|*|0|SNO|0|1|0|100|NOK|18718|26036|lyfalmen||||90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||18718||18718|26036|
373324|R03AK0602|Seretide Diskus|innúđadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|||0|0|B|0|GSK|0|0|0|100|GBP|4105|6594|lyfalmen||||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4105||4105|6594|
373340|R03AK0602|Seretide Diskus|innúđadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|6781|10255|lyfalmen|V0436|10254||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6781||6781|10255|
373365|R03AK0602|Seretide Diskus|innúđadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|9360|13783|lyfalmen|V0437|13783||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9360||9360|13783|
373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|||0|0|*|0|MED|0|0|0|100|XEU|6972|7313|lyfalmen|V0420|7313||30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíđ||4630||4630|7313|
373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|1482|3006|lyfalmen|V0126|1742||2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1482||1482|3006|
374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|||0|1|0|1|AZA|0|0|0|100|SEK|389268|490414|lyfsjukr||||30|0||Vistor hf|AstraZeneca AB|Vandetaníb||389268||389268|490414|
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|||0|0|*|0|MCK|0|0|0|100|SEK|684|1915|lyfalmen|V0500|1522||100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||684||684|1915|
374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|5377|7760|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5377||5377|7760|
374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|||0|0|E|0|ASP|0|0|0|100|XEU|4311|6876|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4311||4311|6876|
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|||0|0|E|0|GSK|0|0|1|100|GBP|11451|16643|lyfalmen||||60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11451||11451|16643|
374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól||||||
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|8827|13054|lyfalmen||||6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8827||8827|13054|
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|10476|15310|lyfalmen||||8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10476||10476|15310|
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|12239|17905|lyfalmen||||10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12239||12239|17905|
376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|31042|41503|lyfalmen|V0459|41503||168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||31042||31042|41503|
376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|19052|26455|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||19052||19052|26455|
376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|87300|112107|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||87300||87300|112107|
377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|||0|0|0|0|ABS|0|0|1|100|DKK|4022|6481|lyfalmen||||14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4022||4022|6481|
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|||0|0|E|0|GSK|0|0|1|100|GBP|11090|8906|lyfalmen|V0182|8765||42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||5795||5795|8906|
378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|||0|0|0|0|ALM|0|0|0|100|XEU|15344|21802|lyfalmen||||100|0||Vistor hf|Almirall S.A.|Önnur húđlyf-Diclofenacum||15344||15344|21802|
379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|138923|176231|lyfsjukr||||4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||138923||138923|176231|
379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|107866|137254|lyfsjukr||||2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||107866||107866|137254|
379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|151976|192612|lyfsjukr||||2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||151976||151976|192612|
379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|192420|243370|lyfsjukr||||2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||192420||192420|243370|
379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|||0|0|0|0|AGT|0|0|1|100|DKK|1416|2916|lyfalmen||||12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1416||1416|2916|
379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|||0|0|0|0|AGT|0|0|1|100|DKK|1750|3373|lyfalmen||||12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1750||1750|3373|
380276|N03AX1406|Zelta|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|7852|5515|lyfalmen|V0515|5515||100|0|16,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||3316||3316|5515|
381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín||||||
381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|||0|0|*|0|ELD|0|0|0|100|XEU|5248|8158|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5248||5248|8158|
381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|7140|7055|lyfalmen|V0143|7055||12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||4442||4442|7055|
383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|||0|0|B|0|AZD|0|0|0|100|SEK|6988|10538|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||6988||6988|10538|
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||L|||0|0|0|0|BAN|0|0|0|100|DKK|1207|2106|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||||1207|2106|
383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|||0|0|0|0|BAN|0|0|0|100|DKK|7269|12680|vetorma||||20|0||Icepharma hf|Bayer Animal Health GmbH|||7269||7269|12680|
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||60|0||Actavis Group hf|Actavis hf|Ketókónazól||||||
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||120|0||Actavis Group hf|Actavis hf|Ketókónazól||||||
386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|5775|5723|lyfalmen|V0144|5723||8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3468||3468|5723|
386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|||0|0|*|0|AZA|0|0|0|100|SEK|57707|74967|lyfalmen|V0184|14033||98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||57707||57707|74967|
387579|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|0|100|XEU|870|1924|lyfalmen|V0308|1924||60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||691||691|1924|
387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|||0|0|0|0|ICE|0|0|0|100|XEU|686|1365|vetalmen||||100|0||Icepharma hf|Icepharma hf|||686||686|1365|
387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|||0|0|0|1|CEP|0|0|0|100|DKK|188612|238591|lyfsjukr||||200|0|28,5714|Icepharma hf|Cephalon France (I)|Amfóterícín||188612||188612|238591|
388198|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|153192|194138|lyfsjukr||||1|0||Icepharma hf|Pfizer Limited|Temsirolímus||153192||153192|194138|
388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|||0|0|0|0|AZD|0|0|1|100|SEK|3322|5523|lyfalmen||||25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3322||3322|5523|
388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|||0|0|0|0|AZD|0|0|1|100|SEK|4188|6708|lyfalmen||||30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4188||4188|6708|
388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa||||2|0||Vistor hf|AstraZeneca A/S DK|Blöndur||||||
388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|||0|0|0|0|AZD|0|0|1|100|SEK|8126|12095|lyfalmen||||20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||8126||8126|12095|
388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|753|1536|lyfalmen|V0466|1536||28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||407||407|1536|
389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|||0|0|E|0|BIP|0|0|0|100|DKK|2233|4034|lyfalmen|V0410|4034||84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2233||2233|4034|
389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|||0|0|E|0|BIP|0|0|0|100|DKK|2040|3770|lyfalmen||||84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2040||2040|3770|
389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|||0|0|E|0|BIP|0|0|0|100|DKK|647|1864|lyfalmen|V0128|1864||84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||647||647|1864|
389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|||0|0|E|0|BIP|0|0|0|100|DKK|599|1798|lyfalmen||||84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||599||599|1798|
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|912|2226|lyfalmen|V0367|1264||3|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||912||912|2226|
389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|2526|3441|lyfalmen|V0143|2352||4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1800||1800|3441|
389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|4900|2466|lyfalmen|V0267|2466||100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||1087||1087|2466|
389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|58247|75645|lyfalmen||||2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||58247||58247|75645|
389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|17561|24584|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||17561||17561|24584|
390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|77258|98841|lyfsjukr||||50|0||Vistor hf|Orion Corporation|Dexmedetómid||77258||77258|98841|
390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|||0|0|E|0|BRS|0|0|1|100|DKK|2751|4742|lyfalmen||||100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2751||2751|4742|
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|6592|9996|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6592||6592|9996|
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|2604|4541|lyfalmen|V0037|4541||20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2604||2604|4541|
391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|30289|40558|lyfalmen||||1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||30289||30289|40558|
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|12704|18489|lyfalmen|V0196|18487||100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||12704||12704|18489|
391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|||0|0|0|0|AZD|0|0|1|100|SEK|2675|4638|lyfalmen||||50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2675||2675|4638|
392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|234343|295983|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||234343||234343|295983|
392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|fl||A04AA01|01.08.2009||R|||0|0|E|0|PCO|0|0|0|100|IKR|12000|17605|lyfalmen||||50|1|2,5000|Distica|Distica - óskráđ lyf|Ondansetrón||||12000|17605|
393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|||0|0|0|0|PAL|0|0|0|100|DKK|5294|10338|vetalmen||||24|0||Icepharma hf|Pfizer Oy Animal Health|||5294||5294|10338|
393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4452|4623|lyfalmen|V0327|4623||100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2664||2664|4623|
394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|||0|1|0|1|AMG|0|0|0|100|DKK|140061|176563|lyfsjukr||||1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||139188||139188|176563|
395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|SEK|27994|37182|lyfalmen|V0356|37182||360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27599||27599|37182|
395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|170350|215672|lyfsjukr||||300|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||170350||170350|215672|
396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|3816|6199|lyfalmen||||100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3816||3816|6199|
397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|||0|1|0|1|MKA|0|0|0|100|SEK|36342|47492|lyfsjukr||||20|0||Icepharma hf|Merck KgaA|Cetúxímab||36342||36342|47492|
397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|9325|13458|lyfsjukr||||60|0||Icepharma hf|Roche|Capecitabín||9325||9325|13458|
397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|53468|68985|lyfsjukr||||120|0||Icepharma hf|Roche|Capecitabín||53468||53468|68985|
397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat||||||
398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|7175|3287|lyfalmen|V0012|2864||56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1687||1687|3287|
399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|3313|1871|lyfalmen|V0009|1868||28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||652||652|1871|
399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.05.2012||R|||0|0|E|0|GLP|0|0|1|100|SEK|395|1519|lyfalmen|V0225|1473||100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||395||395|1519|
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|||0|0|E|0|GSK|0|0|0|100|IKR|2049|2856|lyfalmen|V0244|2668||56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1372||1372|2856|
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|8500|12606|lyfalmen||||3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8500||8500|12606|
399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|40581|52812|lyfsjukr||||2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||40581||40581|52812|
399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír||||||
399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|||0|1|0|1|RRL|0|0|0|100|DKK|107443|136723|lyfsjukr||||2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||107443||107443|136723|
400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|||0|0|E|0|SNO|0|0|1|100|NOK|1465|2983|lyfalmen||||8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1465||1465|2983|
400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0||Actavis Group hf|Actavis hf|Blöndur||||||
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|||0|0|0|0|PER|0|0|0|100|DKK|4854|7619|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||4854||4854|7619|
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|210|1266|lyfalmen||||25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||210||210|1266|
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|382|1501|lyfalmen||||100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||382||382|1501|
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|182|1228|lyfalmen||||25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||182||182|1228|
401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|10725|15650|lyfalmen|V0459|13834||56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||10725||10725|15650|
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|||0|0|B|0|LBK|0|1|0|100|DKK|714|1956|lyfalmen||||100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||714||714|1956|
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|||0|0|B|0|LBK|0|1|0|100|DKK|1143|2542|lyfalmen||||100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1143||1143|2542|
401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|||0|0|B|0|ACA|0|0|0|100|XEU|1122|2514|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1122||1122|2514|
401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|||0|0|B|0|ACA|0|0|0|100|XEU|1801|3443|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1801||1801|3443|
402651|J07BB0205|Influvac|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|||0|0|0|0|AHP|0|0|0|100|XEU|614|1819|lyfalmen||||0|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir  mótefnavakar||614||614|1819|
402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|||0|0|0|0|BID|0|0|0|100|DKK|1574|3131|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim Danmark|||1574||1574|3131|
403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.03.2011||R|||0|1|*|0|LYF|0|0|0|100|XEU|19393|23927|lyfalmen|V0470|23927||100|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||17037||17037|23927|
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|||0|0|0|0|IBV|1|0|0|100|DKK|4841|9468|vetalmen||||20|0||Vistor hf|Intervet International BV|||4841||4841|9468|
403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|||0|0|B|0|NOH|0|0|0|100|DKK|5528|8541|lyfalmen||||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||5528||5528|8541|
403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|||0|1|0|1|PER|0|0|0|100|DKK|34830|45594|lyfsjukr||||50|0||Icepharma hf|Pfizer ApS|Metótrexat||||34830|45594|
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|||0|0|E|0|SNO|0|0|0|100|NOK|1398|2891|lyfalmen||||14|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1398||1398|2891|
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1805|
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|||0|0|0|1|BOI|0|0|0|100|DKK|61346|78872|lyfsjukr||||1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||61346||61346|78872|
404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|||0|0|0|1|ROC|0|0|0|100|DKK|644|929|lyfsjukr||||5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||644||644|929|
405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|||0|0|0|0|AEL|1|0|0|100|XEU|7647|14856|vetalmen||||10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||7647||7647|14856|
405589|J07BD5203|Priorix|bóluefni|||0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|||0|0|0|0|GSK|0|0|0|100|GBP|1783|3418|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1783||1783|3418|
405597|J07BD5203|Priorix|bóluefni|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|||0|0|0|0|GSK|0|0|0|100|GBP|19003|26394|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||19003||19003|26394|
405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|17074|23973|lyfalmen||||28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||17074||17074|23973|
406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813|
406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|19479|26991|lyfalmen||||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||19479||19479|26991|
406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|21349|29338|lyfalmen||||28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21349||21349|29338|
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|19259|26715|lyfalmen||||100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||19259||19259|26715|
406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901|
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|58067|75419|lyfalmen||||100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||58067||58067|75419|
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|68165|88092|lyfalmen||||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||68165||68165|88092|
406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|77284|99537|lyfalmen||||100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||77284||77284|99537|
406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|5894|9042|lyfalmen||||30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||5894||5894|9042|
406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|74813|95773|lyfsjukr||||8|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||74813||74813|95773|
407142|C09CA0304|Valsartan LYFIS|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|3140|3003|lyfalmen|V0072|3003||98|0|98,0000|LYFIS ehf|LYFIS ehf|Valsartan||1480||1480|3003|
407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|||0|0|E|0|REP|0|0|0|100|SEK|2189|3973|lyfalmen||||100|0|12,5000|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||2189||2189|3973|
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|158|1195|lyfalmen||||25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||158||158|1195|
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|343|1448|lyfalmen||||100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||343||343|1448|
408266|N05BA1206|Alprazolam Krka|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|0|100|XEU|1839|3102|lyfalmen|V0310|3102||60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1552||1552|3102|
408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2705|4679|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2705||2705|4679|
408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2121|3880|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2121||2121|3880|
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|||0|0|0|0|PER|0|0|1|100|DKK|4024|6484|lyfalmen||||35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4024||4024|6484|
409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|3500|5767|lyfalmen||||28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3500||3500|5767|
409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|||0|0|E|0|AZD|0|0|1|100|SEK|4242|6782|lyfalmen||||200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4242||4242|6782|
409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|11719|17010|lyfalmen||||98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||11719||11719|17010|
409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|2795|4802|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2795||2795|4802|
409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|||0|0|0|0|PAB|1|0|0|100|DKK|9973|19322|vetalmen||||120|0||Vistor hf|Pharmaxim AB|||9973||9973|19322|
409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|77942|100362|lyfalmen||||1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||77942||77942|100362|
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|9496|13969|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||9496||9496|13969|
410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|||0|0|0|0|REP|0|0|0|100|SEK|1137|2534|lyfalmen||||20|0|6,2000|Vistor hf|Recip AB|Klórókín||1137||1137|2534|
410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|||0|0|0|0|JAS|0|0|0|100|SEK|777|2042|lyfalmen||||30|0||Vistor hf|Janssen-Cilag AB|Tretínóín||777||777|2042|
411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|||0|0|E|0|MYL|0|0|1|100|SEK|680|1909|lyfalmen||||50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||680||680|1909|
411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|||0|0|0|1|ROC|0|0|0|100|DKK|4591|6626|lyfsjukr||||50|0|16,6667|Icepharma hf|Roche|Mídazólam||4591||4591|6626|
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|||0|1|0|1|VII|0|0|0|100|GBP|25258|33581|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||25258||25258|33581|
411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|||0|0|E|0|GSK|0|0|0|100|GBP|7389|11087|lyfalmen||||6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7389||7389|11087|
412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.01.1990||R|||0|1|*|0|AZA|0|0|0|100|SEK|22735|31078|lyfalmen|V0183|31075||1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||22735||22735|31078|
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|||0|0|0|1|SNO|0|0|0|100|NOK|3675|5304|lyfsjukr||||3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3675||3675|5304|
412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|||0|0|0|0|MER|1|0|0|100|DKK|8027|15586|vetalmen||||100|0||Vistor hf|Merial|||8027||8027|15586|
412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|120352|152924|lyfsjukr||||2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||120352||120352|152924|
412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|60619|78622|lyfalmen||||1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||60619||60619|78622|
412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|||0|0|*|0|MYL|0|0|0|100|SEK|3417|5653|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3417||3417|5653|
412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|||0|0|*|0|MYL|0|0|0|100|SEK|4197|6720|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4197||4197|6720|
414006|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|||0|0|B|0|BLU|0|1|0|100|XEU|830|1878|lyfalmen|V0062|1878||30|0|15,0000|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Cítalópram||657||657|1878|
414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|||0|0|E|0|WIH|0|0|0|100|XEU|26771|15482|lyfalmen|V0342|14189||98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||10602||10602|15482|
414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|||0|0|E|0|SEV|0|0|0|100|DKK|4052|6522|lyfalmen||||90|0|54,0000|Icepharma hf|Servier|Indapamíđ||4052||4052|6522|
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|||0|0|E|0|NOH|0|0|0|100|DKK|1244|2681|lyfalmen||||300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1244||1244|2681|
415556|B03AC0204|Venofer  (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|||0|0|E|0|DAC|0|0|1|100|CHF|14192|18127|lyfalmen|V0034|18077||25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíđ (sykurflétta)||12416||12416|18127|
415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|||0|0|E|0|NAS|0|0|0|100|DKK|1788|3425|lyfalmen||||15|0|15,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1788||1788|3425|
415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|12098|8545|lyfalmen|V0253|8411||100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||5531||5531|8545|
416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|||0|0|0|0|MSD|0|0|0|100|DKK|8942|9044|lyfalmen|V0088|2598||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||5896||5896|9044|
416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|3928|1768|lyfalmen|V0005|1768||28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||577||577|1768|
416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|||0|0|E|0|PCO|0|0|0|100|GBP|5061|7902|lyfalmen||||300|1|15,0000|Distica|Distica - óskráđ lyf|Ranitidín||5061||5061|7902|
416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.03.2011||R|||1|0|0|1|RBP|0|0|0|100|DKK|4617|6663|lyfsjukr||||7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||4617||4617|6663|
416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|||0|0|E|0|GOG|0|0|1|100|XEU|2720|4700|lyfalmen||||10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||2720||2720|4700|
416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|||0|0|E|0|GOG|0|0|1|100|DKK|24478|33265|lyfalmen||||150|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||24478||24478|33265|
416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|1232|2664|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1232||1232|2664|
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|||0|1|0|1|VII|0|0|0|100|GBP|41342|53767|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||41342||41342|53767|
417880|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.07.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|93601|119352|lyfsjukr||||1000|0|2,2200|Icepharma hf|Pfizer Limited|Storkuţáttur IX||93601||93601|119352|
418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|||0|0|E|0|BII|0|0|0|100|DKK|32260|43031|lyfalmen|V0460|43031||180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||32260|43031|
418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|ţpakki||A07EC02|01.10.1991||R|||0|0|B|0|SNO|0|0|0|100|NOK|4754|7482|lyfalmen||||100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4754||4754|7482|
418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|||0|1|0|1|BIO|0|0|0|100|DKK|126841|161068|lyfsjukr||||19|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||126841||126841|161068|
418665|D07XC0101|Diprosalic|smyrsli|||50|g|1|túpa||D07XC01|01.11.1979||R|||0|0|B|0|SPL|0|0|1|100|DKK|1508|3042|lyfalmen||||50|0||Vistor hf|Schering-Plough Europe|Betametasón||1508||1508|3042|
418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|||0|0|B|0|SNO|0|0|0|100|NOK|7241|10884|lyfalmen|V0014|10884||60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||7241||7241|10884|
418950|N05AH0310|Zalasta (LYFIS)|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|22203|18351|lyfalmen|V0475|18351||28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||12594||12594|18351|
418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2012||R|||0|0|E|0|APC|0|0|1|100|XEU|3678|6010|lyfalmen|V0458|6010||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||3678||3678|6010|
418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|||0|0|0|0|BID|0|0|0|100|DKK|1927|3833|vetalmen||||200|0||Vistor hf|Boehringer Ingelheim Danmark|||1927||1927|3833|
418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|||0|0|0|0|BID|0|0|0|100|DKK|2500|4973|vetalmen||||200|0||Vistor hf|Boehringer Ingelheim Danmark|||2500||2500|4973|
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|||0|0|B|0|LEP|0|0|0|100|DKK|3133|5265|lyfalmen||||100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||3133||3133|5265|
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|||0|0|B|0|LEP|0|0|0|100|DKK|6700|10144|lyfalmen||||100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||6700||6700|10144|
419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|||0|1|0|1|MSD|0|0|0|100|DKK|49193|63620|lyfsjukr||||180|0|30,0000|Vistor hf|M.S.D.|Indínavír||49193||49193|63620|
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|||0|1|0|1|ORP|0|0|0|100|DKK|37329|48730|lyfsjukr||||100|0|7,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mecaptamín||37329||37329|48730|
419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|835|2121|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||835||835|2121|
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|11358|16516|lyfalmen||||10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||11358||11358|16516|
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|||0|0|B|0|SNO|0|0|0|100|NOK|1495|3024|lyfalmen|V0036|3023||30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1495||1495|3024|
422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|||0|0|B|0|AZD|0|0|0|100|SEK|1515|3051|lyfalmen|V0051|2900||100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1515||1515|3051|
422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|||0|0|B|0|AZD|0|0|0|100|SEK|3463|5716|lyfalmen|V0049|3987||98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3463||3463|5716|
422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|||0|0|B|0|AZD|0|0|0|100|SEK|5968|9143|lyfalmen|V0054|6920||98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||5968||5968|9143|
422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|||0|1|0|1|CSB|0|0|0|100|SEK|73440|94050|lyfsjukr||||1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||73440||73440|94050|
423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|6383|3530|lyfalmen|V0011|2864||56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1865||1865|3530|
423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|||0|0|0|1|BRU|0|0|0|100|XEU|20583|27714|lyfsjukr||||1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||20583||20583|27714|
424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||L|||0|0|0|0|IBV|0|0|0|100|DKK|1527|2664|vetorma||||24|0||Vistor hf|Intervet International BV|||||1527|2664|
425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|||1|0|0|0|MYL|0|0|0|100|SEK|808|2084|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||808||808|2084|
425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|||1|1|0|1|RBP|0|0|0|100|DKK|4496|6446|lyfsjukr||||28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4466||4466|6446|
425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|||0|0|B|0|ACA|0|0|0|100|SEK|2153|3761|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis hf|Lósartan||2034||2034|3761|
426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|676|1904|lyfalmen||||20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||676||676|1904|
426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|883|2187|lyfalmen||||30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||883||883|2187|
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|||0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen||||30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2738|
428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|||0|0|B|0|SPL|0|0|1|100|DKK|810|2087|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||810||810|2087|
428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|||0|0|B|0|SPL|0|0|1|100|DKK|951|2280|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||951||951|2280|
428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|49546|64063|lyfsjukr||||2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||49546||49546|64063|
428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|0|0|POF|0|0|0|100|IKR|6185|3246|lyfalmen|V0113|3246||100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||1657||1657|3246|
428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|25998|26344|lyfalmen|V0344|26344||112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||18963||18963|26344|
429167|J07CA0602|Pentavac|bóluefni|||0,5|ml|1|hgl|+ dreifa í dćlu|J07CA06|01.10.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|3974|6415|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||3974||3974|6415|
429225|J07CA0602|Pentavac|bóluefni|||0,5|ml|10|hgl||J07CA06|01.12.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|39104|51621|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||39104||39104|51621|
429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.07.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|95075|121202|lyfsjukr||||105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||95075||95075|121202|
429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|||0|0|E|0|PER|0|0|0|100|DKK|3848|6243|lyfalmen||||100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||3848||3848|6243|
430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|||1|0|0|1|JAS|0|0|0|100|SEK|1704|2459|lyfsjukr||||50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||1704||1704|2459|
430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|||0|0|0|1|ROC|0|0|0|100|DKK|1359|1961|lyfsjukr||||50|0|3,3333|Icepharma hf|Roche|Mídazólam||1359||1359|1961|
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|||0|0|0|0|IBV|0|0|0|100|DKK|4214|8264|vetalmen||||100|0||Vistor hf|Intervet International BV|||4214||4214|8264|
430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|||0|0|*|0|WIH|0|0|0|100|XEU|27558|15482|lyfalmen|V0184|14033||98|0|98,0000|Portfarma ehf|Williams & Halls|Anastrózól||10602||10602|15482|
430417|N03AX2101|Trobalt|filmhtfl|400|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|33576|44683|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||33576||33576|44683|
430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|2789|3531|lyfalmen|V0144|2862||4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1866||1866|3531|
430710|J07AP0301|Typhim Vi|bóluefni|||0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|||0|0|0|0|SPM|0|0|0|100|XEU|2306|4133|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2306||2306|4133|
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|||0|0|0|0|LEP|0|0|1|100|DKK|717|1960|lyfalmen||||15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||717||717|1960|
431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|ţpakki||C01DA08|01.07.1989||R|||0|0|B|0|REP|0|0|0|100|SEK|1166|2574|lyfalmen||||100|0|16,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1166||1166|2574|
431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|||0|1|0|1|AVS|0|0|0|100|NOK|229640|290081|lyfsjukr||||8|0||Vistor hf|Aventis Pharma SA|Docetaxel||229640||229640|290081|
431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|||0|0|E|0|PER|0|0|1|100|DKK|1331|2800|lyfalmen||||20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1331|2800|
431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|||0|0|E|0|PER|0|0|1|100|DKK|4514|7154|lyfalmen||||100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4514||4514|7154|
432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|||0|0|E|0|NDR|0|0|0|100|SEK|37659|49807|lyfalmen|V0209|49807||12|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||37659|49807|
432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|||0|0|0|0|ACA|0|0|1|100|XEU|1081|2458|lyfalmen||||300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1081||1081|2458|
432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|||0|0|0|0|NOB|1|0|0|100|XEU|3488|6870|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3488||3488|6870|
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|||0|0|E|0|ORC|0|0|0|100|DKK|10416|15227|lyfalmen||||100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10416||10416|15227|
433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|2436|4311|lyfalmen||||28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2436||2436|4311|
433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|5333|8274|lyfalmen||||28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5333||5333|8274|
433342|N02AA0106|Contalgin Uno|forđahlk|150|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|8139|12113|lyfalmen||||28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||8139||8139|12113|
433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|561|1672|lyfalmen|V0004|418||7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||507||507|1672|
434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|||0|0|0|0|IBV|0|0|0|100|DKK|1070|1867|vetorma||||10|0||Vistor hf|Intervet International BV|||||1070|1867|
434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|MCS|0|0|1|100|SEK|898|2207|lyfalmen||||50|0||Vistor hf|McNeil Sweden AB|Blöndur||898||898|2207|
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|||0|0|B|0|MEB|0|0|1|100|DKK|5463|8452|lyfalmen||||1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5463||5463|8452|
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|||0|0|B|0|MEB|0|0|1|100|DKK|5463|8452|lyfalmen||||1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5463||5463|8452|
434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|||0|0|0|0|ELI|0|1|0|100|XEU|9669|14206|lyfalmen||||100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||9669||9669|14206|
435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|||0|0|E|0|ASZ|0|0|0|100|SEK|6724|10177|lyfalmen||||6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6724||6724|10177|
435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998||R|||0|0|E|0|ASZ|0|0|0|100|SEK|4665|7360|lyfalmen||||6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4665||4665|7360|
435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|8297|10879|lyfalmen|V0284|3455||100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7237||7237|10879|
435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|IKR|929|2250|lyfalmen|V0284|2073||60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||929||929|2250|
435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|||0|0|B|0|REP|0|0|0|100|SEK|2807|4819|lyfalmen||||250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2807||2807|4819|
436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|222377|280966|lyfsjukr||||500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||222377||222377|280966|
436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|||0|0|0|0|NOH|0|0|0|100|DKK|3331|5536|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||3331||3331|5536|
436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||||||
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|||0|0|0|0|LEP|0|0|1|100|DKK|698|1934|lyfalmen||||15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||698||698|1934|
436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|228055|288092|lyfsjukr||||500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||228055||228055|288092|
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|||0|0|*|0|JAS|0|1|0|100|SEK|959|2291|lyfalmen||||100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||959||959|2291|
436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|||0|0|*|0|JAS|0|1|0|100|SEK|3507|5776|lyfalmen||||100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3507||3507|5776|
437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|9477|7726|lyfalmen|V0029|7726||100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||4932||4932|7726|
437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|63921|82103|lyfsjukr||||125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||63921||63921|82103|
438225|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|glas||N07XX07|01.12.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|30713|40427|lyfsjukr||||28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||30713||30713|40427|
438333|N06AX1602|Efexor Depot|forđahlk|150|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|5806|8921|lyfalmen||||28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||5806||5806|8921|
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|||0|0|E|0|SAL|0|0|1|100|USD|1229|2660|lyfalmen||||10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1229||1229|2660|
438424|N06AX1602|Efexor Depot|forđahlk|75|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|3041|5139|lyfalmen|V0259|2936||28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3041||3041|5139|
438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|10458|15285|lyfalmen|V0334|5733||98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10458||10458|15285|
438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|ţpakki||L01XE15|01.08.2012||R|||0|1|0|1|RRL|0|0|0|100|DKK|326457|411586|lyfsjukr||||56|0|-1,0000|Icepharma hf|Roche Registration Limited|Vemurafeníb||326457||326457|411586|
438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|||0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín||||||
438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||R|||0|0|0|0|SCP|0|0|1|100|DKK|1772|3403|lyfalmen||||30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||1772||1772|3403|
438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||R|||0|0|E|0|SCP|0|0|1|100|DKK|5578|8609|lyfalmen|V0362|2176||100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||5578||5578|8609|
438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|154986|196390|lyfsjukr||||3|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||154986||154986|196390|
439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|||0|0|0|0|GSK|0|0|1|100|GBP|2742|4730|lyfalmen||||14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2742||2742|4730|
439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|||0|0|B|0|AZD|0|0|0|100|SEK|8572|12705|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||8572||8572|12705|
439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|||0|0|0|0|GSK|0|0|1|100|IKR|1066|2437|lyfalmen||||70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2437|
440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|1394|2012|lyfsjukr||||10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1394||1394|2012|
440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|2201|3177|lyfsjukr||||10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2201||2201|3177|
441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|||0|0|E|0|PER|0|0|0|100|DKK|871|2170|lyfalmen|V0046|2170||100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||871||871|2170|
441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|JAS|0|0|1|100|SEK|1259|2701|lyfalmen||||30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1259||1259|2701|
441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|||0|1|0|1|GIL|0|0|0|100|DKK|118035|150016|lyfsjukr||||30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtrícítabín, rilpívírin og tenófóvír||118035||118035|150016|
441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|||0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa||||59|0||Aco Hud Nordic AB|ACO Hud AB|Permetrín||||||
441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|||0|0|E|0|BAP|0|0|0|100|SEK|1000|2347|lyfalmen||||30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1000||1000|2347|
442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|||0|0|E|0|BII|0|0|0|100|DKK|10753|15688|lyfalmen|V0460|14344||60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||10753|15688|
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|||0|0|*|0|NAS|0|0|1|100|DKK|3247|5421|lyfalmen||||1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3247||3247|5421|
443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|||1|0|E|0|PER|0|0|0|100|DKK|24757|33615|lyfalmen||||90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||24757||24757|33615|
444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|7168|10784|lyfalmen||||20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7168||7168|10784|
444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|||0|0|0|0|ELI|0|1|0|100|DKK|2943|5005|lyfalmen|V0061|3184||30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2943||2943|5005|
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|||0|0|E|0|ROC|0|0|0|100|DKK|2143|3910|lyfalmen||||100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2143||2143|3910|
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|||0|0|B|0|LEO|0|0|1|100|DKK|1495|3024|lyfalmen||||30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1495||1495|3024|
446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|||0|0|0|0|IBV|0|0|0|100|DKK|1361|2707|vetalmen||||50|0||Vistor hf|Intervet International BV|||1361||1361|2707|
446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|||0|1|E|0|EIS|0|0|0|100|SEK|19509|27029|lyfalmen||||460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíđ||19509||19509|27029|
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|9970|14617|lyfalmen||||4|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||9970||9970|14617|
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|5682|8752|lyfalmen||||2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||5682||5682|8752|
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|7033|10600|lyfalmen||||2|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7033||7033|10600|
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|8369|12427|lyfalmen||||3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8369||8369|12427|
448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|633|1845|lyfalmen||||10|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||633||633|1845|
448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|1236|2670|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1236||1236|2670|
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|||0|0|E|0|NOH|0|0|1|100|DKK|1993|3705|lyfalmen|V0202|3571||50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||1993||1993|3705|
449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|||0|0|0|1|Bru|0|0|0|100|XEU|1079|1557|lyfsjukr||||0|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1079||1079|1557|
449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|||0|0|B|0|MYL|0|0|0|100|SEK|1397|2890|lyfalmen||||98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1397||1397|2890|
449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|5221|7535|lyfsjukr||||10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5221||5221|7535|
449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|||0|0|*|0|ELI|0|0|0|100|XEU|5065|7908|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5065||5065|7908|
450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|||1|0|0|0|LEV|1|0|0|100|XEU|4392|8606|vetalmen||||100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4392||4392|8606|
450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|ţp 875+125 mg|J01CR02|01.01.1997||R|||0|0|0|0|GSK|0|0|1|100|IKR|1115|2382|lyfalmen|V0169|2367||12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2382|
450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|ţpakki||N05CF02|01.10.1992||R|||0|0|0|0|SNO|0|0|1|100|NOK|861|1737|lyfalmen|V0060|1039||20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||554||554|1737|
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|||0|0|0|0|SNO|0|0|0|100|NOK|2991|4036|lyfalmen|V0313|4036||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2235||2235|4036|
450979|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA03|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|7010|12229|vetorma||||2|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||7010||7010|12229|
451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|53899|69526|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||53899||53899|69526|
451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|80849|103348|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||80849||80849|103348|
451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|107798|137169|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||107798||107798|137169|
451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|||0|0|0|0|LBK|0|1|0|100|DKK|5390|7615|lyfalmen||||28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4851||4851|7615|
451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|||0|0|0|0|LBK|0|1|0|100|DKK|14235|20410|lyfalmen||||100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||14235||14235|20410|
452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||120|0||Vistor hf|McNeil Sweden AB|Ketókónazól||||||
452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|||0|0|E|0|ROA|0|0|1|100|DKK|1094|2475|lyfalmen||||5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1094||1094|2475|
452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|||0|0|0|0|LHS|0|0|0|100|XEU|10502|18320|vetorma||||50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||10502||10502|18320|
452482|V07AB09|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||2000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|||0|0|0|0|LAB|0|0|1|100|SEK|11923|17289|lyfalmen||||3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||11923||11923|17289|
452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|||0|0|0|0|LCC|0|0|0|100|DKK|2207|3998|lyfalmen||||90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2207||2207|3998|
452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|2238|4040|lyfalmen||||28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2238||2238|4040|
452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|6577|9976|lyfalmen||||98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||6577||6577|9976|
452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|4320|6888|lyfalmen||||28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4320||4320|6888|
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||L|||0|0|0|0|MEF|0|0|0|100|XEU|1387|2420|vetorma||||6|0||Vistor hf|Merial (MSD)|||||1387|2420|
453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|12738|18531|lyfalmen||||98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||12738||12738|18531|
453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|8268|12289|lyfalmen||||28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||8268||8268|12289|
453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|23217|31682|lyfalmen||||98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||23217||23217|31682|
453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|||0|0|0|1|PER|0|1|0|100|DKK|2593|3742|lyfsjukr||||1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2593||2593|3742|
453795|J07AL0102|Pneumo 23|bóluefni|||0,5|ml|1|dćla||J07AL01|01.09.2003||R|||0|0|0|0|SPM|0|0|0|100|XEU|2163|3938|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||2163||2163|3938|
454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|14449|20679|lyfalmen||||28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||14449||14449|20679|
454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|40991|36862|lyfalmen|V0341|12928||98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||27344||27344|36862|
454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|1994|1672|lyfalmen|V0004|1671||28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||507||507|1672|
454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|16219|22900|lyfalmen||||28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||16219||16219|22900|
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|45162|41062|lyfalmen|V0342|14189||98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||30691||30691|41062|
454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|||0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa||||10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól||||||
454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|||0|1|0|1|SKB|0|0|0|100|GBP|53269|68735|lyfsjukr||||1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||53269||53269|68735|
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|||0|0|0|0|BID|0|0|0|100|DKK|1082|2152|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim Danmark|||1082||1082|2152|
455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|||0|0|*|0|BAP|0|0|0|100|SEK|1019|2373|lyfalmen||||30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||1019||1019|2373|
455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|ţpakki||A10BF01|01.12.1997||R|||0|0|*|0|BAP|0|0|0|100|SEK|3663|5990|lyfalmen||||120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||3663||3663|5990|
455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|||0|0|E|0|NOH|0|0|1|100|DKK|20657|28470|lyfalmen||||21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||20657||20657|28470|
455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki|0|J01AA02|01.10.2008||R|||0|0|0|0|AGT|0|0|1|100|XEU|867|2165|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||867||867|2165|
455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|||0|0|0|0|AGT|0|0|1|100|XEU|981|2321|lyfalmen||||15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||981||981|2321|
455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki|0|J01AA02|01.10.2008||R|||0|0|0|0|AGT|0|0|1|100|XEU|2033|3760|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2033||2033|3760|
457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|753|1536|lyfalmen|V0003|1536||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||407||407|1536|
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|||0|0|0|0|CHE|0|0|1|100|SEK|1176|2588|lyfalmen||||25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1176||1176|2588|
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|||0|0|0|0|LEP|0|0|1|100|DKK|1358|2837|lyfalmen|V0577|2527||20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1358||1358|2837|
458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|||0|0|E|0|XEL|0|0|1|100|DKK|22814|31177|lyfalmen||||28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||22814||22814|31177|
459104|N05AH0310|Zalasta (LYFIS)|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|2338|1787|lyfalmen|V0278|1787||28|0|7,0000|LYFIS ehf|LYFIS ehf|Olanzapín||591||591|1787|
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|||0|0|0|1|PER|0|0|0|100|DKK|807|1165|lyfsjukr||||2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||807||807|1165|
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|||0|0|0|1|PER|0|0|0|100|DKK|1478|2133|lyfsjukr||||4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1478||1478|2133|
459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|7168|10784|lyfalmen||||20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7168||7168|10784|
459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|||0|0|E|0|MAS|0|0|1|100|SEK|2196|3983|lyfalmen||||30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2196||2196|3983|
459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|ţpakki||B02AA02|01.04.1989||R|||0|0|E|0|MAS|0|0|1|100|SEK|4459|7079|lyfalmen||||60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4459||4459|7079|
460170|J07BC0202|Avaxim|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|||0|0|0|0|MEX|0|0|0|100|XEU|3784|6155|lyfalmen||||0|0||Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3784||3784|6155|
460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|ţpakki||J04AB02|01.09.2012||R|||0|0|E|0|SAD|0|0|0|100|DKK|7755|11587|lyfalmen||||100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||7755||7755|11587|
460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|ţpakki||J01CA04|01.07.1989||R|||0|0|0|0|ASP|0|0|1|100|XEU|530|1704|lyfalmen||||20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||530||530|1704|
460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|6705|13047|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||6705||6705|13047|
460972|J07BB0205|Influvac|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|||0|0|0|0|AHP|0|0|0|100|XEU|5269|8187|lyfalmen||||5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir  mótefnavakar||5269||5269|8187|
461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|||0|0|0|0|ACA|0|0|1|100|XEU|177|1221|lyfalmen||||10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||177||177|1221|
462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|667|1891|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||667||667|1891|
462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|667|1891|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||667||667|1891|
462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|7629|11415|lyfalmen||||7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7629||7629|11415|
462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|||0|0|E|0|XEL|0|0|1|100|DKK|11391|16561|lyfalmen||||28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||11391||11391|16561|
462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|||0|0|0|0|PAL|1|0|0|100|DKK|6316|12300|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||||6316|12300|
463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|8970|13249|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||8970||8970|13249|
463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|||0|0|0|0|PAL|0|0|0|100|DKK|5039|9848|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||5039||5039|9848|
464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|||0|0|*|0|LPL|0|1|0|100|DKK|1667|3259|lyfalmen||||100|0|8,3333|Swedish Orphan Biovitrum A/S|Lundbeck Pharmaceuticals|Melperón||1667||1667|3259|
465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|||0|0|*|0|APC|0|0|0|100|DKK|3842|6185|lyfalmen|V0376|6185||8|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||3806||3806|6185|
465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|||0|0|0|0|IBV|0|0|0|100|DKK|1119|2226|vetalmen||||100|0||Vistor hf|Intervet International BV|||1119||1119|2226|
465237|QJ01CR5001|Duplocillin L.A., vet.|stl|||100|ml|1|hgl||QJ01CR50|01.05.1983||R|||0|0|0|0|IBV|1|0|0|100|DKK|1057|2103|vetalmen||||100|0||Vistor hf|Intervet International BV|||1057||1057|2103|
465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|||0|0|0|0|IBV|0|0|0|100|DKK|1133|2254|vetalmen||||100|0||Vistor hf|Intervet International BV|||1133||1133|2254|
465278|QJ51RC2301|Nafpenzal DC,  vet.|spenalyf|||3|g|4|spr||QJ51RC23|01.04.1985||R|||0|0|0|0|IBV|0|0|0|100|XEU|596|1186|vetalmen||||12|0||Vistor hf|Intervet International BV|||596||596|1186|
466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|629|1839|lyfalmen||||25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||629||629|1839|
466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|||1|0|E|0|PER|0|0|0|100|DKK|1945|3640|lyfalmen||||100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||1945||1945|3640|
466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|1393|2884|lyfalmen||||25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1393||1393|2884|
466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|||1|0|E|0|PER|0|0|0|100|DKK|5443|8425|lyfalmen||||100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5443||5443|8425|
466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|||1|0|E|0|PER|0|0|0|100|DKK|2589|4521|lyfalmen||||25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2589||2589|4521|
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|7458|11181|lyfalmen||||50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7458||7458|11181|
466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|4260|6806|lyfalmen||||25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4260||4260|6806|
466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|||0|0|B|0|MAS|0|1|0|100|SEK|4552|7206|lyfalmen||||100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||4552||4552|7206|
467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|||0|1|0|1|AEU|0|0|0|100|DKK|14387|19938|lyfsjukr||||0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||14387||14387|19938|
467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|||0|1|0|1|AEU|0|0|0|100|DKK|22048|29553|lyfsjukr||||0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||22048||22048|29553|
467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|||0|1|0|1|SCP|0|0|0|100|DKK|17414|23737|lyfsjukr||||1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||17414||17414|23737|
467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|||0|1|0|1|SCP|0|0|0|100|DKK|28087|37132|lyfsjukr||||1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||28087||28087|37132|
467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|||0|1|*|0|WTE|0|0|0|100|DKK|31914|42597|lyfalmen||||60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||31914||31914|42597|
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|14550|20805|lyfalmen||||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||14550||14550|20805|
467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|||0|1|0|1|SCP|0|0|0|100|DKK|52237|67440|lyfsjukr||||1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||52237||52237|67440|
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|27704|37314|lyfalmen||||50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||27704||27704|37314|
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|||0|0|0|1|JAS|0|1|0|100|SEK|507|732|lyfsjukr||||5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||507||507|732|
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|||0|0|B|0|LBK|0|1|0|100|DKK|6038|6330|lyfalmen|V0317|3823||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3912||3912|6330|
468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|||1|0|0|1|JAS|0|0|0|100|SEK|385|556|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||385||385|556|
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|||0|0|B|0|LBK|0|1|0|100|DKK|8791|6033|lyfalmen|V0318|3615||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3695||3695|6033|
468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|22213|12093|lyfalmen|V0320|6407||100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8125||8125|12093|
468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|||0|0|E|0|APC|0|0|0|100|IKR|4530|3374|lyfalmen|V0207|3113||12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||1751||1751|3374|
468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|||0|0|E|0|APC|0|0|0|100|XEU|4172|5077|lyfalmen|V0467|5077||100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5077|
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|||0|0|0|0|PER|0|0|0|100|DKK|5308|8240|lyfalmen||||98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5308||5308|8240|
469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|7148|10316|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7148||7148|10316|
469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|5945|9111|lyfalmen|V0228|9096||100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||5945||5945|9111|
469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|4834|7592|lyfalmen|V0227|7076||100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||4834||4834|7592|
469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|3156|5296|lyfalmen|V0226|4657||100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3156||3156|5296|
470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|5875|9016|lyfalmen||||120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5875||5875|9016|
470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|29121|38429|lyfsjukr||||16|0||Vistor hf|Orion Corporation|Dexmedetómid||29121||29121|38429|
470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|||0|0|0|1|GEH|0|0|0|100|NOK|7024|10137|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Jóhexól||7024||7024|10137|
471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|9376|13532|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||9376||9376|13532|
471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371|
471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|9367|13519|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||9367||9367|13519|
471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|13452|18765|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||13452||13452|18765|
471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|||0|0|*|0|PER|0|0|0|100|DKK|1148|2549|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1148||1148|2549|
471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|||0|0|0|0|IBV|0|0|0|100|DKK|2002|3492|vetorma||||20|0||Vistor hf|Intervet International BV|||||2002|3492|
471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|||0|0|*|0|BAM|0|0|0|100|SEK|3337|5544|lyfalmen||||100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3337||3337|5544|
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|||0|0|0|0|ORC|1|0|0|100|DKK|4485|8784|vetalmen||||10|0||Vistor hf|Orion Corporation|||4485||4485|8784|
472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|2128|3890|lyfalmen|V0048|2655||98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2128||2128|3890|
472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|3134|5266|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3134||3134|5266|
472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|13009|5012|lyfalmen|V0012|5012||98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2948||2948|5012|
474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|||0|0|0|1|MAB|0|0|0|100|SEK|15527|21369|lyfsjukr||||400|0||Vistor hf|Meda AB|Dextran||15527||15527|21369|
474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.06.2012||R|||1|0|0|1|AGP|0|0|0|100|XEU|4965|7166|lyfsjukr||||5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||4965||4965|7166|
474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|||0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa||||50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||||
474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|||0|0|E|0|REP|0|0|0|100|SEK|1024|2380|lyfalmen||||30|0|3,7500|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||1024||1024|2380|
474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|||0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa||||15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||||
474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|ţpakki||J05AG01|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|34418|45077|lyfsjukr||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||34418||34418|45077|
474431|N05AH0310|Zalasta (LYFIS)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|13575|9109|lyfalmen|V0456|9109||28|0|28,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5943||5943|9109|
474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|||0|0|E|0|SPL|0|0|1|100|DKK|1744|3365|lyfalmen||||140|0|35,0000|Vistor hf|Schering-Plough Europe|Mómetasón||1744||1744|3365|
474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|||0|0|0|0|PHM|0|0|0|100|DKK|26039|50171|vetalmen||||1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||||26039|50171|
474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|752|1095|lyfalmen|V0266|1095||30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||85||85|1095|
475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|||0|0|E|0|ACA|0|0|0|100|IKR|930|2251|lyfalmen||||100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||930||930|2251|
475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|3194|5348|lyfalmen|V0130|5348||26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3194||3194|5348|
475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||0|0|0|0|ACA|0|0|1|100|NOK|281|1363|lyfalmen||||20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||281||281|1363|
475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||0|0|0|0|ACA|0|0|1|100|NOK|343|1448|lyfalmen||||30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||343||343|1448|
475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||1|0|0|0|ACA|0|0|1|100|NOK|957|2288|lyfalmen||||100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||957||957|2288|
475798|R03AC1302|Oxis Turbuhaler|innúđadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|||0|0|0|0|AZD|0|0|1|100|SEK|3679|6012|lyfalmen||||60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3679||3679|6012|
475822|R03AC1302|Oxis Turbuhaler|innúđadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|||0|0|0|0|AZD|0|0|1|100|SEK|4846|7608|lyfalmen||||60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4846||4846|7608|
475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|||0|0|*|0|ELD|0|0|0|100|XEU|5249|8159|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5249||5249|8159|
476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|||0|0|*|0|ELI|0|0|0|100|XEU|5672|8738|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5672||5672|8738|
476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|72988|93482|lyfsjukr||||1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||72988|93482|
476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|||0|0|0|0|GSK|0|0|1|100|IKR|1200|2620|lyfalmen||||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1200||1200|2620|
476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|11167|6752|lyfalmen|V0282|6752||56|0|56,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||4220||4220|6752|
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|||0|0|0|0|GSK|0|0|0|100|GBP|5162|8040|lyfalmen||||12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5162||5162|8040|
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||1000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|||0|0|*|0|APC|0|0|0|100|XEU|466|1616|lyfalmen|V0500|1522||100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||466||466|1616|
479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|||0|1|*|0|WIL|0|0|0|100|XEU|27627|37217|lyfalmen|V0454|37217||100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||27627||27627|37217|
480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|||0|0|E|0|WIH|0|0|0|100|XEU|24645|14221|lyfalmen|V0341|12928||98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||9680||9680|14221|
480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999||R|||0|0|E|0|DSG|0|0|0|100|SEK|12694|18476|lyfalmen||||84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||12694||12694|18476|
481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|||0|0|0|0|GSK|0|1|0|100|GBP|13915|20008|lyfalmen||||100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||13915||13915|20008|
481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.05.2012||R|||0|0|E|0|GLP|0|0|1|100|SEK|333|1434|lyfalmen|V0055|1252||20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||333||333|1434|
483217|B01AX0601 |Xarelto|filmhtfl|20|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|36647|48537|lyfalmen|V0030|48486||98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||36647|48537|
483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|||0|0|0|1|PER|0|0|0|100|DKK|2612|3770|lyfsjukr||||50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2612||2612|3770|
483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|||0|0|E|0|SHS|0|0|1|100|DKK|3329|5533|lyfalmen||||3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||3329||3329|5533|
483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|||0|0|0|1|PER|0|0|0|100|DKK|4508|6506|lyfsjukr||||100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4508||4508|6506|
483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2283|4102|lyfalmen|V0374|4102||2|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2283||2283|4102|
483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|||0|0|E|0|AGP|0|0|1|100|XEU|274|1252|lyfalmen|V0055|1252||20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||200||200|1252|
484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|||0|1|0|1|FER|0|0|0|100|DKK|53872|69492|lyfsjukr||||3|0|83,9552|Vistor hf|Ferring|Triptórelín||53872||53872|69492|
484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|||0|0|0|0|MSD|0|0|0|100|DKK|5598|8637|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||5598||5598|8637|
484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|144184|182833|lyfsjukr||||1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||144184||144184|182833|
484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|||0|0|E|0|MEB|0|0|1|100|SEK|1380|2867|lyfalmen||||300|0||Vistor hf|Meda AB (V)|Benzýdamín||1380||1380|2867|
484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|52683|68662|lyfalmen||||50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||52683||52683|68662|
485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|||0|0|E|0|ANS|0|0|1|100|XEU|1169|2578|lyfalmen||||5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1169||1169|2578|
486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||||||
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|||0|0|E|0|SAL|0|0|1|100|USD|469|1620|lyfalmen||||5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||469||469|1620|
486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|||0|0|E|0|SAL|0|0|1|100|USD|670|1895|lyfalmen||||5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||670||670|1895|
487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|18510|25775|lyfalmen|V0573|25775||98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||18510||18510|25775|
487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4452|4623|lyfalmen|V0326|4623||100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2664||2664|4623|
487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|||0|1|*|0|WIL|0|0|0|100|XEU|30854|41267|lyfalmen|V0453|41267||100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||30854||30854|41267|
488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|954|2284|lyfalmen||||20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||954||954|2284|
488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|||0|0|E|0|MAB|0|0|1|100|SEK|2652|4607|lyfalmen|V0198|3794||60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2652||2652|4607|
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|||0|1|B|0|APC|0|0|0|100|DKK|5918|9074|lyfalmen||||50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||5918||5918|9074|
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|||0|1|B|0|APC|0|0|0|100|DKK|10643|15538|lyfalmen||||50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||10643||10643|15538|
489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|97291|123983|lyfsjukr||||2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||97291|123983|
489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|0|0|NOH|0|0|1|100|IKR|338|1242|lyfalmen|V0188|463||10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1242|
489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|E|0|NOH|0|0|1|100|IKR|882|1618|lyfalmen|V0188|1389||30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1618|
490417|G03FB0504|Evorel Sequi|forđapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|||0|0|E|0|JAS|0|0|0|100|SEK|2387|4244|lyfalmen||||8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2387||2387|4244|
490425|G03FA0104|Evorel Conti|forđapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|||0|0|E|0|JAS|0|0|0|100|SEK|2515|4419|lyfalmen||||8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2515||2515|4419|
490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|3726|6076|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3726||3726|6076|
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|10199|10025|lyfalmen|V0112|2527||100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6613||6613|10025|
490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|4954|7756|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4954||4954|7756|
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|14474|13570|lyfalmen|V0113|3246||100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9204||9204|13570|
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|18409|16868|lyfalmen|V0114|6047||100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||11615||11615|16868|
491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|||0|1|0|1|ORG|0|0|0|100|DKK|46508|60250|lyfsjukr||||3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||46508||46508|60250|
492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|||0|0|E|0|ROC|0|0|0|100|DKK|3092|5209|lyfalmen||||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3092||3092|5209|
492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||||
492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|||0|0|0|0|AZD|0|0|0|100|SEK|12610|18371|lyfalmen|V0002|6646||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12610||12610|18371|
492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||||
493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|22563|16743|lyfalmen|V0516|16359||100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||11524||11524|16743|
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|||0|0|B|0|SNO|0|1|0|100|NOK|1379|2865|lyfalmen||||100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1379||1379|2865|
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|||0|0|E|0|NOH|0|0|0|100|DKK|2324|4158|lyfalmen||||100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2324||2324|4158|
494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|76139|97437|lyfsjukr||||20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||76139||76139|97437|
494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|190347|240768|lyfsjukr||||50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||190347||190347|240768|
494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|||0|0|0|0|PER|0|0|0|100|DKK|1897|3574|lyfalmen||||60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1897||1897|3574|
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|||0|0|E|0|NAS|0|0|0|100|DKK|2128|3890|lyfalmen|V0128|1864||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2128||2128|3890|
494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|||0|0|E|0|NAS|0|0|0|100|DKK|3092|5209|lyfalmen|V0410|4034||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3092||3092|5209|
494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|||0|0|E|0|BII|0|0|0|100|DKK|1758|3384|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1758||1758|3384|
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|18550|8286|lyfalmen|V0384|7362||15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||5342||5342|8286|
495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|7215|6397|lyfalmen|V0382|6062||10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3961||3961|6397|
495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|10308|9940|lyfalmen|V0383|9445||20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||6551||6551|9940|
495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|2831|4852|lyfalmen||||20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2831||2831|4852|
496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|28269|28278|lyfalmen|V0345|28278||112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||20504||20504|28278|
496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|3980|7815|vetalmen||||10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||3980|7815|
496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|11967|17349|lyfalmen|V0572|17349||98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||11967||11967|17349|
496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|||0|0|B|0|APT|0|0|0|100|GBP|5886|9031|lyfalmen||||100|0|0,8333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||5886||5886|9031|
496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|||0|0|B|0|APT|0|0|0|100|GBP|1032|2391|lyfalmen||||50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||1032||1032|2391|
496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|||0|1|0|1|SOI|0|0|0|100|DKK|80966|103495|lyfsjukr||||3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||80966||80966|103495|
496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|||0|0|B|0|APT|0|0|0|100|GBP|3239|5410|lyfalmen||||100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||3239||3239|5410|
496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|441|1582|lyfalmen||||10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||441||441|1582|
496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|797|2069|lyfalmen||||20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||797||797|2069|
497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|ţpakki||A07AA12|01.08.2012||R|||0|0|0|1|APE|0|0|0|100|XEU|232992|294287|lyfsjukr||||20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||232992||232992|294287|
497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|3040|5137|lyfalmen||||100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3040||3040|5137|
497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|320|1417|lyfalmen||||30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||320||320|1417|
497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|474|1365|lyfalmen|V0448|1365||100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||282||282|1365|
497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|985|1816|lyfalmen|V0449|1816||100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||612||612|1816|
497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|1416|2860|lyfalmen|V0369|2860||5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1375||1375|2860|
498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|||0|0|B|0|SPL|0|0|1|100|DKK|1282|2733|lyfalmen||||2|0|9,3300|Vistor hf|Schering-Plough Europe|Betametasón||1282||1282|2733|
498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|15971|22589|lyfalmen||||56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||15971||15971|22589|
498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|17036|23925|lyfalmen||||56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17036||17036|23925|
499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|21222|29179|lyfalmen||||56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||21222||21222|29179|
499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|25638|34721|lyfalmen||||56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||25638||25638|34721|
499273|B01AX0601 |Xarelto|filmhtfl|20|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|10511|15357|lyfalmen||||28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||10511|15357|
501734|M01AB0508|Vostar-R|forđatfl|75|mg|100|stk|1|glas|0|M01AB05|01.03.2000||R|||0|0|E|0|ACA|0|0|1|100|XEU|2620|4563|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||2620||2620|4563|
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|||0|0|E|0|ROC|0|0|0|100|DKK|2883|4923|lyfalmen|V0434|4244||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2883||2883|4923|
502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|||0|0|B|0|AML|0|1|0|100|DKK|2811|4824|lyfalmen||||100|0|25,0000|Vistor hf|Amdipharm Limited|Maprótilín||2811||2811|4824|
503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|||0|1|0|1|FER|0|0|0|100|DKK|28347|37458|lyfsjukr||||1|0|27,9851|Vistor hf|Ferring|Triptórelín||28347||28347|37458|
503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|6234|6738|lyfalmen||||28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||4210||4210|6738|
503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||||
504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|1556|3107|lyfalmen|V0494|3084||90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1556||1556|3107|
504191|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.07.1988||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole||||||
504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|||0|0|E|0|ORG|0|0|0|100|DKK|1923|3609|lyfalmen||||90|0|45,0000|Vistor hf|N.V. Organon|Estríól||1923||1923|3609|
504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|||0|0|0|0|ROC|0|0|1|100|DKK|1093|2474|lyfalmen||||100|0|30,0000|Icepharma hf|Roche|Brómazepam||1093||1093|2474|
505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|||0|0|B|0|AML|0|1|0|100|DKK|7732|11556|lyfalmen||||100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||7732||7732|11556|
505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|1700|2454|lyfsjukr||||5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1700||1700|2454|
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|3394|4898|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3394||3394|4898|
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|7746|11179|lyfsjukr||||25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||7746||7746|11179|
506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|||0|0|B|0|PER|0|1|0|100|DKK|2321|4154|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2321||2321|4154|
506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|||0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa||||25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl||||||
507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|||0|0|0|0|ERC|0|0|0|100|DKK|377|1495|lyfalmen||||100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||377||377|1495|
507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|620|1082|vetorma||||24|0||Icepharma hf|Pfizer Oy Animal Health|||||620|1082|
507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|2638|4602|vetorma||||120|0||Icepharma hf|Pfizer Oy Animal Health|||||2638|4602|
507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|||0|0|0|0|IBV|0|0|0|100|DKK|15145|26420|vetorma||||1000|0||Vistor hf|Intervet International BV|||15145||15145|26420|
508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|||0|0|B|0|ABS|0|0|0|100|DKK|2408|4273|lyfalmen||||98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2408||2408|4273|
508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|4812|9412|vetalmen||||100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4812|9412|
508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|3860|7584|vetalmen||||50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3860||3860|7584|
508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|11941|23101|vetalmen||||100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||11941||11941|23101|
508921|L01CD0401|Jevtana|irţ|60|mg|15|ml|1|hgl|+ leysir|L01CD04|01.08.2011||R|||0|1|0|1|SOF|0|0|0|100|NOK|705819|887685|lyfsjukr||||15|0||Vistor hf|SANOFI|Cabazitaxel||705819||705819|887685|
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|8565|12695|lyfalmen||||10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8565||8565|12695|
509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|||0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen||||15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2713|
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|||0|1|0|1|VII|0|0|0|100|GBP|47979|62096|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||47979||47979|62096|
510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|15671|21550|lyfsjukr||||2|0|12,0000|Icepharma hf|Roche|Epóetín||15671||15671|21550|
510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|23457|31321|lyfsjukr||||2|0|18,0000|Icepharma hf|Roche|Epóetín||23457||23457|31321|
510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|38477|50171|lyfsjukr||||2|0|30,0000|Icepharma hf|Roche|Epóetín||38477||38477|50171|
510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|76091|97377|lyfsjukr||||4|0|60,0000|Icepharma hf|Roche|Epóetín||76091||76091|97377|
510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|176674|223608|lyfsjukr||||1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||176674|223608|
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|||0|0|E|0|ACA|0|0|0|100|XEU|3921|5258|lyfalmen|V0445|5258||98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||3128||3128|5258|
511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|2552|4470|lyfalmen||||28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2552||2552|4470|
511245|N05AH0310|Zalasta (LYFIS)|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|34230|29298|lyfalmen|V0540|29298||28|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||21317||21317|29298|
511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|||0|0|E|0|NAS|0|0|0|100|DKK|2535|4447|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2535||2535|4447|
511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|||0|0|0|1|MAB|0|0|0|100|SEK|23358|31197|lyfsjukr||||6000|0||Vistor hf|Meda AB|Dextran||23358||23358|31197|
511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|||0|0|0|1|MAB|0|0|0|100|SEK|14612|20221|lyfsjukr||||6000|0||Vistor hf|Meda AB|Dextran||14612||14612|20221|
512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4452|4753|lyfalmen|V0325|4753||100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2759||2759|4753|
512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|||0|0|0|1|FRP|0|0|0|100|DKK|4949|7143|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||4949||4949|7143|
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa||||35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||||||
513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|21505|29534|lyfalmen||||60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||21505||21505|29534|
513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|1994|3966|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||1994||1994|3966|
514265|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|||0|0|B|0|AZD|0|0|1|100|SEK|2047|3779|lyfalmen||||200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2047||2047|3779|
514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|||0|0|B|0|ADG|0|0|0|100|XEU|2940|5001|lyfalmen||||100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2940||2940|5001|
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|||0|0|B|0|PER|0|1|0|100|DKK|4158|4114|lyfalmen||||60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2292||2292|4114|
515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2475|
515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2488|
517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|E|0|APC|0|0|0|100|XEU|5411|6385|lyfalmen||||120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3952||3952|6385|31.08.2012
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|2782|4785|lyfalmen|V0462|2819||90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||2782||2782|4785|
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|3029|5122|lyfalmen|V0471|2943||90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3029||3029|5122|
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|3257|5434|lyfalmen|V0472|3177||90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3257||3257|5434|
517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|||0|0|E|0|AGT|0|0|1|100|DKK|864|2161|lyfalmen||||20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||864||864|2161|
518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|||0|0|E|0|AGT|0|0|1|100|DKK|3184|5334|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3184||3184|5334|
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|||0|0|0|0|ORG|0|0|0|100|DKK|1963|3664|lyfalmen||||84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||1963||1963|3664|
518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|IKR|12890|16768|lyfalmen|V0286|15342||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||11542||11542|16768|
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|1106|2492|lyfalmen||||125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1106||1106|2492|
519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|||0|0|0|0|AEG|0|0|1|100|SEK|1657|3246|lyfalmen||||100|0|2,5000|GlaxoSmithKline ehf|Aspen Europe GmbH|Súlfametoxazól og trímetóprím||1657||1657|3246|
519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|6837|10332|lyfalmen|V0431|8943||2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||6837||6837|10332|
520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|4533|7180|lyfalmen|V0142|7055||4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4533||4533|7180|
520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|5119|7981|lyfalmen|V0143|2352||4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5119||5119|7981|
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|14423|20646|lyfalmen|V0143|7055||12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||14423||14423|20646|
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|5490|8489|lyfalmen|V0144|2862||4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5490||5490|8489|
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|15190|21609|lyfalmen|V0144|8585||12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15190||15190|21609|
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|||0|0|B|0|ACA|0|0|0|100|IKR|1355|1781|lyfalmen|V0056|1737||100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||586||586|1781|
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|||0|0|B|0|ACA|0|0|0|100|IKR|2163|2200|lyfalmen|V0057|2133||100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||893||893|2200|
520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|||0|0|E|0|MEB|0|0|1|100|SEK|357|1467|lyfalmen||||30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||357||357|1467|
520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1671|
520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1681|
521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|30192|40436|lyfalmen|V0269|9483||100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||30192||30192|40436|
521954|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|17518|24530|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||17518||17518|24530|
521966|A10BX0202|Repaglinid Krka (LYFIS)|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|2840|2943|lyfalmen|V0471|2943||90|0|22,5000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1436||1436|2943|
522003|QJ01RA0102|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ01RA01|01.12.1982||R|||0|0|0|0|BID|0|0|0|100|DKK|7899|15340|vetalmen||||320|0||Vistor hf|Boehringer Ingelheim Danmark|||7899||7899|15340|
522599|J07CA0202|Tetravac|bóluefni|||0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|2149|3919|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2149||2149|3919|
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|175129|221669|lyfsjukr||||1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||175129||175129|221669|
522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|SEK|333|1434|lyfalmen|V0055|1252||20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||333||333|1434|
522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|SEK|395|1519|lyfalmen|V0225|1473||100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||395||395|1519|
522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|DKK|2607|4545|lyfalmen||||250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2607||2607|4545|
522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|DKK|371|1486|lyfalmen||||10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||371||371|1486|
523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|||0|0|0|0|ACA|0|0|1|100|NOK|437|1577|lyfalmen||||40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||437||437|1577|
523274|S01XA2008|Artelac|augndr|||10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|||0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1395|
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|1238|2672|lyfalmen||||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1238||1238|2672|
524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|446|1589|lyfalmen||||28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||446||446|1589|
524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|2808|4820|lyfalmen||||98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2808||2808|4820|
524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|0|0|EIS|0|0|0|100|IKR|8619|5951|lyfalmen|V0010|5215||98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|5951|
524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|||0|0|0|0|INI|0|0|0|100|DKK|1789|3559|vetalmen||||1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||1789||1789|3559|
525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|||0|0|E|0|MEB|0|0|1|100|SEK|875|2176|lyfalmen||||100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||875||875|2176|
525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|728|1975|lyfalmen||||15|0|3,7500|Vistor hf|Novartis Healthcare A/S-|Díklófenak||728||728|1975|
525076|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|LVR|0|0|0|100|IKR|4621|4674|lyfalmen|V0006|4217||100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól||2701||2701|4674|
525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|||0|0|E|0|ACA|0|0|1|100|XEU|1403|2898|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1403||1403|2898|
525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|||0|0|E|0|ACA|0|0|1|100|XEU|4677|7377|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||4677||4677|7377|
525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|||0|0|0|0|CPA|0|0|0|100|DKK|10200|14932|lyfalmen||||30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||10200||10200|14932|
525720|B01AX0601 |Xarelto|filmhtfl|20|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|37394|49475|lyfalmen|V0030|49475||100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||37394|49475|
525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|5100|7361|lyfsjukr||||1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5100||5100|7361|
525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|4643|6701|lyfsjukr||||1000|0||Actavis Group hf|Braun|Natríumklóríđ||4643||4643|6701|
525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
526004|V07AB09|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|||0|0|E|0|ROC|0|0|0|100|DKK|4195|6717|lyfalmen|V0435|6717||100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4195||4195|6717|
526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|3905|6321|lyfalmen||||100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3905||3905|6321|
526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|||0|0|0|0|IBV|0|0|0|100|DKK|6274|12220|vetalmen||||188|0||Vistor hf|Intervet International BV|||6274||6274|12220|
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|3340|5548|lyfalmen||||100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3340||3340|5548|
527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|||0|0|0|0|APC|0|0|1|100|IKR|||lyflausa||||20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||||||
527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|||0|0|0|1|SNO|0|0|0|100|NOK|14961|20659|lyfsjukr||||2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||14961||14961|20659|
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|||0|0|E|0|ALC|0|0|0|100|USD|1241|2677|lyfalmen||||5|0||K.Pétursson hf|Alcon|Emedastín||1241||1241|2677|
528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|||0|0|E|0|BGB|0|0|0|100|SEK|17235|24175|lyfalmen||||4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||17235||17235|24175|
528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|SEK|9825|13565|lyfalmen|V0356|12394||120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9201||9201|13565|
528584|A07EC0202|Pentasa|forđatfl|1|g|60|stk|1|ţpakki|6 x 10 stk|A07EC02|01.06.2012||R|||0|0|B|0|FEL|0|0|0|100|DKK|6469|9828|lyfalmen||||60|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Mesalazín (5-amínósalicýlsýra)||6469||6469|9828|
529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|||0|0|0|0|PAL|0|0|0|100|DKK|4228|8291|vetalmen||||72|0||Icepharma hf|Pfizer Oy Animal Health|||4228||4228|8291|
529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|||0|0|0|0|PAL|0|0|0|100|DKK|4495|8804|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||4495||4495|8804|
529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|||0|0|0|1|PER|0|0|0|100|DKK|64533|82871|lyfsjukr||||100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||64533||64533|82871|
529852|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2012||R|||0|0|*|0|BLP|0|0|0|100|XEU|26749|14033|lyfalmen|V0184|14033||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||9543||9543|14033|
530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|||0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen||||50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6496|
530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.2012||R|||0|0|*|0|BLP|0|0|0|100|XEU|11046|7055|lyfalmen|V0186|7055||28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||4442||4442|7055|
530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|||0|0|E|0|NAS|0|0|0|100|DKK|2919|4972|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2919||2919|4972|
530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|5610|8097|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||5610||5610|8097|
531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|||0|0|B|0|AZD|0|0|0|100|SEK|2974|5047|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2974||2974|5047|
531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|7714|11133|lyfsjukr||||240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||7714||7714|11133|
532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|ţpakki||L04AA06|01.03.2011||R|||0|1|*|0|LYF|0|0|0|100|XEU|19019|13680|lyfalmen|V0187|12501||50|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||9285||9285|13680|
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|||0|0|0|0|JAS|0|0|0|100|SEK|658|1879|lyfalmen||||30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||658||658|1879|
532504|R06AX2704|Desloratadine ratiopharm|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.09.2012||R|||0|0|E|0|RGM|0|0|1|100|XEU|1143|2332|lyfalmen|V0366|2332||30|0|30,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||989||989|2332|
532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|348|1455|lyfalmen||||30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||348||348|1455|
532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|1009|2359|lyfalmen||||100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1009||1009|2359|
532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|279|1361|lyfalmen||||14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||279||279|1361|
532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|1778|3411|lyfalmen||||100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1778||1778|3411|
533302|N05AH0310|Zalasta (LYFIS)|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|13591|8475|lyfalmen|V0283|8475||28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5480||5480|8475|
533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|||0|0|B|0|AZD|0|0|0|100|SEK|2016|3737|lyfalmen||||100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2016||2016|3737|
534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|ţpakki||L04AA10|01.06.2012||R|||0|1|*|0|IPI|0|0|0|100|DKK|55237|71868|lyfalmen|V0567|71868||100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||55237||55237|71868|
535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum||||||
535844|N05AH0310|Zalasta (LYFIS)|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|3058|2408|lyfalmen|V0279|2336||28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1045||1045|2408|
535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|ţpakki||G04BD04|01.06.1998||R|||0|0|E|0|SNO|0|0|0|100|NOK|6404|9739|lyfalmen||||84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6404||6404|9739|
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|||0|0|*|0|SAL|0|0|0|100|USD|437|1577|lyfalmen||||10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||437||437|1577|
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|||0|0|*|0|SAL|0|0|0|100|USD|558|1742|lyfalmen||||10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||558||558|1742|
536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|IKR|12900|18735|lyfalmen|V0115|18735||100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||12900||12900|18735|
536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|108085|138192|lyfalmen||||1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||108085||108085|138192|
536840|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|glas||N07XX07|01.12.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|61425|78971|lyfsjukr||||56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||61425||61425|78971|
537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|554|966|vetorma||||2|0||Icepharma hf|Pfizer Oy Animal Health|||||554|966|
537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|5942|8576|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||5942||5942|8576|
537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|||0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen||||15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2326|
538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda||||||
538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda||||||
538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda||||||
538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|||0|1|0|1|MSE|0|0|0|100|SEK|135041|171359|lyfsjukr||||6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||135041||135041|171359|
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|||0|1|E|0|SNO|0|0|0|100|NOK|10267|15024|lyfalmen||||100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10267||10267|15024|
539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|IKR|5863|8999|lyfalmen|V0285|7682||60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||5863||5863|8999|
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|208|1263|lyfalmen||||25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||208||208|1263|
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|0|100|DKK|515|1683|lyfalmen||||100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||515||515|1683|
539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||15|0||Vistor hf|McNeil Sweden AB|Blöndur||||||
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|||0|0|E|0|PER|0|0|0|100|DKK|1690|3291|lyfalmen||||40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1690||1690|3291|
540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|||0|0|0|0|SON|0|0|1|100|DKK|2624|4568|lyfalmen||||250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2624||2624|4568|
540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|||0|0|*|0|MSD|0|0|0|100|DKK|5536|8552|lyfalmen|V0373|6946||15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||5536||5536|8552|
541060|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989|30.06.2012|R|||0|0|B|0|AZD|0|0|1|100|SEK|2066|3805|lyfalmen||||200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2066||2066|3805|
541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|||0|0|B|0|SGM|0|0|0|100|DKK|8951|13223|lyfalmen|V0199|13223||200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||8951||8951|13223|
541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|||0|0|B|0|SGM|0|0|0|100|DKK|14498|20740|lyfalmen|V0200|20740||200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||14498||14498|20740|
541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl|.|J01GB03|01.08.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|5524|7973|lyfsjukr||||800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5524||5524|7973|
542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|||0|1|E|0|LDR|0|0|0|100|IKR|4756|7485|lyfalmen||||100|1|100,0000|Parlogis hf|Parlogis - óskráđ lyf|Dapsón||4756||4756|7485|
543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|||0|0|B|0|NOH|0|0|0|100|DKK|2736|4722|lyfalmen||||98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||2736||2736|4722|
543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|2082|3025|lyfalmen|V0373|2315||5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1496||1496|3025|
543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)||||||
543743|N05AH0310|Zalasta (LYFIS)|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|6932|4689|lyfalmen|V0457|4689||28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||2712||2712|4689|
543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|483457|608621|lyfsjukr||||336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||483457||483457|608621|
544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|12226|17889|lyfalmen||||50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12226||12226|17889|
544919|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|918|2168|lyfalmen|V0005|442||7|0|9,3300|Portfarma ehf|Portfarma|Esómeprazól||869||869|2168|
545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|||0|0|0|0|GSK|0|0|1|100|GBP|977|2315|lyfalmen||||15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||977||977|2315|
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|852|2144|lyfalmen||||100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||852||852|2144|
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|2102|3854|lyfalmen||||100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2102||2102|3854|
545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|28449|38249|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||28449||28449|38249|
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|22937|31331|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||22937||22937|31331|
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|28616|38458|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|grasfrjó||28616||28616|38458|
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24311|33055|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|grasfrjó||24311||24311|33055|
546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól||||||
546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|||0|0|0|0|ACA|0|0|1|100|XEU|1072|2445|lyfalmen||||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1072||1072|2445|
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|||0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen||||60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4791|
547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|3215|2066|lyfalmen|V0004|1671||28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||795||795|2066|
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|||0|1|0|1|GGL|0|0|0|100|GBP|10245|14740|lyfsjukr||||100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||10245||10245|14740|
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|||0|1|0|1|GGL|0|0|0|100|GBP|3376|4872|lyfsjukr||||10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3376||3376|4872|
547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|||0|1|E|0|ORG|0|0|0|100|DKK|7340|11020|lyfalmen||||0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||7340||7340|11020|
548120|C07AB0312|Atenolol LYFIS|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|538|1623|lyfalmen|V0542|1623||100|0|66,6600|LYFIS ehf|LYFIS ehf|Atenólól||471||471|1623|
548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|ţpakki||M01AE01|01.09.2012||L|||0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa||||10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen||||||
548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|ţpakki||M05BA07|01.03.2001|31.08.2012|R|||0|0|0|0|SNO|0|0|0|100|NOK|15650|22186|lyfalmen||||84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||15650||15650|22186|
549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|||0|0|0|1|ABT|0|0|0|100|DKK|88992|113567|lyfsjukr||||1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||88992||88992|113567|
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|||0|0|*|0|JAS|0|1|0|100|SEK|9500|13974|lyfalmen||||5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9500||9500|13974|
549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|||0|0|0|1|ABT|0|0|0|100|DKK|131779|167265|lyfsjukr||||1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||131779||131779|167265|
549674|B01AX0601 |Xarelto|filmhtfl|15|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|36647|48537|lyfalmen|V0031|48486||98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||36647|48537|
550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001|31.08.2012|R|||0|0|0|0|GSK|0|0|0|100|GBP|2230|4029|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsađir  mótefnavakar||2230||2230|4029|
550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen||||24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1592|
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
551183|N05AH0310|Zalasta (LYFIS)|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|10612|8546|lyfalmen|V0280|8546||56|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5532||5532|8546|
551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|||0|0|0|1|BAM|0|0|0|100|SEK|9067|13086|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Mannitól||9067||9067|13086|
551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|||0|0|E|0|AZA|0|0|0|100|SEK|10720|15643|lyfalmen|V0235|15643||12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||10720||10720|15643|
551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|||0|0|B|0|MAB|0|0|1|100|SEK|1831|3484|lyfalmen||||1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1831||1831|3484|
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|3907|6323|lyfalmen|V0198|6323||100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||3907||3907|6323|
551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|||1|0|E|0|LDR|0|0|0|100|IKR|738|1988|lyfalmen||||20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|1988|
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|2157|1752|lyfalmen|V0466|1536||28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752|
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|3931|3432|lyfalmen|V0467|2843||56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432|
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|||0|0|0|0|EIS|0|0|0|100|SEK|1446|2957|lyfalmen|V0003|768||14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||1446||1446|2957|
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|3631|1752|lyfalmen|V0003|1536||28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752|
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|7648|3432|lyfalmen|V0010|2980||56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432|
551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|22563|16359|lyfalmen|V0516|16359||100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||11243||11243|16359|
552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.04.1985||R|||0|0|B|0|BAP|0|0|0|100|SEK|3571|5864|lyfalmen||||100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3571||3571|5864|
552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|||0|0|0|0|MYL|0|0|0|100|SEK|5038|7871|lyfalmen||||500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5038||5038|7871|
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|3097|5215|lyfalmen||||100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3097||3097|5215|
553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|11297|16433|lyfalmen|V0237|16433||18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||11297|16433|
553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|3864|6265|lyfalmen|V0237|5478||6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||3864||3864|6265|
554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|||0|0|0|0|BID|0|0|0|100|DKK|7161|13923|vetalmen||||500|0||Vistor hf|Boehringer Ingelheim Danmark|||7161||7161|13923|
556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|26712|35406|lyfsjukr||||1|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||26712||26712|35406|
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|4589|7256|lyfalmen||||100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||4589||4589|7256|
556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|6241|9516|lyfalmen|V0242|6609||50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6241||6241|9516|
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|8946|13217|lyfalmen|V0242|13217||100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8946||8946|13217|
557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|||0|0|0|0|ASP|0|0|0|100|XEU|1501|3032|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1501||1501|3032|
558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|264153|333395|lyfsjukr||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||264153|333395|
559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995||R|||0|0|B|0|ABS|0|0|0|100|DKK|797|2069|lyfalmen||||28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||797||797|2069|
559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|||0|0|B|0|ABS|0|0|0|100|DKK|1829|3481|lyfalmen||||98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1829||1829|3481|
559104|N02AX0201|Nobligan|eţ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|||0|0|E|0|GRU|0|0|1|100|DKK|621|1828|lyfalmen||||20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||621||621|1828|
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|||0|0|0|0|STD|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ||||||
559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1469|2988|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1469||1469|2988|
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|||0|0|0|0|STD|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ||||||
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|||0|0|E|0|PER|0|0|0|100|DKK|5388|8349|lyfalmen||||1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5388||5388|8349|
559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|||0|0|B|0|MEB|0|0|0|100|SEK|3498|5764|lyfalmen||||30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3498||3498|5764|
559989|N01AB0701|Suprane|innönd.l|||240|ml|1|fl||N01AB07|01.01.1995||R|||0|0|0|1|BAX|0|0|0|100|SEK|13673|19042|lyfsjukr||||240|0||Icepharma hf|Baxter|Desflúran||13673||13673|19042|
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|||0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1395|
560244|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|||0|0|B|0|BLU|0|1|0|100|XEU|737|1761|lyfalmen|V0067|1761||30|0|30,0000|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Cítalópram||572||572|1761|
560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|||0|0|E|0|GSK|0|0|1|100|GBP|3052|5154|lyfalmen||||25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3052||3052|5154|
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír||||||
560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|||0|0|E|0|GSK|0|0|1|100|GBP|1519|3057|lyfalmen||||4|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1519||1519|3057|
560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|||0|0|E|0|GSK|0|0|1|100|GBP|5817|8936|lyfalmen||||125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5817||5817|8936|
560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|||0|0|E|0|GSK|0|0|1|100|GBP|6308|9608|lyfalmen||||100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6308||6308|9608|
560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|||0|1|0|1|ORC|0|0|0|100|DKK|94335|120273|lyfsjukr||||5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||94335||94335|120273|
560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|||0|1|0|1|ORC|0|0|0|100|DKK|436273|549405|lyfsjukr||||20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||436273||436273|549405|
561145|N03AX2101|Trobalt|filmhtfl|150|mg|63|stk|1|ţpakki|21x50mg+42x100mg|N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|5637|8690|lyfalmen||||63|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||5637||5637|8690|
561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1613|3185|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1613||1613|3185|
562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|||0|0|B|0|APC|0|0|0|100|XEU|2348|4191|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||2348||2348|4191|
562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|102189|130130|lyfsjukr||||1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||102189||102189|130130|
563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|||0|1|0|0|INT|0|0|0|100|DKK|108024|138115|lyfalmen||||63|0||Vistor hf|InterMune Europe Ltd.|Pírfenidon||108024||108024|138115|
563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|19917|27541|lyfalmen|V0431|26830||6|0|17,1667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||19917||19917|27541|
563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|33602|44716|lyfalmen|V0431|44716||10|0|28,6111|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||33602||33602|44716|
563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|751|2006|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||751||751|2006|
563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|679|1908|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||679||679|1908|
563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|||1|0|E|0|PER|0|0|0|100|DKK|1300|2757|lyfalmen||||100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1300||1300|2757|
563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|193732|245679|lyfalmen||||60|0|171,6667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||193732||193732|245679|
563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|3366|5583|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3366||3366|5583|
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|3490|5753|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3490||3490|5753|
563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.07.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|2109|3113|lyfalmen|V0207|3113||12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||1560||1560|3113|
563899|QP54AA0105|Noromectin|áhella|0,5|w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|10685|18639|vetorma||||1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||10685||10685|18639|
564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|77059|98592|lyfsjukr||||168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||77059||77059|98592|
565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|||0|0|B|0|UCB|0|0|0|100|DKK|10870|15849|lyfalmen||||100|0|50,0000|Vistor hf|U.C.B|Olsalazín||10870||10870|15849|
565982|H01BA0401|Glypressin|stl|1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|||0|0|0|1|FEL|0|0|0|100|DKK|34161|44755|lyfsjukr||||42|0|3,5500|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||34161||34161|44755|
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|||0|0|*|0|ALC|0|0|0|100|USD|1385|2874|lyfalmen|V0444|2190||5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíđ||1385||1385|2874|
567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995|31.07.2012|R|||0|0|E|0|SNO|0|0|1|100|NOK|2326|4161|lyfalmen||||100|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||2326||2326|4161|
567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|206233|260705|lyfsjukr||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||206233||206233|260705|
567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|||0|0|B|0|ALK|0|0|1|100|DKK|5463|8452|lyfalmen||||1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5463|8452|
567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|3360|5575|lyfalmen|V0291|3373||60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3360||3360|5575|
567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|6800|10281|lyfalmen|V0292|5566||60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6800||6800|10281|
567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|9939|14575|lyfalmen|V0293|8178||60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||9939||9939|14575|
567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|13053|18927|lyfalmen|V0294|10467||60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13053||13053|18927|
567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín||||||
567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|||0|0|0|0|GSK|0|0|1|100|GBP|1091|2471|lyfalmen||||3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1091||1091|2471|
568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|||0|0|B|0|ACA|0|0|0|100|XEU|1322|2787|lyfalmen|V0058|2787||100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1322||1322|2787|
568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|||0|0|B|0|ACA|0|0|0|100|XEU|2094|3843|lyfalmen|V0059|3843||100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2094||2094|3843|
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|16178|22186|lyfsjukr||||5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||16178||16178|22186|
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|18602|25228|lyfsjukr||||20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||18602||18602|25228|
571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|79019|101714|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||79019||79019|101714|
572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|12098|8545|lyfalmen|V0253|8411||100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||5531||5531|8545|
572768|B02BC1001|Tisseel Duo Quick|vefjalím|||0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|159973|202649|lyfsjukr||||5|0||Icepharma hf|Baxter|Fíbrínógen manna||159973||159973|202649|
572776|B02BC1001|Tisseel Duo Quick|vefjalím|||1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|189818|240104|lyfsjukr||||10|0||Icepharma hf|Baxter|Fíbrínógen manna||189818||189818|240104|
572784|B02BC1001|Tisseel Duo Quick|vefjalím|||2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|399724|503536|lyfsjukr||||20|0||Icepharma hf|Baxter|Fíbrínógen manna||399724||399724|503536|
572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|9783|5012|lyfalmen|V0011|5012||98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2948||2948|5012|
573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|||0|0|E|0|ACA|0|0|0|100|IKR|5300|5035|lyfalmen|V0245|4595||98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||2965||2965|5035|
573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|3555|5842|lyfalmen|V0464|5097||2|0|25,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3555||3555|5842|
573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|3241|5412|lyfalmen|V0129|5412||26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3241||3241|5412|
573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|90944|116017|lyfsjukr||||1|0||Icepharma hf|Roche|Trastuzumab||90944||90944|116017|
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|||0|0|0|1|AZA|0|0|0|100|SEK|23954|31945|lyfsjukr||||5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||23954||23954|31945|
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|||0|0|0|1|AZA|0|0|0|100|SEK|40559|52784|lyfsjukr||||10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||40559||40559|52784|
573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|E|0|NOH|0|0|1|100|IKR|2756|2659|lyfalmen|V0189|2116||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2659|
575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|||0|0|0|0|PER|0|1|0|100|DKK|2328|2039|lyfalmen|V0151|2039||28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||775||775|2039|
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|||0|0|B|0|PER|0|1|0|100|DKK|7253|6587|lyfalmen|V0322|4247||98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4100||4100|6587|
575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|||0|0|0|0|PER|0|1|0|100|DKK|4294|2039|lyfalmen|V0152|2039||28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||775||775|2039|
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|||0|0|B|0|PER|0|1|0|100|DKK|12855|6587|lyfalmen|V0323|6587||98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4100||4100|6587|
575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|||0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa||||40|0||Icepharma hf|Norpharma |Malatíón||||||
575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|||0|0|0|1|SAA|0|0|0|100|NOK|6751|9743|lyfsjukr||||12|0|2,4000|Vistor hf|Sanofi - Aventis|Adenósín||6751||6751|9743|
576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|||0|0|E|0|ACA|0|0|0|100|IKR|1150|1834|lyfalmen|V0243|1632||42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||625||625|1834|
578259|A04AA0104|Ondansetron Billev|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.05.2012||R|||0|0|E|0|MYL|0|0|0|100|SEK|3701|5660|lyfalmen|V0384|4908||10|0|5,0000|Actavis Group PTC ehf|Mylan AB|Ondansetrón||3422||3422|5660|
578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|||0|0|0|0|ICE|0|0|0|100|USD|5697|9938|vetorma||||20|0||Icepharma hf|Icepharma hf|||5697||5697|9938|
579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|||0|0|B|0|AZD|0|0|0|100|SEK|1291|2745|lyfalmen||||10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1291||1291|2745|
579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|4499|2114|lyfalmen|V0005|1768||28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||830||830|2114|
579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|||0|0|*|0|PER|0|0|0|100|DKK|664|1887|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||664||664|1887|
580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|2610|2466|lyfalmen|V0324|2466||100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1087||1087|2466|
580227|A10BX0202|Repaglinid Krka (LYFIS)|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|2739|2819|lyfalmen|V0462|2819||90|0|11,2500|LYFIS ehf|LYFIS ehf|Repaglíníđ||1345||1345|2819|
581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|3160|3177|lyfalmen|V0472|3177||90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1607||1607|3177|
581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|||0|0|0|0|ANI|1|0|0|100|XEU|13532|26156|vetalmen||||20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||13532||13532|26156|
581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|2313|4143|lyfalmen||||2|0|25,0000|K.Pétursson hf|Alcon|Cýklópentólat||2313||2313|4143|
582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|26438|35062|lyfsjukr||||1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||26438||26438|35062|
582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|51021|65914|lyfsjukr||||1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||51021||51021|65914|
582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|102042|129945|lyfsjukr||||1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||102042||102042|129945|
582213|R01AA0503|Nezeril|nefúđi|0,1|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|1,8750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|||0|0|0|1|GEH|0|0|0|100|NOK|64658|83028|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||64658||64658|83028|
582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|||0|0|0|0|PAL|1|0|0|100|DKK|4674|8154|vetorma||||50|0||Icepharma hf|Pfizer Oy Animal Health|||4674||4674|8154|
582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|||0|0|0|0|PAL|1|0|0|100|DKK|17614|30727|vetorma||||200|0||Icepharma hf|Pfizer Oy Animal Health|||17614||17614|30727|
582451|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|4286|3531|lyfalmen|V0011|2864||56|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||1866||1866|3531|
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|43478|56447|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||43478||43478|56447|
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|98914|126020|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||98914||98914|126020|
582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|ţpakki||C07AB02|01.12.2001||R|||0|0|B|0|AZD|0|0|0|100|SEK|817|2097|lyfalmen||||28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||817||817|2097|
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|47928|62032|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||47928||47928|62032|
582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|53380|68874|lyfsjukr||||2|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||53380||53380|68874|
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|95311|121498|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||95311||95311|121498|
583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|1100|2484|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1100||1100|2484|
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|113762|144654|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||113762||113762|144654|
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|51946|67075|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||51946||51946|67075|
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|107007|136176|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||107007||107007|136176|
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|116972|148682|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||116972||116972|148682|
583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|3578|5164|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3578||3578|5164|
584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|2167|3128|lyfsjukr||||9000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2167||2167|3128|
584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|||0|0|B|0|MAS|0|1|0|100|SEK|1851|3511|lyfalmen||||30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1851||1851|3511|
585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981|31.07.2012|R|||0|0|0|1|LEP|0|0|0|100|DKK|10163|14637|lyfsjukr||||20|0|50,0000|Vistor hf|LEO Pharma A/S|Heparín||10163||10163|14637|
585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|||0|0|0|1|LEP|0|0|0|100|DKK|4302|6209|lyfsjukr||||25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4302||4302|6209|
585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|4423|7029|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4423||4423|7029|
585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|440|1575|lyfalmen|V0541|1575||100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||436||436|1575|
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|30577|40919|lyfalmen||||50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||30577||30577|40919|
586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|||0|0|B|0|ASP|0|0|1|100|XEU|1629|3207|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1629||1629|3207|
586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|13289|18560|lyfsjukr||||800|0|10,0000|Actavis Group hf|Braun|Gentamícín||13289||13289|18560|
586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|||0|1|0|1|NOE|0|0|0|100|DKK|355541|448086|lyfsjukr||||224|0|20,9100|Vistor hf|Novartis Europharm Ltd|Tobramýcín||355541||355541|448086|
587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|9485|13300|lyfalmen|V0095|13300||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||9007||9007|13300|
588395|N03AX2101|Trobalt|filmhtfl|50|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|4603|7276|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||4603||4603|7276|
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|||0|0|0|0|PER|0|0|1|100|DKK|2053|3787|lyfalmen|V0461|3787||20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2053||2053|3787|
588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|9381|13812|lyfalmen||||100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||9381||9381|13812|
588772|H05BA0103|Miacalcic Nasal|nefúđi|200|ae/sk|2|ml|1|úđagl|14 skammt|H05BA01|01.03.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|8236|12245|lyfalmen||||2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||8236||8236|12245|
589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|5706|9954|vetorma||||3|0||Icepharma hf|Pfizer Animal Health|||5706||5706|9954|
589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|2211|3857|vetorma||||1|0||Icepharma hf|Pfizer Animal Health|||2211||2211|3857|
589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|5505|9603|vetorma||||6|0||Icepharma hf|Pfizer Animal Health|||5505||5505|9603|
589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|2974|5188|vetorma||||1|0||Icepharma hf|Pfizer Animal Health|||2974||2974|5188|
589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|3089|5389|vetorma||||2|0||Icepharma hf|Pfizer Animal Health|||3089||3089|5389|
589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|DKK|2980|5198|vetorma||||2|0||Icepharma hf|Pfizer Animal Health|||2980||2980|5198|
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|||0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa||||20|0||Icepharma hf|Bayer AB|Klótrímazól||||||
590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|||0|0|B|0|ACA|0|0|0|100|XEU|1903|3582|lyfalmen|V0041|3582||98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||1903||1903|3582|
590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|||0|0|*|0|LBK|0|1|0|100|DKK|21514|29545|lyfalmen||||10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||21514||21514|29545|
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|||0|0|0|1|BOI|0|0|0|100|DKK|168951|213916|lyfsjukr||||1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||168951||168951|213916|
592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|||0|0|0|0|REM|0|0|0|100|IKR|||lyflausa||||500|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||||
592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|||0|1|0|1|AZA|0|0|0|100|SEK|794278|998701|lyfsjukr||||30|0||Vistor hf|AstraZeneca AB|Vandetaníb||794278||794278|998701|
593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|485|1642|lyfalmen|V0238|718||50|0|3,1250|Icepharma hf|Roche|Klónazepam||485||485|1642|
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|859|2154|lyfalmen|V0238|2154||150|0|9,3750|Icepharma hf|Roche|Klónazepam||859||859|2154|
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|1268|2713|lyfalmen||||100|0|25,0000|Icepharma hf|Roche|Klónazepam||1268||1268|2713|
593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín||||||
594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|||0|0|B|0|MAB|0|0|1|100|SEK|20784|28629|lyfalmen||||12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||20784||20784|28629|
594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|0|0|POF|0|0|0|100|IKR|7867|6047|lyfalmen|V0114|6047||100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||3705||3705|6047|
594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|317|553|vetorma||||10|0||Icepharma hf|Pfizer Oy Animal Health|||||317|553|
594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|2638|4602|vetorma||||100|0||Icepharma hf|Pfizer Oy Animal Health|||||2638|4602|
595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|||0|0|0|1|NOH|0|0|0|100|DKK|5600|8082|lyfsjukr||||5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||5600||5600|8082|
595991|J07BB0201|Fluarix|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|617|1823|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||617||617|1823|
596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|||0|0|0|0|REM|0|0|0|100|IKR|||lyflausa||||250|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||||
596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|60908|78322|lyfsjukr||||2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||60908|78322|
596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|18201|24725|lyfsjukr||||10|0||Vistor hf|Orion Corporation|Dexmedetómid||18201||18201|24725|
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|||0|0|0|0|PER|0|0|1|100|DKK|2194|3980|lyfalmen||||24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2194||2194|3980|
597433|L01XC1101|Yervoy|stţ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|||0|1|0|1|BMS|0|0|0|100|DKK|641401|806841|lyfsjukr||||10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||641401||641401|806841|
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||30|0||Vistor hf|McNeil Sweden AB|Ekónazól||||||
598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|||0|0|0|0|SNO|0|0|1|100|NOK|443|1585|lyfalmen||||150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||443||443|1585|
598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.09.2012||L|||0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen||||||
692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|||1|0|0|0|PCO|0|0|0|100|DKK|3863|6263|lyfalmen||||100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||3863|6263|
916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|||0|0|0|0|PCO|0|0|1|100|SEK|2764|4760|lyfalmen||||100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2764||2764|4760|
923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|||0|0|E|0|PCO|0|0|0|100|IKR|480|1636|lyfalmen||||4|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1636|
938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|||0|0|E|0|LDR|0|0|0|100|GBP|6155|9399|lyfalmen||||100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6155||6155|9399|
938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|||0|0|0|0|LDR|0|0|0|100|GBP|17682|24736|lyfalmen||||100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||17682||17682|24736|
940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|||0|0|E|0|PCO|0|0|0|100|GBP|2885|4925|lyfalmen||||1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||2885||2885|4925|
944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|||0|0|E|0|PCO|0|0|1|100|DKK|5076|7923|lyfalmen||||100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5076||5076|7923|
944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|||0|0|0|0|LDR|0|0|0|100|IKR|342|1447|lyfalmen||||12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||342||342|1447|
944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|||0|0|0|0|LDR|0|0|0|100|IKR|664|1887|lyfalmen||||12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1887|
945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|||0|0|0|0|PCO|0|0|1|100|IKR|2293|4116|lyfalmen||||10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4116|
947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|||0|0|E|0|LDR|0|0|1|100|IKR|5033|7864|lyfalmen||||100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|Kortisón||5033||5033|7864|
948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|||0|0|E|0|LDR|0|0|1|100|IKR|1990|3701|lyfalmen||||100|1|33,3300|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1990||1990|3701|
951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|||0|0|E|0|PCO|0|0|1|100|DKK|5076|7923|lyfalmen||||100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5076||5076|7923|
954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|||0|0|E|0|LDR|0|0|0|100|IKR|1870|3537|lyfalmen||||60|1||Parlogis hf|Parlogis - óskráđ lyf|Fúrósemíđ||||1870|3537|
954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|||0|0|0|0|LDR|0|0|0|100|IKR|5690|8763|lyfalmen||||150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||||5690|8763|
961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|||0|0|E|0|LDR|0|0|1|100|IKR|1960|3660|lyfalmen||||20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1960||1960|3660|
961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|||0|0|E|0|LDR|0|0|1|100|IKR|1850|3510|lyfalmen||||20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1850||1850|3510|
961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|||0|0|E|0|LDR|0|0|1|100|IKR|4320|6888|lyfalmen||||25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||4320||4320|6888|
962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|||0|0|E|0|LDR|0|0|1|100|IKR|3451|5700|lyfalmen||||100|1|266,6600|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||||3451|5700|
962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|||0|0|E|0|LDR|0|0|0|100|IKR|2360|4207|lyfalmen||||30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||2360||2360|4207|
965767|A03AA0703|Dicykloverin Syrup|mixtúra|2|mg/ml|120|ml|1|glas||A03AA07|01.08.2011||R|||0|1|E|0|LDR|0|0|0|100|IKR|8480|12579|lyfalmen||||120|1|3,0000|Parlogis hf|Parlogis - óskráđ lyf|Dícýklóverín||8480||8480|12579|
967333|N05AH0408|Quetiapin Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|||0|0|*|0|BLP|0|1|0|100|IKR|1200|2073|lyfalmen|V0284|2073||60|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||800||800|2073|
967341|N05AH0408|Quetiapin Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|||0|0|*|0|BLP|0|1|0|100|IKR|6800|7682|lyfalmen|V0285|7682||60|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||4900||4900|7682|
967359|N05AH0408|Quetiapin Bluefish|filmhtfl|200|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|||0|0|*|0|BLP|0|1|0|100|IKR|12500|15342|lyfalmen|V0286|15342||60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||10500||10500|15342|
967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|||0|0|0|0|BLP|0|1|0|100|IKR|25000|33920|lyfalmen|V0287|33920||60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||25000||25000|33920|